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The last few decades have witnessed an immense effort to develop working retinal implants 
for patients suffering from retinal degeneration diseases such as retinitis pigmentosa. However, 
it is becoming apparent that this approach is unable to restore levels of vision that will be 
sufficient to offer significant improvement in the quality of life of patients. Herein, a new type 
of retinal prosthesis that is based on genetic expression of microbial light sensitive ion channel, 
Chanelrhodopsin-2 (ChR2), and a remote light stimulation is examined. First, the dynamics of 
the ChR2 stimulation is characterized and it is shown that (1) the temporal resolution of 
ChR2-evoked spiking is limited by a continuous drop in its depolarization efficiency that is due 
to (a) frequency-independent desensitization process and (b) slow photocurrent shutting, 
which leads to a frequency-dependent post-spike depolarization and (2) the ChR2 response to 
light can be accurately reproduced by a four-state model consisting of two interconnected 
branches of open and close states. Then, a stimulation prototype is developed and its 
functionality is demonstrated in-vitro. The prototype uses a new micro-emissive matrix which 
enables generating of two-dimensional stimulation patterns with enhanced resolution 
compared to the conventional retinal implants. Finally, based on the micro-emitters matrix, a 
new technique for sub-cellular and network-level neuroscience experimentations is shown. The 
capacity to excite sub-cellular compartments is demonstrated and an example utility to fast 
map variability in dendrites conductance is shown. The outcomes of this thesis present an 
outline and a first proof-of-concept for a future photogenetic retinal prosthesis. In addition, 
they provide the emerging optogenetic technology with a detailed analysis of its temporal 
resolution and a tool to expand its spatial resolution, which can have immediate high impact 
applications in modulating the activity of sub-cellular compartments, mapping neuronal 
networks and studying synchrony and plasticity effects. 
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Preface 
The concept of using light for eliciting action potentials in neurons, also known as 
photostimulation, started during the early 1970‘s. Photostimulation in those days and for 
almost three decades thereafter was based on a direct irradiation with high power lasers or on a 
photolysis of caged-neurotransmitters with UV light. Neither of these techniques would have 
been applicable for retinal prosthesis due to fundamental safety flaws. 
A new paradigm in photostimulation started during the year 2005, a year before I started to 
work on this thesis, when Melanopsin (Opn4), Channelrhodopsin-2 (ChR2) and light-activated 
K+ channel (SPARK) were independently introduced to neuroscience. The aim of this thesis 
was to explore the possibility of utilizing these emerging technologies for retinal prosthesis 
application. 
Chapter 1 describes the clinical background and looks at in-lieu therapeutic strategies. Then it 
reviews the hitherto work in the field of retinal prosthesis and analyzes the technological 
challenges that limit the success of current approaches. 
Chapter 2 assesses the potential usefulness of each of the photostimulation techniques for 
retinal prosthesis application. The chapter concludes that at present, the microbial ChR2 has 
the highest potential to fulfill the requirements for retinal prosthesis. 
In order to realize a retinal prosthesis based on ChR2, the following objectives needs in 
principle to be fulfilled  
1) Developing genetic tools and delivery techniques to maximize the efficacy and specificity 
of ChR2 expression in the targeted retinal cells 
iv 
2) Developing a knowledge on the dynamics of the ChR2 stimulation, e.g. Input-Output 
characteristics and limitations 
3) Developing high-resolution optical hardware that can generate precise two-dimensional 
stimulation patterns on the retina 
4) Developing optoelectronic hardware to capture the physical visual information and convert 
it to series of stimulation patterns 
Since genetics is not my major expertise, I decided to leave the 1st objective to more 
competence researchers. Indeed, during the time course of this thesis extensive efforts have 
been made in this direction by for example Karl Deisseroth (1) and Botond Roska (1) labs. 
Nonetheless, I made basic proof-of-concept experiments, shown in chapter 2, together with 
Robert Maclaren (at that time at Moorfields Eye Hospital) using AAV vector that was initially 
proposed by Zhuo-Hua Pan‘s group (2). In addition, since the 4th objective is practically 
shared with the developmental ambitions of retinal implant projects, realization imaging and 
image processing hardware for a photogenetic retinal prosthesis can utilizes the so-far 
technological progress of retinal implants.  
Thus, the focus of this thesis was to build a better understanding of the dynamics of ChR2 
stimulation and to develop an optical hardware that makes the ChR2 technology relevant to 
retinal prosthesis application.  
The study of ChR2 stimulation in neurons is described in two chapters:  
Chapter 3 explores the dynamics of ChR2 photocurrents. It characterizes the kinetic of the 
response and builds a representative model of the light-input/current-out behavior of ChR2.  
v 
Chapter4 examines how ChR2 photocurrents are translated into action potentials in neuron 
cells. It explains the underlying mechanisms that limit the temporal resolution of ChR2-evoked 
spiking and deduces preferable illumination strategies for the retinal prosthesis. 
Following the study of ChR2 stimulation, the second part of the thesis involves with the 
development of the optical hardware and a test platform for the retinal prosthesis as well as 
with the exploitation of its functionality to meet a general technological gap in neuroscience 
research. 
Chapter 5 describes the development of a lab prototype based on a matrix of individually 
addressed micro-emitters which is capable of generating precise two-dimensional excitation 
patterns on a ChR2-expressing retina. The prototype is characterized and basic proof-of-
concept experiments are shown. 
Chapter 6 presents a technique that utilizes the lab prototype described in chapter 5 for two-
dimensional sub-cellular and network level stimulation experimentations- a long lasting desire 
of the neuroscience community. The capacity to excite sub-cellular compartments is 
demonstrated and example utility to map dendrites conductivity in ChR2 expressing neurons is 
shown. 
My work on studying the ChR2 stimulation was assisted by Konstantin Nikolic who 
implemented the model we co-developed and by Matt Grubb from Kings College London 
who performed the patch clamp recording during the photostimulation experiments. The 
prototype I developed for the retinal prosthesis utilized a micro-emissive matrix that was 
fabricated by Martin Dawson‘s group in the Institute of Photonics at Strathclyde University 
and a control board that was made by Vincent Poher at that time a PhD student in Mark Neil‘s 
group at the Department of Physics.  
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Chapter One: Background  
Visual prostheses are artificial devices that aim to restore visual sensation to the blind by 
stimulation of the nerve cells that survive the disease. The concept of visual prosthesis goes far 
back to the end of 1755, four decades before the description of bioelectric stimulation by 
Galvani (4), when Le Roy (5) used electrical stimulation to induce phosphenes- perceptions of 
light without actual light stimuli, in blind people. The underlying mechanism of modern visual 
prosthesis is based on generating a complete set of these phosphenes that would potentially 
represent the visual field as a pixelized image.  
Visual prostheses can be implanted at different locations along the visual path: in the 
retina, in the optic nerve, in the lateral geniculate nucleus (LGN) and in the visual cortex, as 
can be seen in Figure ‎1.1. Retinal prostheses have distinct advantages over optic nerve and 
cortical implants with regards to access to target nerve cells. In addition, the retina covers the 
back of the eye, and the mapping of the retina to a physical location in space is known (6). On 
the other hand, the effectiveness of retinal prosthesis is limited to those diseases in which the 
retinal ganglion cells (the communication cells to the LGN and thus towards visual cortex) and 
the visual path to the brain remain healthy. 
The aim of this chapter is to establish the clinical and scientific backgrounds for the 
photogenetic retinal prosthesis. First, the anatomy of the eye which defines the requirements 
of the prosthesis is described. Then, the retinal diseases that can be potentially treated with 
retinal prostheses are discussed. Finally, the state of the art in the field of retinal prostheses is 




Figure ‎1.1 Schematic Illustration of the Visual Path and of the Eye. Light is imaged by the cornea and 
the lens on the retina where it is converted to neural signals that propagates through the optic nerve 
(crossing corpus collosum) to the lateral geniculate nucleus (LGN) that projects it to the visual cortex. 
Brain image was modified from the web. 
1.1 Anatomy and Physiology of the Eye 
The human eye is a 2.5-cm-diameter sac filled with a clear vitreous except in its anterior most 
part and is largely composed of 99% physiological saline and a 1% hylaruonic acid. A cross 
section of the eye illustrating its basic structure is shown in Figure ‎1.1. The eye is held in orbit 
primarily by the ocular muscles and a complex fluid flow mechanism maintains a constant 
 3 
3 
pressure keep the eye shape. The vitreous is invested by three coverings: sclera, choroid and 
retina. 
 
Figure ‎1.2 Schematic illustration of the Retina. The five neural cell types (photoreceptors, horizontal, 
bipolar, amacrine and ganglion) are coloured and the retinal layers are designated on the left. Schematic 
was modified from the web. 
The outer layer is the sclera- a thick stiff layer of connective tissue which is composed 
mostly of collagen that maintains the shape of the eyeball and serves as an attachment for the 
extraocular muscles. On the posterior end, the sclera is continuous with the dura mater that 
covers the optic nerve and on the anterior end it becomes the cornea, the curved circular 
transparent layer at the front of the eye which does most (approximately 2/3) of the focusing 
of the light. The middle layer is the choroid- a thin highly vascular dark brown layer that 
contains pigment cells which absorb light (hence preventing internal reflection within the eye). 
Anteriorly the choroid becomes the ciliary body and the iris, which is a diaphragm surrounding 
a central aperture, the pupil. The iris is made of two intraocular muscles that control the size of 
 4 
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the pupil and give rise to numerous thin fibres that attach to the capsule of the lens- a 9mm 
diameter crystalline biconvex structure that helps to focus the light on the retina.  
The posterior half of the eye‘s interior wall is covered by the retina- a thin (~400 m) 
film of nervous tissue that absorbs the light, converts it to neural signals, processes the 
information and transmits it outside the eye toward the brain. An illustration of the retina‘s 
cross-section is shown in Figure ‎1.2. The outer layer of the retina is the retinal pigment 
epithelium (RPE), which regulates the exchanges of nutrients and waste to the retina. Next to 
the RPE are the outer segments of the photoreceptors, which are light-sensitive cells that 
convert photons to neural signals. There are two types of photoreceptors in human retina: 
rods and cones. Rod cells are approximately 20-fold more numerous than cones and have 1000 
times higher sensitivity to light. Rods are used for scotopic vision, i.e. dim light, and in fact 
they are typically saturated during the daylight. Cones photoreceptors are highly dense in the 
fovea and their numbers fall off sharply beyond 5 degrees of eccentricity. The cones are 
subdivided into red, green, and blue cones, operate at ambient daylight levels and mediate 
color vision. The cell bodies of the photoreceptors are found in the outer nuclear layer. The 
photoreceptors signal the information to the bipolar cells via synapses in the outer plexiform 
layer. The cell bodies of the bipolar cells are located in the inner nuclear layer together. In 
response to light, the membrane potentials of the photoreceptor cells hyperpolarize which 
reduces the release of glutamate neurotransmitters to the bipolar cells. The decrease in 
glutamate release depolarizes the bipolar cells with invaginated synapses and hyperpolarizes the 
bipolar with flat synapses (the opposite responses of the two types of bipolar cells are due to 
expression of metatropic ionotropic glutamate receptors). In general, multiple rods are 
connected to a single bipolar cell (higher sensitivity) while cones have one-to-one connection 
 5 
5 
with bipolar cells (higher spatial resolution). The outer plexiform also comprises of synapses of 
the GABAergic horizontal cells that help to integrate and regulate the input of multiple 
photoreceptors. 
The bipolar cells relay the information to the retinal ganglion cells (RGCs) via synapses 
in the inner plexiform layer. The RGCs are the output cells of the retina which fire action 
potentials in a response to the input from the bipolar cells. The output of the RGCs is 
modulated by amacrine cells, which their cell bodies are located as well in the inner nuclear 
layer. Typically, the RGCs are categorized into once that project to the parvocellular or the 
magnocellular pathways of the lateral geniculate nucleus (LGN). The parvocellular RGCs are 
small, slowly conducting, receive signal from few photoreceptors, color sensitive and show 
sustained responses. In contrast, the magnocellular RGCs are large, rapidly conducting, 
brightness (but not color) sensitive and have transient response. The light response of the 
RGCs depends on their bipolar cells, thus they form distinguished On and Off channels. In 
the On channel, which consists of the depolarizing RGC-bipolar cells, the spiking increases in 
response to light, whereas in the Off channel, which consists of the hyperpolarizing RGC-
bipolar cells, the spiking decreases in response to light. The receptive fields of the both the On 
and Off cells are comprised of multiple photoreceptors and typically organized in a circular 
manner with centre and surround regions. Stimulation of these two regions separately 
produces opposite effects. For example, light on the centre photoreceptors produces 
depolarization and increase in the firing rate of a particular RGC, whereas light on the 
surrounding photoreceptors produces hyperpolarization and decrease in the firing rate of that 
cell (stimulation of both regions produces only a mild effect).  
The axons of the RGCs run across the retinal surface (nerve fibre layer) and penetrate 
it at the optic disc from which the information is transmitted outside of the eye via the optic 
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nerve, see Figure ‎1.1. The optic nerve contains fibres of axons encapsulated by myelin sheets 
that help to increase their conducting velocity and the length over which impulses can be 
conducted without severe attenuation. It synapses with neurons in the LGN of the thalamus 
see Figure ‎1.1. The LGN has layered structure where the retina is represented with high 
topographic precision. The optic nerves from both eyes are crossed in the optic chiasm of the 
LGN. The nasal fibres (~50%) of each nerve cross to the contra lateral side so that the right 
visual fields from both eyes are processed in the left side and vice versa.  
The majority of the neurons in the LGN send axons to the primary visual cortex, V1 
via the optic tracks. Others synapse with the pretectum in the midbrain which controls pupil 
and accommodation reflexes or with the superior colliculus in the tectum of the midbrain. The 
pupil reflex controls the amount of light entering the eye be altering the size of the pupil. This 
ranges between 1.5 and 8 mm in diameter, being maximal in complete darkness. The 
accommodation reflex is used to focus close objects by changing the form and therefore the 
focal length of the lens. Other LGN neurons synapse with the hypothalamus to entrain the 
circadian rhythms.   
The visual cortex occupies about 60% of the human cortex. The primary visual cortex 
(V1) is located in the striate cortex (Brodmann‘s area 17) on the medial surface of the tip of the 
occipital lobe and has a 6 layers structure (layer number 4 is where the LGN axons synapse). 
V1 has multiple two-dimensional columnar areas (approximately 1 mm2) in which one 
direction contains domains receiving alternating projections from the two eye, and the 
perpendicular direction contains cell populations with a gradual shift in preferred  stimulus 
orientation. The areas are hierarchy organized and each area performs a partial-processing task 
in analyzing of the scene. From the V1 information is sent to the extrastriate visual cortex (a 
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global name for all cortical areas involved in vision other than V1) and includes much of the 
occipital cortex and parts of the parietal and temporal cortex.  
1.2 Clinical Background for Retinal Prostheses 
From a strictly numerical point of view, blindness is the most common disability (7). In the 
industrialized countries retinal diseases account for the majority of patients who are blind. 
Since retinal prosthesis requires the presence of viable retinal ganglion cells, treatable diseases 
are limited primarily to those that damage the outer retina. Two of the most common outer 
retinal degenerative diseases are age-related macular degeneration (AMD) and Retinitis 
Pigmentosa (RP) (8). Neither AMD nor RP are treatable today in a sense of being able to 
restore lost vision. The notion of using prosthesis to treat these diseases is based upon the 
more recent observations that neurons in the inner retina including RGCs are relatively spared 
in these diseases (9-13).  
People with AMD lose their central vision and are disabled to perform essential 
activities such as reading or driving a car. In early stage of AMD yellow lesions, termed drusen 
are formed at the RPE basement membrane and RPE pigmentary changes. The disease 
advances in one two form: dry and wet AMD. The dry AMD, also known as nonneovascular 
AMD (NNVAMD), involves the geographic atrophy in the central RPE cells that causes the 
death of the macular photoreceptors and as a result vision loss. Wet AMD (10-20% of AMD 
cases), also known as neovascular AMD (NVAMD) involves abnormal growth of fibrovascular 
tissue from the choroid, named choroidal neovascularisation or CNV, through Bruch's 
membrane into the RPE (Type 1 CNV) and/or the sub-photoreceptors (Type 2 CNV) spaces. 
Bleeding and exudation from these vessels damage the outer retina, leading to photoreceptor 
degeneration and vision loss.  
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AMD is more prevalent, in the United States for example there are approximately 
700,000 new AMD patients each year, 10% of whom will become legally blind (14, 15). 
Nevertheless, RP is considered almost universally to be the primary target for use of retinal 
prosthesis since: (a) AMD affects the central vision and hence patients typically maintain a 
functional peripheral vision that allows them to have some degree of independency and (b) 
restoration of central vision is much more demanding since the RGCs are stacked upon one 
another (in the parafovea). Thus, this section will focus on retinitis pigmentosa.  
1.2.1 RP Pathology 
Retinitis pigmentosa (RP) is a collective name for a number of genetic defects that result in 
photoreceptor inactivation loss (16, 17). RP is the major cause of inherited blindness with 
overall incidence of 1 in 4000 live births, though it can be higher in specific ethnic groups (e.g. 
Navaho Indians have a rate of 1:1800 live births) (8, 17). RP is characterized by the progressive 
loss of rods and then cones, resulting in a typical patterned symptoms of Nyctalopia (night 
blindness), peripheral vision loss (tunnel vision) and in the later stage loss of the central vision 
and thus blindness (18). The degenerated areas are visible in most cases due to depigmentation 
of the RPE and the appearance of pigment granules accumulates in perivascular clusters, 
known as ―bone-spicule‖(8). The different stages of RP and their symptoms are illustrated in 




Figure ‎1.3 Progression of Retinitis Pigmentosa (RP). Top: Photographs of patient‘s retina with early 
(left), mid (middle) and late (right) stages of RP.  The pigmentation pattern (highlighted with an arrow) 
progresses from the peripheral retina in the mid stage to the entire retina in the later stage. Photographs 
adopted from Hamel et al. (18). Bottom: Corresponding effect on vision:  Nyctalopia but good day 
vision (left), peripheral vision loss, i.e. tunnel vision (middle) and in the later stage loss of the central 
vision and thus blindness (right). 
1.2.2 RP Aetiology  
The inactivation and death of rods in RP can be due to a host of varied mutations, with 
associated defects in the biochemical pathways.  Over 100 genetic defects which involve all 
modes of inheritance have been identified as causative agents of RP (19). In the UK for 
example, the X-linked recessive form represents up to 25% of the RP, while in the US X-
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linked RP accounts for only 6-9% (20, 21). The different forms of mutations can be grouped 
by their mechanism type. Below an example of two known RP mechanisms is given. 
In normally functioning rod cells, light stimulates the activation of rhodopsin which in 
turn induces the G protein transduction to activate cGMP-phosphodiesterase (22). The 
reduction of cGMP results in the closing of cGMP-gated sodium channels and leads to 
hyperpolarization of the rods. The expression of cGMP-phosphodiesterase can be affected by 
a null mutation called PDE6. In this case, cGMP-phosphodiesterase is absent which leads to a 
high level of cGMP and as a result to a persistent opening of the cGMP-channels and hence to 
the blocking of light induced hyperpolarization (23). This process accounts for Nyctalopia. It 
was hypothesised that the fact that the sodium potassium ATPase pumps have to compensate 
for the failed ion channels results in a metabolic overload that can lead eventually to the death 
of the rod cells (24). 
Another common mechanism of rods death is via a single pair mutation in the 
rhodopsin gene called P23H (25). P23H rhodopsins do not fold in a normal fashion and hence 
do not function properly. Instead, they aggregate to form aggresomes inside the cell which was 
hypothesized to be toxic and to lead eventually to the cell death (25).  
A separate area of research is attempting to find the casual links between rod cell death 
and the subsequent death of cone cells. An early theory suggested that cones display delayed 
degradation simply because they are less metabolically or biochemically active. However, more 
recently Kedzierski et al. (26) suggested that rod apoptosis is a causative factor for cone death. 
This can be for example due to a release of toxic molecules (27) or by withdrawal of survival 




Early impairments in visual acuity of RP patients are typically corrected with glasses or with 
night vision goggles (NVGs) (29). In addition, it has been suggested that relaxations and a diet 
rich with vitamin A can slow the progression of the disease (30).  
1.2.4 In-lieu Rehabilitation Strategies for Retinal Prosthesis 
Several future rehabilitation strategies for RP patients are being researched today. This 
includes: sensory substitution, retinal transplantation, molecular genetics and non-retinal visual 
prostheses. This section briefly reviews these in-lieu approaches. 
1.2.4.1 Sensory Substitution  
In a sensory substitution approach, alternative sensory modality is used to provide the 
otherwise visual information about the environment. In 2004 Rach-y-Rita (31) reported that 
using a device that provides tactile inputs to the skin or tongue, subjects were able to 
experience a sense of objects in space. A more recent device that uses ultrasound scanning to 
create an auditory landscape was presented by Amedi et al. (32). The technology, known as 
vOICe vision, converts images taken by a camera to a three-dimensional sound-space consists 
of loudness, frequency and inter-ear disparity. The authors reported that some completely 
blind subjects were able to navigate through a maze. 
1.2.4.2 Gene Therapy 
Gene therapy involves the delivery of a corrective genetic material to cells possessing a unique 
genetic defect. Typically adeno-associated virus (AAV) is used as vehicle to transfer genetic 
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material to retinal pigment epithelium and photoreceptor cells (33). In 2001 Bennet et al. (34) 
demonstrated that dogs suffer from RPE 65 gene mutation were able within three months to 
navigate in a dimly lit room. Since then there have been substantial evidence that gene 
replacement or gene silencing therapies can treat certain types of RP in animal models (35, 36) 
and gene therapy trials for RP are underway in the United States and UK (37). 
Nevertheless, gene therapy cannot effectively restore a degenerated retina to its normal 
state. It can only potentially halt the progression of a disease, and preserve those 
photoreceptors that have not yet been destroyed. Moreover, the diversity in the genetic defects 
involved in RP and the difficulties in diagnosing the disease early enough for the treatment to 
be effective limit the potential impact of this treatment strategy for RP patients. 
1.2.4.3 Transplantation  
Retinal transplantation efforts have started about two decades ago (38). Human 
transplantations have been performed using RPE neurons, partial thickness sections of retina 
and stem cells. In one of the proof-of-concept experiments in 2002, Sauve et al. (39) 
demonstrated that RP rats transplanted with retinal neurons were capable to restore some 
pupillary reflexes. Most of the studies since then reported that retinal transplants have been 
well tolerated and can lead to some improvement in visual acuity (40-43). 
The transplantation approach, in contrary to gene therapy, can potentially restore some lost 
vision. Nevertheless, the success of a neural transplantation depends upon rewiring of new 
neuronal connection between the degenerated retina and the transplant, which is very 
challenging to control, especially in degenerated retinas. 
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1.2.4.4 Occipital Cortex Prosthesis 
The work on visual cortex implants to restore vision started in the early 1960‘s and 1970‘s (44-
47).  The most notable modern attempt was done in 1996 by Schmidt, Bak and Hambrecht 
(48) who implanted 38 electrodes into the cortex of RP patient. They reported that they could 
successfully induce phosphenes with acceptable thresholds and good two-point resolution.  
Nevertheless, cortical implants suffer from significant biocompatibility problems which 
hinder their acceptance (49). Moreover, the convoluted topography of the visual cortex and 
the need for substantial surgical procedure impose challenges on the widespread use of 
occipital prostheses. It seems that current efforts are focused to show efficacy in animal studies 
in order to gain approval again for human trials. For example, Bradley et al. (50) implanted 
recently 152 intracortical microelectrodes into the V1 of a male macaque and showed that the 
monkey was capable of directing its eyes towards the phosphenes locations.  
1.2.4.5 Optic Nerve Prosthesis 
Optic nerves prosthesis allows the opportunity to target the output of entire retina within a 
small area. This has been done by placing an electrode-bearing circumferential cuff around the 
optic nerve. Using a cuff approach, a few electrodes can be used to generate a large number of 
stimulation field shapes in the nerve, which can in theory activate different parts of the nerve 
and thus localized phosphenes (51). The potential of optic nerve prosthesis was first 
demonstrated by Veraart and Delbeke in 1998 (52), when they chronically implanted a cuff 
electrode around the optic nerve of a blind patient with intact retinal ganglion cells. The study 
showed that the pre-chiasmatic optic nerve maintains some retinoptic arrangement. However, 
the size of the phosphenes obtained by the optic nerve stimulation was considerably small. In a 
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later study (53),  Veraart and Delbeke reported that with an improved optic nerve implant, 
patients could recognize some spatial patterns and were able to grasp objects, although patients 
needed a long time (about a minute) to perform each task.  
All together these studies demonstrated some functionality of optic nerve prosthesis. 
However, the fact that the optic nerve is covered by all three meningeal sheets results in high 
stimulation thresholds which limit the capacity to localize the stimulation. Alternately, cuff 
electrodes can be placed in the intracranial region of the optic nerve, where the dura and 
arachnoid maters are not present, however this requires a substantial operation.  
1.2.4.6 LGN Prosthesis 
The notion of LGN prosthesis is relatively new. Stimulating the LGN has the advantage that 
the cells are separated out by their location within the visual field and by their physiological 
type (54). However, placement of a large number of electrodes on the LGN will require a large 
craniotomy (surgical operation in which part of the skull called bone flap is removed) (7). 
Nevertheless, the development of new surgical techniques for deep brain stimulators and the 
encouraging acceptance of these devices might lead to a first LGN implant in the near future.   
1.3 Requirements from Retinal Prostheses 
Retinal prostheses need to image the physical environment of the patient, transduce the 
information into an artificial stimulus and deliver the artificial stimulus to evoke a visual 
perception. As a system, the prosthesis must be safe and effective, acceptable by the patient, 
and functional inside the human body for many years. Moreover, due to the substantial risk 
that is involved with a visual prosthesis treatment, these devices must prove a clear benefit for 
the patients before they will be accepted by regulatory bodies and used by the blind. In other 
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words, the prosthesis must be able to restore sufficient vision that will lead to a substantial 
improvement in the quality of life of patients. 
 
 
Figure ‎1.4 Simulation of Phosphenized Vision. The word RETINA is reproduced by a grid of 4x4, 
10x10 and 20x20 white dots. 
It has been suggested that restoration of reading and mobility are likely to confer the 
most benefit to low vision sufferers in their daily lives(55). Several studies tried to assess the 
minimum resolution that will be required in order to achieve these goals. In principle, 
phosphenized image can be simulated by sampling an underlying image at the locations of the 
prospective phosphenes and using the sampled intensities to modulate the size or intensity of a 
bright spot that occupies some location in the subject‘s visual field. A simple example of 
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phosphenized vision is shown in Figure ‎1.4. The figure shows black-&-white images of a 6-
letter word (―RETINA‖) reproduced by 4x4, 10x10 or 20x20 phosphenized images.  
The degree of visual restoration is affected by the number, size and density of the 
phosphenes. Cha et al. (56-58) quantified, using simulation studies, the reading and pattern 
recognition efficiency with phosphenes. They used a small video camera and a monitor that 
was worn by normally sighted human subjects. They concluded that a visual sense composed 
of about 625 discrete phosphenes within a visual field of 1.7° providing 20/30 visual acuity can 
be sufficient for basic pattern recognition and reading tasks. 
In more recent studies Sommerhalder et al.(55, 59, 60) reported that the most 
important factors for reading are the number of phosphenes and their spacing, while for 
example contrast has little effect. In a first set of experiments (55), in which the setup was 
equivalent to observing a paper-based printout of phosphenized images through a restricted 
window stabilized on the retina, the subjects were asked to read isolated 4-letter words 
presented at various degrees of pixelization. The results of the study implied that, after 
substantial training, a minimum of 300 pixels is required in order to read a 4-letter word with 
the central vision. In a second set of simulation experiments (60), Sommerhalder and 
coworkers tested a full-page reading efficiency. They reported that about 600 stimulation 
contacts, distributed on an implant surface of 3 × 2 mm2 was the minimum that allowed still 
useful reading performance. Using this resolution, trained subjects were able to read 20 
words/min, with more than 80% accuracy. 
The efficiency of visual prosthesis in eye-hand coordination was simulated by Dagnelie 
et al. (61). The subjects had a real-time head-mounted display in a free-viewing or in a gaze-
locked (using pupil tracker) condition. The display consisted of 6x10 circular Gaussian dots, 
equivalent to 20/2400 visual acuity. The subjects task was to count 1 to 16 white fields 
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randomly distributed across an otherwise black checkerboard (counting task) or to place a 
black checker on each of the white fields (placing task). The authors reported that in both free-
view and gazed-locked conditions a good eye-hand coordination can be achieved even with the 
low resolution of 60 phosphenes. In the case of gazed-locked condition, performance level 
improved significantly when subjects used head movements to maximize the information 
gained. 
The simulation studies summarized above demonstrated that tasks like reading and 
object grasping can be performed with phosphenized vision. The number of phosphenses and 
their spacing appeared to be the most important factors to determine the level of 
performances. Training and head movement were shown to have significant contributions for 
the level of performances. The minimum number of phosphenes that are required depends 
upon the particular task. Nevertheless, it is currently accepted (6) that a minimum of 625 to 
1000 independent pixels will be required to ensure sufficient improvements in the level of 
reading and mobility in future patients.  
1.4 Review of Retinal Prosthesis To-Date 
1.4.1 Early Attempts 
The notion for retinal prosthesis emerged from the pioneering work on visual cortex implants 
during the late 1960‘s. In 1967, Brindley (45) followed the earlier work of Button and Puttnam 
(44), and implanted 80 surface electrodes in the subdural area over the occipital pole of the 
cortex of a blind patient. A few years later in 1974, Brindley repeated the experiment using for 
the first time a microelectrode configuration (46). The Brindley surface electrode stimulator 
was impractical due to the large electrode-neuron distance which resulted in a high threshold 
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and a poor resolution. Nevertheless, his studies together with those performed later by 
Dobelle (47), demonstrated for the first time that (a) multiple phosphenes can be 
simultaneously generated following stimulation of multiple electrodes and (b) phosphenes 
perceptual alignment was roughly correlated with the spatial location of the electrodes.  
The first intraocular implant was tested by Dawson and Radtke in 1977 (62) (it should 
be noted that intraocular implants to treat blind were suggested already two decades earlier by 
Tassicker (63, 64)). Dawson and Radtke used a new vitreoretinal surgery technique,  developed 
by Machemer (65), to place an array of microelectrodes in a cat eye. Their implant gave the 
first proof of concept that an intraocular implant can be stably positioned, tolerated by the 
body and induce visual responses in the cortex. 
Other studies during the 1960‘s and 1970‘s tried to characterize the responses evoked 
by electrical stimulations of animal retinas. One distinguished example is the transretinal 
stimulation study of Crapper and Noell (66), who measured thresholds, compared the efficacy 
of cathodal and anodal stimulation, and attempted to determine the best site for stimulation. 
Their work was followed by Molotchnikoff (67), who studied the responses of the On and Off 
ganglion cells. 
Despite Dawson and Radtke encouraging results in the retina and the background 
work of Brindley and Dobelle with occipital implants, the visual prosthesis field almost 
disappeared from the literature during the 1980‘s. The breakthrough came in the early 1990‘s 
due to three reasons: a) post-modern findings about possible survival of RGCs in RP and 
AMD patients (9, 68) b) technological advances in microelectronics and packaging techniques 
and c) emerging success of the cochlear implants to restore hearing in deaf patients. These 
trends generated the creation of new concepts of retinal implants (69-73) that since then 
became the main avenue in the field of visual prosthesis. 
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1.4.2 Conceptual Designs of Retinal Prosthesis 
There are currently more than 20 different groups worldwide researching the restoration of 
vision by electrical stimulation of the retina (74). The work can be categorised into epiretinal or 
subretinal approaches.  
1.4.2.1 Epiretinal  
In epiretinal prostheses, the stimulating electrodes are placed on the retina surface and target 
the RGCs cells. Apart of from imaging device, epiretinal prostheses also require an image 
processor to compensate for the fact that the stimulation bypasses the processing layers of the 
retina. The image processor is typically implemented extraorbitally and the stimulating 
information is transmitted to the implant via wired or wireless connections. The implanted 
module then converts the information into patterns of electrical currents that are directed 
toward the RGCs. The implanted module is typically powered by induction coils, penetrating 
wires, or lasers. The conceptual design of epiretinal prostheses can vary in terms of how much 
electronic circuitry is contained in an intraocular device versus extraocular elements. A 
summary of the different approaches is shown in Figure ‎1.5A. 
The advantages of the epiretinal approach are: (a) this site is accessible (b) does not rely 
on a functional circuitry of the outer retinal neurons (e.g. bipolar cells) and (c) the vitreous acts 
as a sink for heat dissipation from the microelectronic device. The disadvantages of the 




Figure ‎1.5 Different Designs of Retinal Implants. (A) Epiretinal devices. (1) First generation with 
intraocular receiver. (2) Extraocular receiver is connected with a cable penetrating the sclera, choroid 
and retina to the microelectrode. (3) Minimal invasive design in which receiver is placed with other 
electronics extrorbital. (B) Subretinal devices. (1) First generation with infrared receiver integrated with 
the microelectrodes. (2) Receiver is connected with a cable via posterior penetration of sclera and 
choroid. (3)  Minimal invasive design with an extraorbital placement of receiver. me: microelectrodes, 
rc: receiver. 
compensate for retina algorithms and (b) it typically has high stimulation thresholds. 
1.4.2.2 Subretinal 
In subretinal prostheses, the stimulating electrodes are placed between the bipolar cell layer 
and RPE and target primarily the bipolar cells. In one approach, the implanted electrodes will 
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have microphotodiode (solar cells) array that essentially replicates the functionality of the 
photoreceptors. The positioning of the implant is performed via an intraocular approach 
through an incision in the retina (ab interno) or an incision of the sclera, choriocapillaris and 
RPE (ab externo). Like the epiretinal prostheses, the subretinal devices can vary in their 
conceptual design. Figure ‎1.5B summarizes the different approaches. Recently, sub-choroidal 
(behind the choroid) and sub-scleral (behind the sclear) on the outer surface of the eye designs 
were proposed as well (75). 
The advantages of subretinal approach include: (a) targeting the bipolar cells allows 
significant retinal processing and lower stimulation thresholds (b) it uses the retina to hold the 
electrodes in close proximity to the cells. The disadvantages of the subretinal approach include: 
(a) limited subretinal space to place electronics (b) higher risk for thermal injury to the neurons 
which consequently limits the thermal budget of the implant (c) if a cable across the sclera is 
used to interface/power the implant, it may results in subretinal haemorrhage (bleeding) and a 
total or a local retinal detachment.  
1.4.3 First Human Tests  
The first retinal prosthesis tests in human were done acutely, i.e. were left for less than three 
hours and patients stayed in the operating room. The first study was performed in 1998 by 
Humayun et al. (76) who reported that blind patients were able to localize the spatial position 
of the phosphenes and detect movement. In a subsequent study in 1999 (77), Humayun et al. 
reported that a patterned electrical stimulation with a multielectrode array allowed patients to 
perceive shapes. However, in both cases induction of phosphenes required large currents- on 
average 600μA for 1ms (later the high threshold was partially attributed to the fact that the 
implant was hand-held).  
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Another set of early acute tests were done in 2003 by Rizzo et al. (78) who improved 
the positioning of the implant by using a gold weight. Rizzo et al. reported consistent 
stimulation thresholds of 300–500μA for 1ms. The authors also reported on a potential 
problem since the phosphenes location did not always match the pattern of stimulation. 
1.4.4 Clinical Trials  
To-date four companies have performed chronic implants of retinal prostheses in humans. 
This section reviews the outcomes of these trials. Nevertheless, it should be noted that this 
review provides only partial picture since the data that is published by these companies is often 
limited and noticeably was never confirmed by independent researches. 
Optibionics Inc. (Wheaton, IL), founded in 1990 (but since gone out of business) 
implanted a 2mm diameter passive multiphotodiode subretinal array, i.e. it was powered solely 
by the incident light, in the eyes of six RP patients. Patients reported some phosphenes 
perception, however it was not predictable since the stimulus from the photodiode was too 
weak. Nonetheless, all patients reported some improvements in visual function which was later 
attributed to a ―trophic‖ effect that might have been related to the production of protective 
growth factor produced by the RPE that slowed the progression of the disease (79, 80). 
Second Sight Medical Products Inc. (California) founded in 1998, conducted 
chronic testing of a 16-electrode epiretinal device (Argus 16) in six RP patients. The 
developmental work was leveraging on cochlear implant technology from affiliated company. 
The electronic elements were implanted behind the ear and connected to the implant via a 
cable that penetrates the eye at the pars plana (7, 81). The company reported that the patients 
were able to detect moving bars and distinguish common household objects (82). Currently, 
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Second Sight is conducting multinational clinical trial with a second generation device which 
consists of 60 electrodes (83).  
Intelligent Medical Implants (IMI) AG (Zug, Switzerland) founded in 2002 and 
emerged from research work led by Eckmiller (72) in Bon, Germany. The company has an 
ongoing chronical testing since 2005. The unique feature of the system is an ‗adaptive retina 
encoder‘ that was developed to assist with the adjustment of stimulation parameters (74). The 
company initially used 19-electrode epiretinal device that was implanted through the pars 
plana. Current generation includes 49 electrodes.  
Data regarding the outcomes of their clinical trials is not available. However, in their earlier 
acute test with 20 RP patients, it was reported that the patients were able to recognize basic 
patterns such as line and spots and detect motion (84). Most of the patients reported the 
phosphenes to have the brightness of a candle light or a lamp bulb and were predominantly 
seen white, yellow or blue (7). 
Retina Implant AG (Tubingen, Germany) founded in 2003 and emerged from the 
research work led by Zrenner (73). In 2006, a hybrid device, consisting of 1500 
microphotodiode array (MPDA) and 16 microelectrodes, was implanted into the subretinal 
space of six patients for 30 days (74). In contrary to the early version of Optibionics, the 
stimulus of the MPDA can be amplified by the hard-wired electrodes that were powered from 
external source. The surgical team developed as well a new trans-choroidal technique to place 
the implant in the subretinal space. Two of the patients reported phosphenes when large areas 
of the MPDA were illuminated and four patients reported some degree of pattern recognition 
via the 16-electrode stimuli (7).  
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1.4.5 Technological Challenges 
This section examines the technological challenges that limit the scaling up of the resolution in 
retinal implants. In principle, scaling up the number of independent stimulation points 
requires:  
1) Reduction in electrode diameter 
2) Increase in overall device area 
3) Increase in number of channels 
Electrode size 
The electrodes that have been used to-date had diameters of 50–500μm and hence stimulate 
groups of cells nonspecifically (6). Thus, reduction of electrodes diasmeter has been an 
important goal for retinal prosthesis engineers since it will also enable them to address the 
ganglion cells more individually (which is important since ganglion cell classes can have 
specific function). The advantage of small electrode size is illustrated in Figure ‎1.6. 
The minimum size of the electrode is however limited by current density safety 
considerations. For a given threshold current, small electrodes result in higher charge densities 
which if exceeded by a certain value can induce evolution of O2 and H2, dissolution of the 
electrode and local pH shifts. The safety limit for Platinum, the standard electrode in 
neurostimulation (6), is 0.1-0.3 mC/cm2 (85). The charge densities as a function of the 
electrode diameter was calculated for the currents thresholds of 600µA for 1ms (76), 300–




Figure ‎1.6 Illustration of Electrode-Retina Interface. Two microelectrodes generate electric fields (curve 
lines) that depolarize some retinal cells (highlighted in red). The microelectrode on the left has smaller 
diameter (d) and smaller distance to the cell (h) and hence requires less electric field which enables more 
confined stimulus. RGCs: retinal ganglion cells, BPCs: bipolar cells. 
The following equation was used: 𝑐ℎ𝑎𝑟𝑔𝑒 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 = 𝐼𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑 · 𝑡𝑝𝑢𝑙𝑠𝑒 𝐴𝑟𝑒𝑎𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒 . The 
results indicate that electrodes must have diameters larger than 500m or 150m in case of 
current thresholds similar to (76, 86) or (87), respectively.  
Another problem that is associated with reducing the electrode size is the fact that the 
smaller electrode the larger electrode-retina impedance (due to reduction of the electrode area) 
which requires higher voltage (Ohm‘s law V=IR) in order to achieve the same current 
thresholds. However, high voltages are not desirable since (a) it will probably entail the use of 
nonstandard CMOS circuits (standard CMOS circuits operates up to ±5V) and (b) it will 
produce more heat. The European standards require that the surface of the implant not exceed 




Figure ‎1.7 Threshold and Charge Density in Retinal Implants. (A) Calculated charge density vs. 
electrode for perception thresholds: black: 600µA for 1ms (76), red: 500µA for 1ms (86), blue: 28 µA 
for 1ms (87). Green area: safe densities for a Pt electrode. (B) Threshold current as a function of the 
electrode-RGCs distance. 
Overall Implant Size 
The overall size of the device is limited by biocompatibility issues. The retina has a spherical 
structure with non consistent curvatures. Hence, large implants can be harder to align, 
especially when even a small discrepancy of 200μm can lead to a large increase in threshold, as 
is seen in the simulation shown in Figure ‎1.7B- the relation was adopted from Ahuja et al. (89). 
Moreover, a larger implant can introduce a mechanical pressure that will damage the retina 
(90). It was noted recently that the maximum size of an implant should not be more than 
4x4mm2 (6). 
Number of Channels  
Increasing the number of channels will scale the power consumption of the device and the 
heat that it dissipates to the tissue. Moreover, there is a good chance that the eye will not 
tolerate passing a 1000-wire cable through a hole in its sclera (6). 
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1.5 Summary & Conclusions  
There is a need for rehabilitation solutions for patients suffering from degenerated retinal 
diseases such as retinitis pigmentosa. During the last decade there have been immense efforts 
worldwide to develop a retinal implant device that can restore visual sensation in a similar way 
as cochlear implants restore hearing.  
To date the collective outcome of these efforts has demonstrated that using implanted 
retinal prosthesis: (a) phosphenes can be repeatedly stimulated in blind patients (b) modulation 
of the stimulating parameters could generate multiple images that are similar to the pattern of 
the electrical stimulation. Patients that were implanted with retinal prosthesis were capable to 
detect large moving objects and identify large letters by scanning their heads.  
Nevertheless, a useful retinal prosthesis that offers substantial improvement in the 
reading and the navigating performances of patients requires a minimum of 625-1000 
independent stimulation points. However, after more than two decades of research, the 
present state-of-the-art retinal implant only succeeds in providing 60-electrode resolution and 
has fundamental limitations in improving the spatial quality of perception to a level that will 




Chapter Two: Principles of  Photogenetic Retinal 
Prosthesis 
2.1 Introduction 
In the previous chapter the need for a new type of retinal prosthesis was established. It was 
shown that there is a pressing need for effective solutions for patients suffering from 
degenerated retinal diseases. It was also shown that the potential benefit of current efforts 
toward electrical retinal implants is uncertain. In this chapter, a concept of a new type of retinal 
prosthesis is described. The prosthesis is based on an emerging technology that uses light 
instead of electricity to stimulate neuronal activity. The target retinal cells are rendered light 
sensitive and their depolarization state is controlled remotely via a remote light source. First, 
the different photostimulation strategies are reviewed and their potential applicability for 
retinal prosthesis is assessed. It is argued that at present photosensitization by ectopic (i.e. a 
non native) expression of light sensitive ion channels such as Channelrhodopsin-2 (ChR2) has 
the highest potential to succeed in retinal prosthesis applications. Then, a design for a retinal 
prosthesis based on ChR2 is described and initial proof-of-concept experiments of ectopic 
expression of ChR2 in retinal cells are shown. 
2.2 Review of Photostimulation Technology 
The early attempts to use light to generate action potentials in ―blind‖ neurons emerged from 
the shortcomings of the traditional electrical stimulation technology to provide: good spatial 
resolution, cell type selectivity and flexible stimulation site. These attempts made possible due 
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to advert in laser technology and biochemistry. This section reviews the different 
photostimulation strategies.  
Different unite are used in the literature for light. This work uses primarily irradiance I 
in (mW/mm2). For convenient some useful conversions are derived. The energy of a photon 
in (eV) with a wavelength  is given by the equation below  








 𝑛𝑚  
    ‎2.1 
Since 1eV=1.6·10-16mJ the photon energy in (mJ) is given by  
𝐸𝑝ℎ𝑜𝑡𝑜𝑛 (𝑚𝐽) =
1242
 𝑛𝑚  
∙ 1.6 · 10−16      ‎2.2 
Therefore the conversion between photon flux F, which is typically given in (photons·s-1·cm-2), 
to irradiance I in (mW/mm2) can be described by the following equations  
𝐼(𝑚𝑊/𝑚𝑚2) = 𝐹(𝑝ℎ𝑜𝑡𝑜𝑛𝑠 ∙ 𝑠−1 ∙ 𝑐𝑚−2) ∙  
1242
 𝑛𝑚  
∙ 1.6 · 10−18  ‎2.3 
And hence,  
 𝐹(𝑝ℎ𝑜𝑡𝑜𝑛𝑠 ∙ 𝑠−1 ∙ 𝑐𝑚−2) =
𝐼(𝑚𝑊/𝑚𝑚 2)
1242
 𝑛𝑚  
∙1.6·10−18
     ‎2.4 
The conversion between energy density E, which is typically given in (J·cm-2) to irradiance I in 




      ‎2.5 
And hence,  
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𝐸(𝑗 ∙ 𝑐𝑚−2) =
𝐼(𝑚𝑊 )·𝑡𝑝𝑢𝑙𝑠𝑒 (𝑚𝑠)
104
     ‎2.6 
2.2.1 Direct Lasing  
The first successful demonstration of evoking action potentials with light was reported in 1971 
by Fork (91). Fork showed that action potentials can be generated in Aplysia ganglia by 
focusing a high power blue (488nm) laser light. Fork‘s beam had a diameter of 10m and optic 
power of 5mW (corresponding to irradiance of ~15W/mm2). This approach is illustrated in 
Figure ‎2.1A. A decade later in 1983, Farber and Grinvald (92) used Fork‘s approach in 
conjunction with fluorescent staining in order to increase the local brightness on the cell 
membrane. However, this approach was found later to be toxic for the cells. Allegre et al. (93) 
tried to improve the technique by using a UV light. In 1994, they reported a successful 
stimulation of the sciatic nerve fibre bundle using excimer laser. The authors reported that 
with a single 40ns pulse of ~1 J/cm2 (corresponding to irradiance of 250kW/mm2) they could 
induce responses similar to that obtained with electrical stimulation. 
Following similar strategy, in 2002, Hirase et al. (94) used high intensity mode-locked 
infrared femtosecond laser (typically used for two-photon absorption) to induce action 
potentials firing in pyramidal neurons. The authors reported that the probability of generating 
action potentials depended on the laser radiant. Later, in 2005, Wells et al. (95, 96) performed 
more detailed studies on the efficiency of infrared stimulation. They used tuneable free-
electron laser to test various wavelengths. They concluded that stimulation without visible 





Figure ‎2.1 Different Photostimulation Strategies. (A) Direct lasing (B) Photolysis of caged-
neurotransmitter. (C) Light-activated glutamate receptor. (D) light-activated K+ channel blocker. (E) 
Melanopsin (indirect light activation of ion channel). (F) Channelrhodopsin-2 (direct light activation 
of ion channel). 
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Recently, in 2008, Reece et al. (97) reported that they could inhibit neural activities using the 
same illumination strategy. They illuminated C1 neurons of Helix apersa snails with a green 
(532nm) laser. The authors reported that the laser evoked inhibition of the C1 neurons and 
suggested that it might have been a result of a specific action on Cl− ion channels. 
Moreover, direct laser stimulation was recently suggested for cochlear prostheses (98-
100). The notion for laser-based cochlear prostheses came from the original demonstration of 
Izzo et al. (98) in 2006, who showed that the auditory nerve can be successfully stimulated with 
infrared lasers (2.12m). Izzo and co-workers used 250s pulse with minimum 0.02 J/cm2 
energy density (corresponding to irradiance of 800mW/mm2) to evoke compound action 
potentials in normal hearing animals and in deafened animals, which lack the outer and inner 
hair cells.  
The exact mechanism by which focused light can directly induce polarization change in 
neuron cells is still unknown. In principle, light interacts with the neurons through a process of 
absorption and scattering. It is possible light from pulsed laser induces thermoelastic pressure 
waves that may either activate various ion channels sensitive to stretch or simply creates 
temporal micropores in the cell membrane (94). Alternatively, the light energy can be 
transform to heath and cause local temperature changes. In fact at mid-infrared wavelengths, 
light can be absorbed by the water which will then release it as heat (peak absorption of water 
is 2.8m). The rise in temperature may lead to (a) local demolitions of the membrane and 
formation of temporal micropores (b) activations of heat sensitive membrane channels or (c) 
changes in membrane permeability to Na+ and K+  (101).  
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2.2.2 Photolysis of Caged-Neurotransmitters 
With the development of new biochemical techniques, it became possible during the late 
1970‘s to render neurotransmitter biologically inert by attaching a photo-removable blocking 
molecule. Scientists then started to use this technique to photostimulate neurons. The principle 
idea was to use a focused light to photolyse the bond between the neurotransmitter and the 
blocking compound and consequently boost its local concentration, which would then activate 
the cellular receptors, as can be seen in Figure ‎2.1B. The technique was first demonstrated by 
Kaplan et al. in 1978 (102). The authors covalently attached to ATP molecule a 2-nitrobenzyl 
(NB), which blocks its stimulation capacity. Then they used focused UV (<340nm) laser to 
locally detach the ATP from the NB and activate enzymatic activity or open ion channels. 
Despite Kaplan‘s successful demonstration, the merit of this technique was not really 
recognized until in 1986 Walker et al. (103) used a NB-caging of acetylcholine receptor agonist 
(NB-carbamoylcholine) to study the kinetics of nicotinic acetylcholine receptors. Walker‘s 
demonstration was followed by syntheses of caged amino acids by Wilcox et al. (104) and later 
of caged Glutamate, by Wiebolt et al. (105). In 1993 Callaway and Katz (106) demonstrated the 
utility of caged-glutamate to study neuron circuitry. Since then caged-Glutamate has been 
widely used in neuroscience studies e.g. (107-110). It was later found that NB, the by-product 
of the photolysis, is itself bioactive (111) and hence it was replaced with more advanced 
blocking compounds such as carboxy-2-nitrobenzyl (CNB), 4,5-dimethoxy-2-nitrobenzyl 
(DMNB), 6-bromo-7-hydroxycoumarin-4ylmethyl (BHC) or 4-methoxy-7-nitroindolinyl 
(MNI). The kinetic of the un-caging process is very fast. It was reported that action potentials 
can be elicited with latency of only 3ms (109, 112). Nevertheless, the spatial resolution can be 
limited by the diffusion of the photolyzed molecules and by the ubiquitous presence of 
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glutamate receptors. Recent studied have shown that the spatial resolution can be improved 
using two-photon un-caging (107, 113, 114).  
2.2.3 Incorporation of Light-Activated Switch into Native Ion Channels  
In 2004 Kramer‘s group (115) reported the development of a light-activated K+ channel 
(SPARK), that consisted of a photoswitchable ligand attached to a genetically engineered 
Shaker K+ channel, as can be seen in Figure ‎2.1D. Kramer and coworkers synthesized a 
blocking molecule tetraethylammonium (TAE) that was held near the external mouth of a 
voltage-gated K+ channel with the help of a light sensitive azobenzene arm. The arm had a 
maleimide group which was disulfide-bonded to a cysteine residue that was engineered at the 
outside of the pore. The authors reported that they could use UV light (380nm) to retract the 
arm and thus open the pore and a green light (500nm) to extend the arm and hence cause its 
blockage. 
Two years later, Kramer and coworkers (116) reported the synthesis of a light-activated 
glutamate receptor (LiGluR). The LiGluR works by attaching a ligand such as glutamate analog 
on a photoisomerizable linker and connecting it to a cysteine on the ligand-binding domain of 
iGluR6. This approach is illustrated in Figure ‎2.1C. The authors showed (117) that in response 
to UV (380nm) illumination, the linker can change geometry and place the glutamate analog in 
the ligand-binding site and hence activating the channel. The channel can stay open for few 
minutes in dark and the geometry can be reversed by illumination of a green (500nm) light. 
They reported that the glutamate switch had a good temporal response of 1–5ms and that it 
was able to induce large (hundreds of pA) currents. 
One drawback of the SPARK and the LiGluR was the requirement for genetic re-
engineering of the typically native channels, in addition to chemical modification. For that 
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reason Kramer et al. (118) recently developed a photoswitchable affinity label (PAL) that does 
not require genetic engineering and exogenous gene expression. PAL is azobenzene with a 
protein-binding ligand in one side, in this case a quaternary ammonium group (QA), and an 
electrophilic group, which enables covalent attachment to nucleophilic amino acid side chains 
in the local ion channel, on the other side . 
2.2.4 Ectopic Expression of Natural Light Sensitive Proteins 
Using natural photosensitive proteins to render light sensitivity has the advantage that these 
proteins have been optimized by the selective process of evolution. Indeed, natural light 
sensitive proteins have an integrated place for incorporating chromophores and the light-
activation processes have typically high quantum efficiencies, i.e. high probability of activation 
per absorbed photon. Most of the photosensitive proteins in the eukaryotic cells are homolog 
of rhodopsin, the protein found in the retinal cone and rod cells. Rhodopsin and its relatives 
all have apoprotein (opsin) that is covalently linked to a photoisomerizable chromophore (such 
as 11-cis retinal). Light absorbed by the retinal can lead to its cis-trans (or trans-cis) isomerisation 
which can then trigger conformational changes in the apoprotein and consequently signalling 
of G protein-coupled cascade. Since the vertebrates phototransduction mechanism leads to 
hyperpolarization, early attempts were focused on the invertebrates phototransduction systems 
which operate with depolarization photocurrents (119) and bistable chromophores (120). 
2.2.4.1 Early Attempts  
The first experimental demonstration of this approach was given in 2002 by Zemelman et al. 
(121). Zemelman and colleagues reported that exogenous expression of three photoreceptor 
proteins from the fly Drosophila melanogaster, collectively referred to as chARGe, in hippocampal 
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neurons can be used to trigger light-evoked action potentials. The proteins Zamelman and 
coworkers used were the blue sensitive opsin NinaE (122), arrestin-2 (123) and a subunit of 
the associated G protein (123). Their activation led to the opening of internal TRP channels. 
The problem with the chARGe was the poor coupling between the stimulus timing and the 
response timing as well as between the stimulus intensity and the spike frequency. In a later 
attempt Zemelman et al. (124) tried to improve the technique by combining ectopic expression 
of a cellular receptor with a laser controlled photolysis of its agonist. The authors expressed for 
example the ionotropic purinergic receptor P2X2 (originated in the peripheral pain-sensing 
neurons) in hippocampal neurons and showed that it can be activated by a local photolysis of 
caged-ATP and lead to good spiking control. 
Since Zemelman original demonstrations several opsins that do not require co-
expression of auxiliary proteins have been suggested. These proteins are reviewed below. 
2.2.4.2 Melanopsin 
Early studies (125, 126), in 2003/2003, which investigated the 24h body clock (circadian 
clock), found that a subset of the retinal ganglion cells (1-3%) is intrinsically photosensitive. 
These cells were also found to be involved in other non-image-forming visual functions such 
as the pupillary light reflex. Subsequent studies (127-129) showed that these cells contain the 
pigment protein melanopsin (officially called Opn4). In 2005, three groups independently 
showed that heterologous (from one species to another) expression of either human or mouse 
melanopsin in Neuro2A cells (130), HEK293 cells (131) and Xenopus oocytes (132) can 
render light sensitivity in those otherwise ―blind‖ cells. These experiments revealed that 
melanopsin functions as a bistable pigment, which is probably an important adaptation to its 
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expression distant from the centre of retinal recycling in the RPE. Action spectrum 
experiments showed peak sensitivity around 480nm.  
Very little is known still about the structure of Opn4 and an image of its 
phototransduction is only beginning to emerge. The current working model (133) hypothesises 
that the light-activated melanopsin interacts with Gq/G11, which in turn activates a 
phospholipase C (PLC-b). The PLC-b generates Ins(1,4,5) P3 and diacylglycerol (DAG), which 
may ultimately modulate a TRPC6 or TRPC7 channels, possibly via a Protein kinase C (PKC). 
The principle of indirect light activation of photocurrent with melanopsin is illustrated in 
Figure ‎2.1E.  
Due to the amplification of the G protein cascade, photostimulation with Opn4 
requires low light intensities. Qiu et al. (131) reported that photocurrent could be recorded 
with a minimum photon flux of 5.6·1012(photons·s-1·cm-2), which corresponds to an irradiance 
of 20nW/mm2 (the conversion formula is deduced in Materials and Methods). Nevertheless, 
photocurrents induced by Opn4 suffer from slow onset/offset kinetics. The onset latency can 
be several hundreds of milliseconds to several seconds long and the photocurrents can persist 
for couple of seconds after termination of the light stimulus (125, 130-132, 134-137). Qiu et al. 
(131) reported that by increasing the stimulus irradiance the onset latency can be reduced to a 
minimum of 0.5s.  
Recently, Lin et al. (136) expressed melanopsin in blind rd/rd mice by intravitreally 
injecting an Adenosine Associated Virus (AAV) construct of Opn4. They reported that most 
of the transduced cells were retinal ganglion cells, although a scattering of amacrine and 
bipolar cells were also transduced. The blind mice restored the pupillary light reflex (PLR), 
showed behavioural avoidance of light in an open-field test and some ability to discriminate a 
light stimulus from a dark one in a two-choice visual discrimination alley. Nevertheless, the 
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photocurrent response had similar slow latencies and as in previous studies persisted for 
seconds after the light was turned off (136). 
2.2.4.3 Channelrhodopsin 
Channelrhodopsin (ChR) are light sensitive proteins that belong to the class of microbial-type 
rhodopsins. Their discovery emerged from the study of the photobiology of green algae during 
the early 1980‘s when Foster et al. (138) reported that the unique pigmented eye spot, which 
was studied earlier by Mast et al. (139), contains photoreceptor proteins and biochemical 
downstream elements (140) that are used by the alga to modulate the beating of its flagella (a 
tail-like structure that function for locomotion). Later analysis of the photocurrents (141, 142) 
revealed that the eye spot consists of at least two distinguished light sensitive receptors with a 
fast (<50s) response that may indicate a direct connection between the rhodopsins and ion 
channels.  
The subsequent discovery of the genetic code of the photoreceptors in Chlamydomonas 
reinhardtii alga (143-145), which were later referred to as Cop3 and Cop4, enabled to test these 
photoreceptors in heterologous expressions. In 2002, Nagel et al. (146) expressed Cop3 in 
oocytes of Xenopus laevis and reported that the photoreceptor rendered light sensitivity to the 
cells. The photocurrents had peak sensitivity around 500nm, they were passive, i.e. ~0V 
reverse potential, pH dependent (outward current was observed at high extracellular pH or low 
intracellular pH) and conducted H+ at physiological pH. Moreover, as in the alga‘s eye spot, 
the photocurrents had fast onset (<200s) and offset (=35ms) responses. Since the fast 
gating was confirmed as well in cell free experiments, the authors concluded that Cop3 must 
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be a rhodopsin with an intrinsic ion channel conductance. This property led to its new name 
channelrhodopsin-1 (ChR1). 
In the following year, Nagel et al. (147) reported the results of an equivalent study with 
Cop4. The authors showed that like ChR1, Cop4 generates passive photocurrents with pH 
dependent response (faster offset at high intracellular pH). However, in this case the peak 
sensitive was around 470nm and under continuous illumination the photocurrents inactivated 
to a smaller steady state. Cop4 had similar fast gating kinetics which led Nagel and his co-
workers to conclude that Cop4 has as well an intrinsic ion channel conductance (which 
resulted in its renaming to channelrhodopsin-2 (ChR2)). Nagel el al. made another observation 
that became a landmark in the field of photostimulation, the authors found that contrary to 
ChR1, ChR2 conducts (non selectively) monovalent and divalent cations like Na+, K+ and Ca2+ 
(it was later reported that ChR1 has similar cation conductivity, which was masked in the initial 
studies due to the low expression level of the protein (143)). The unique cation conductivity of 
ChR2 made the authors to propose its utility for photostimulation of neuron cells.  
Two years later, Boyden et al. (148) and Li et al. (149) reported successful light-evoked 
action potentials in neurons via ectopic expression of ChR2. The principle of direct light-
evoked photocurrent with ChR2 is illustrated in Figure ‎2.1F. The authors demonstrated 
distinctive temporal control over the spiking pattern with millisecond temporal resolution. 
Since then the functionality of ChR2 has been demonstrated in numerous neurons in-vitro (149-
153) , and in-vivo: C. elegans (154, 155), mouse retina and brain (1, 2, 156-163), Drosophila (164-




Halorhodopsin (172-174) is a light-activated Cl- pump originated from ancient archea known 
as halobacteria. It is also homologous to the light-driven proton pump bacteriorhodosin. 
Halorhodopsin has peak sensitivity at 570nm. In 2007 Han et al. (175) and Zhang et al. (176) 
used heterologous expression of halorhodopsin from Natronomonas pharaonis (NpHR) to silence 
neuronal activity. The authors demonstrated that NpHR can be used to knockout single action 
potentials, or sustained blockade of spiking. Moreover, since the action spectrum of NpHR is 
separated from ChR2 a co-expression of NpHR/ChR2 system enables rapid bidirectional 
control.  
2.2.5 Choosing Photostimulation Technique  
Different approaches for controlling neuronal signalling with light were reviewed above. Each 
approach has advantages and disadvantages and its merit. The exploitation of photostimulation 
to retinal prosthesis demands that the stimulation technique will be safe, precise, capable of 
targeting a specific cell type (e.g. On or Off cells) and will be easy to deliver to the retinal cells. 
Kramer‘s sensitized photoswitches (116, 117) are undoubtedly cutting-edge technology. 
However, this nascent technology is not mature yet and in fact at the time of this thesis was 
not tested by any other researcher apart of the inventors themselves. Therefore, despite its 
promising future, it is currently not applicable for the work in this thesis.  
Table ‎2.1 compares the different photostimulation strategies. Direct lasing is probably 
the most straightforward approach, since it does not require any photosensitization of the cells 
or administration of cofactors. Nevertheless, this strategy is unlikely to be safe since it utilizes 
harmful UV or IR (infrared) light with extremely high intensities. Similarly, the need for UV 
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from access 
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Positive: 
(1) Human protein 
(2) Low irradiance 
(≤0.1W/mm2) 
(1) Risk of immune 
reaction in human 




No No Yes (136) Yes (1, 2) 
Table ‎2.1 Comparison of Photostimulation Strategies for Retinal Prosthesis. 
light disqualifies the use of neurotransmitter photolysis technique. In principle, expression of 
melanopsin would have been the ultimate solution since melanopsin is a native protein and it 
can generate large photocurrents with relatively low light intensities. In fact, Lin et al. (136) 
reported that blind mice expressing melanopsin could sense ambient light. However, the 
extremely slow kinetics of Melanopsin photocurrents will not allow the minimum refreshing 
rate (~20Hz) that will be required for real-life visual tasks.  
In contrast, photostimulation with frequencies up to 40Hz was demonstrated with 
ChR2. Its delivery to the retina is relatively simple since it requires expression of only a single 
small protein that can be coded inside an AAV cassette. This functionality was as well 
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successfully demonstrated in retinas of animal models. The disadvantages of ChR2 are that (a) 
in comparison to melanopsin ChR2 requires almost four-order of magnitudes more light and 
(b) it is not a native mammalian protein. Nevertheless, the light requirements of ChR2 are still 
in the safety limits (177). Moreover, ectopic expressions of ChR2 in various animal models 
including in primate‘s brain (171) did not show any signs for immune response.  
Thus, at present, ectopic expression of ChR2 seems to have the highest potential to 
facilitate functional retinal prosthesis. It enables a simple mean to render light sensitivity that 
has the required temporal resolution and the potential for cell-type specificity. 
It should be noted that there is an extensive effort to reduce the light requirements of 
ChR2. The high irradiance demand of ChR2 is a result of a poor single channel conductance- a 
single ChR2 molecule conducts only a few hundreds of ions per absorbed photon (i.e. mean 
conductivity of a few femtosiemens). The photocurrent yield of a single ChR2 molecule can be 
potentially improved by extending the lifetime of its open state or avoiding its desensitization. 
Berndt et al. (178) recently generated a mutation of ChR2, called C128, with an open state that 
could persists for seconds. Nevertheless, the authors noticed that stabilizing the open state 
resulted in a reduction of the photocurrents (by 30-60%) and in lengthening of the onset time 
(by 5 folds).  
In another attempt, Lin et al. (179) generated a ChR variant by making chimeras of the 
transmembrane domains of ChR1 and ChR2, called ChEF, which had half desensitization 
compared to the wild-type ChR2. The problem with ChEF chimera was that it had also a very 
slow closing. In order to correct that, the authors introduced a point mutation in ChEF (and 
renamed it ChIEF) which had better closing rates however, it had lower light response and did 
not recover completely in dark. All together these efforts indicate that there is a scope for 
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future improvement in ChR2 functionality although there is apparently an inevitable tradeoff 
between stability and gating kinetics.  
2.3 Conceptual Design of Photogenetic Retinal prosthesis  
The principle idea of the retinal prosthesis proposed in this thesis is to use light instead of 
electricity to generate membrane potential changes in the RGCs or bipolar cells of degenerated 
retinas, Figure ‎2.2. In the previous section the different strategies by which light sensitivity can 
be imparted on neurons were described and it was argued that at present, ChR2 provides the 
best photosensitizing tool to fulfil the requirements of the retinal prosthesis. In this section, 
the technical design of such prosthesis is described.  
  
Figure ‎2.2 Illustration of Light Stimulation of Photosensitized RGC in Degenerated Retina. Light is 
absorbed by the retinal ganglion cells (RGC) expressing ChR2 (green). The excited RGC (designated 
RGC*) elicits action potentials that propagates via the axon outside the eye toward the visual cortex. 
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The technical concept of the new prosthesis is illustrated in Figure ‎2.3 and Figure ‎2.4. The 
main device constituents are an imaging acquisition module made of a CMOS camera, an 
electronic module with a processing and an energy supply units and a light source module with 
adequate optics to transmit the light stimulation patterns. All these elements are external and in 
principle, can be incorporated in a head-mount device similar to today‘s virtual reality headset. 
Alternatively part of the electronic module can be carried by the patient in a similar fashion as 
portable computers are carried today.  
 
Figure ‎2.3 Illustration of Prosthetic Image Generation. The physical word ―RETINA‖ is captured and 
imaged on the retina using an array of high power light sources. The light pattern activates the 
corresponding RGCs which signal to the brain. The result is generation of phosphene representation of 





Figure ‎2.4 Principle Constituents of Photogenetic Retina Prosthesis 
Images acquired by the camera are sent to a processing unit that translates it into a set of 
spatiotemporal stimulating patterns. The translation process includes two stages: an image 
processing stage and a retinal coding stage. The aim of the image processing stage is to reduce 
the primary image information that arrives from the camera to more tangible representations. 
It typically involves a set of different filters that detect edges, movements, colors etc. The 
output of the image processing stage is fed to a retinal coder, which converts it to the 
predicted spiking output of a healthy retina.  
Yet, judging from the experience gained by the hitherto retinal implants, our ability to 
predict retinal output for a given two-dimensional light input is very limited. This task becomes 
even more difficult since it is typically impossible to know the particular type of the RGC cell 
the stimulus address (i.e. ON or OFF) and since the degenerated retina experiences significant 
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rewiring. Nonetheless, it is very likely that patients will be able to optimize their phosphenes 
perception simply by adjusting the coding parameters of the retinal coder.  
From the retinal coder, the information is fed to the driver unit which converts it to 
biasing currents that modulate the light source. It is expected that this unit will consume the 
highest amount of energy. The technology of the camera, the image processing and the retinal 
coding are, in principle, similar to the ones developed by the retinal implant devices and thus it 
will not be the focus of this thesis.  
The light source must be able to generate a two-dimensional pattern of at least 1000 
independent spots with ideally a single cell resolution (see the section ‎1.3). Each spot must 
contain sufficient light irradiance to elicit action potentials and ideally the peak emission 
spectrum of the light source will coincide with the wavelength sensitivity of ChR2. The 
development of such a unique light source is described in details in chapter 5. 
2.4 Incorporating ChR2 in Retinal Cells 
The mechanism of the retinal prosthesis presented in this thesis is based on the idea that light 
sensitivity can be imparted on the retinal cells that survived the diseases. It was argued that at 
present, ChR2 is the best tool to achieve this aim. In this section the methodology by which 
ChR2 can be incorporated into retinal cells is described and demonstrated first in-vitro and then 
in-vivo. 
2.4.1 In-vitro Transgenic Expression of ChR2 in RGCs 
Rat RGCs were cultured using a method developed by Dr Rolando Berlinguer based on a 
previous work of Lilley and Robbins (180). The eyes are quickly explanted from 2 to 20 days 
old rats, rapidly washed in ethanol 70% to remove any stray fur and blood and placed in ice 
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cold PBS. One to six retinas are dissected under light microscopy in aseptic condition 
accordingly to the number of cell required (typically 7 x 106 cells per retina are collected). With 
fine tweezers and scissors a cut is produced all around the cornea, the vitreous humour and the 
lens are lifted out leaving the retina and the pigmented layer connected only by the optic nerve. 
Once this is cut the retina can be delicately teased apart, collected by means of a plastic pipette 
(cut at the end) and gently transferred to a 2ml room temperature digestive solution. After 30-
60 min, relative to the age of the animal, the digestive solution is washed with PBS, 1 ml of 
DNAase solution is added to the tissue and the retinas are triturated through plastic tips of 
decreasing size until no sign of tissue is visible. This suspension is slowly added to 3 ml of 
gradient mixture and centrifuged at 1200 rpm for 10min at room temperature. At this stage the 
pellet of mixed cells is ready for transfection. 
A fusion protein ChR2-YFP (a gift from Karl Deisseroth, Stanford) that was 
subcloned into a plasmid containing a chick β-actin promoter was used. The plasmid was 
amplified in K-12 strain of E. coli (see Materials and Methods). Following several unsuccessful 
attempts with Lipofectamine (Invitrogen Inc.), it was found that a good in-vitro transfection 
efficiency can be achieved via a nucleofection approach using Amaxa® electroporator (Lonza 
Cologne AG). The PBS is removed and a 100µl of Rat Neuron Nucleofector Solution (Lonza 
Cologne AG) is added per sample (2 x 106 cells) and mixed with 1-2µg DNA of interest. The 
solution is transferred to a 2mm cuvette and an electroporation protocol (program V-01) is 
performed in Amaxa Nucleofector device. 
Following the transfection procedure, the cells are plated in poly-L-Lysine pre treated 
glass coverslips or microelectrode array (MEA) chip (25k-100k cells per 24 multi-well or MEA) 





Figure ‎2.5 In-vitro expression of ChR2 in Retinal Ganglion Cells. Left: ex-vivo culture of rat RGCs. 
Right: Fluorescent image of RGCs expressing the fused protein ChR2-YFP and cultured on MEA 
(black spots are microelectrodes). 
Expression of ChR2 is typically visible between 12 hours to 5 days post transfection. Figure 
‎2.5 shows an example of successful culture and in-vitro transfection of RGCs using the 
methodology described above. 
2.4.2 In-vivo Transgenic Expression of ChR2 in RGCs 
DNA encoding ChR2 can be delivered to the retina using vectors such as adeno-associated 
virus (AAV). AAV is a small, icosahedra (20 faces) and nonenveloped virus. It belongs to the 
Dependovirus genus of the parvovirus family, which require a helper virus, such as adenovirus 
or herpes simplex virus, to facilitate productive infection and replication. The wild AAV capsid 
is approximately 22nm big and encapsulates a linear single-stranded DNA genome of about 





Figure ‎2.6 Transgenic Expression of ChR2 with adeno-associated virus (AAV). (A) The virus is 
delivered to the retina via intravitreous injections. (B) Schematic of the AAV cassette containing hybrid 
CMV and chicken -actin (CAG) promoter, code for ChR2 (Chop2), fluorescent marker (GFP) and 
posttranscriptional regulatory element (WPRE) inserted between two inverted terminal repeats (ITR) of 
the AAV. (C) Once injected: (1) the packaged virus approaches the retinal cells and (2) enter the cell via 
endocytosis. (3) Once in the cell, the virus in integrated into the host cell DNA and later (4) Generates 
messenger-RNA which lead to (5) expression of the ChR2 protein. 
The interest in AAV started in the early 1980s when Hermonat et al. (183) 
demonstrated that recombinant AAV vectors are capable of expressing foreign genes in 
mammalian cells. Since then AAV vectors have rapidly gained high popularity in gene therapy 
 50 
50 
applications, due to the fact that it does not induce pathology and have a natural propensity to 
persist in human cells. To-date, nine subtypes of the virus (AAV1–9) have been described. The 
most common type is AAV2, which exists in 80% of the human population (184). 
There are currently at list 40 different clinical trials that explore possibilities for gene 
therapies with AAV (185). Some trials target the retina (186) and even the central nerve system 
(187). The efficiency of AAV to transfect a particular retinal cell is determined by a number of 
variables including the site of injection, the AAV serotype, the titer value, the amount of DNA, 
the specific gene promoters and the enhancing elements used. Martin et al. (188) reported that 
combination of CMV and chicken -actin (CBA) promoters together with posttranscriptional 
regulator woodchuck hepatitis (WPRE) can lead to a high, approximately 85%, transfection 
efficiency with AAV in rat RGCs. 
In this study a custom made viral expression cassette (originally suggested by Bi et 
al.(2)) that was packaged and purified by GeneDetect Inc was used. The cassette rAAV2-CAG-
Chop2-GFP-WPRE contained the fusion Chop2-GFP chimera subcloned into adeno-
associated virus (AAV) serotype-2 vector together with the hybrid CMV enhancer/chicken -
actin (CAG) promoter, a woodchuck posttranscriptional regulatory element (WPRE), and a 
bovine growth hormone (BGH) polyadenylation sequence.  
In order to test the capacity of the vector to impart expression of ChR2 in the retina 
l of 1011 genomic-particles/ml viral suspension was injected into the intravitreal space of 
the right eyes of three wide-type and two rhodopsin-knockout mice. The injections were done 
by Prof Robert MacLaren (Oxford University). The transfection process is illustrated in Figure 





Figure ‎2.7 In-vivo Expression of ChR2 in Rat‘s Retina. The transfection procedure and imaging were 
done by Prof Robert MacLaren (Oxford University). 
The images were taken four weeks after injection. The fact that the fluorescence is visible in in-
vivo indicates that the expression levels were relatively good. There were no indications for 
inflammatory reactions using these concentrations (although some inflammatory reaction was 
observed earlier in a mouse that was injected with a higher 1012 genomic particle 
concentration).  
2.5 Summary and Conclusions 
This chapter examined the potential of different photostimulation strategies for retinal 
prosthesis application. It was shown that at present, ectopic expression of the microbial ChR2 
has the highest potential to render light sensitivity with sufficient temporal resolution, simple 
sensitization procedure and no evident for safety downsides. A conceptual design for a retinal 
prosthesis based on ChR2 was described and a basic proof-of-concept experiments that 
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demonstrate the possibility to incorporation ChR2 into retinal cells in-vitro and in-vivo were 
shown. 
There are still many open questions to be addressed in regards to the efficiency of the 
incorporation procedure: what is the transfection efficacy, i.e. percentage of RGCs that were 
successfully transfetced with ChR2?  What is the level of specificity, i.e. percentage of non 
RGCs cells that were transfected? Does the level of expression in a single RGC is sufficient to 
enable generation of action potentials with safe level of light? Do the evoked-currents induce 
action potentials at the RGCs that are detectable at the visual cortex and perceive by the 
animal? These questions however have been partially answered by others.  
In 2006, Bi et al. (2) demonstrated successful transmissions of light-evoked action 
potentials to the visual cortex via ChR2 expressing RGCs in a mouse with photoreceptor 
degeneration. The methodology and the viral cassette that was used in this thesis were adopted 
from Bi et al. demonstration. In a later study, Farah et al. (170) demonstrated a successful 
expression of ChR2 in a rat eye. Recently, Lagali et al. (1)  who used electroporation approach 
to transfect retinal bipolar cells of mouse model with degenerated retinas (rd1) reported that 
the light induced signals were relayed to the visual cortex and were sufficient for the animals to 







Chapter Three: Kinetics of  ChR2 Photocurrent 
3.1 Introduction 
The aim of this chapter is to examine the dynamics of ChR2 photocurrents. In particularly, it 
sets to establish the relation between the photocurrents output and the light stimulation input. 
First, photocurrent responses for continuous and pulsed stimulation were systematically 
investigated under voltage clamp conditions. Then, contribution from non-ChR2 factors was 
examined. Finally, a kinetic model was developed to represent the light-input/current-out 
behavior. 
3.1.1 Previous Characterization Studies 
The first analysis of ChR2 photocurrents was published in the original paper of Nagel et al. 
(147). The authors expressed ChR2 in oocytes of Xenopus laevis and in HEK293 cells and 
reported that the photocurrents had initial transient peaks that decayed to smaller steady state 
ones. The size of both the transient peak and the steady state plateau was proportional to the 
light irradiance. The desensitization of ChR2 was later confirmed by many subsequent studies, 
e.g. (2, 150, 179).  
Ishizuka et al. (150), who quantitatively investigated ChR2 photocurrents in PC-12   
neuroblasmoma cells, reported saturation of the steady state currents (but not of the transient 
peak) at high irradiances. In contrary, Bi et al. (2), who studied ChR2 photocurrents in mice 
retinal ganglion cells (RGCs), reported saturation of the transient peak currents (but not of the 
steady state). 
Nagel et al. (147) also reported that ChR2 can be re-sensitized if it left in darkness. 
They estimated that the transient peak is fully recovered after ~10s darkness. The authors 
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showed that the recovery process can be accelerated by high extracellular concentration of H+ 
or negative membrane potential. Similar recovery time scale was reported later by Ishizuka et 
al. (150), however, a longer recovery of 25s was observed by Lin et al. (179). 
The kinetics of the photocurrent onset and offset was also investigated by Nagel et al 
(147). They estimated that the activation time constant is smaller than 1ms and the closing time 
constant is around 20ms (both fitted with a single exponent function). The authors 
commented that the photocurrent‘s offset (decay) is slower at higher intracellular proton 
concentration (i.e. lower pH).  Ishizuka et al. (150) reported onset and offset time constants of 
~2ms and 15ms, respectively. The offset time constant was dependent on the duration of 
illumination (e.g. 6ms time constant, instead of 15ms, was observed after 20ms illumination). 
As was expected, the onset time was reported to decrease (linearly) with light irradiance, while 
the offset time had little irradiance dependency. In a more recent study, Lin et al (179) reported 
2ms (at 20mW/mm2) onset time and 14ms offset time (independent on the light duration). 
3.1.2 Previously Suggested Models  
Several modelled of ChR2 photocurrents have been published to-date. Nagel et al. (147) first 
suggested that the overall waveform of the photocurrents can be reproduced by a circular 
three-state model, shown in Figure ‎3.1A, in which a ground close state (C) can be photo-
excited to an open state (O) which then decays to a closed-deactivated state (D). The closed-
deactivated state (D) then thermally (i.e. slowly) recovers back to the ground state (C). The 
authors pointed out that in order to reproduce the characteristic peak-plateau behaviour and 
the degraded transient response at subsequent stimulus, the recovery rates during illumination 





Figure ‎3.1 Hitherto Kinetic Models of ChR2 Photocurrent. (A) Circular three-state model. Dark 
adapted ground state C is photo-excited to an open state O that decays to close deactivated state D. 
The inactive close D state converts back to ground state C via thermal or light enhanced transition. (B) 
Non-circular three-state model. The deactivated closed state D in (A) is replaced by active state C2 that 
is in thermal equilibrium with the first close state. (C) Circular four-state model. The deactivated closed 
state D in (A) is replaced by a secondary open O2 and a close state C2. 
Nagel et al. suggested that instead of two separate sets of time constants (for light and dark 
conditions) the waveform features can be potentially reproduced by a four-state model in 
which the deactivated state (D) is effectively replaced by one open and one close state. Nikolic 
et al. (189) tested the efficiency of the circular three-state model. The authors confirmed that a 
light-assisted recovery is required.  
During the work on this thesis, several spectroscopic studies that investigated the 
intermediate energy states of ChR2 during its photocycle have been published (190-193). 
Bamann et al. (193) suggested a photocycle consists of five intermediate states for 
Chlamydomonas ChR2. In this model, the ground state can be photo-excited ( <1s) to P1 
intermediate that has double absorption peak (400nm and 520nm). P1 then converts ( 
=150s) to an open state P2 (520nm) that is in a fast equilibrium with a second open state P3 
(520nm). The open state P3 relaxes (=10ms) to a closed deactivated intermediate P4 (480nm) 
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which can slowly (=5s) recover back to the ground state. In principle, the model suggested by 
Bamann can be reduced to a circular four-state kinetic model, similar to the one shown in 
Figure ‎3.1C. In this case, the short-live (<1ms) intermediates are ignored and the ground state, 
P2, P3 and P4 intermediates are represented by the functional states C1, O1, O2 and C2, 
respectively. 
Ernst et al. (192) studied the energetic states of Volvox-ChR2. They suggested a six-
state photocycle that consists of two dark, non-conducting states (470nm and 480nm) with 
pH-dependent equilibrium (480nm entity is more favourable at low pH) that convert (ns) 
by a light-induced retinal isomerisation into an early intermediate (500nm) that quickly (s) 
converts to a second short lived intermediate (390nm) via deprotonation of the Schiff base. 
The 390nm intermediate relaxes (s) to an open channel state (510nm), presumably via 
pH dependent reprotonation of the Schiff base. The conductive 510nm intermediate relaxes to 
the ground states via two intermediates with decay time constants of 20ms and 100ms 
respectively. The authors suggested that the photocycle can be reduced to a non-circular three-
state kinetic model. In this case, two dark states 470nm and 480nm can be photo-excited to a 
single open state that eventually decays to 480nm close state. The peak-plateau shape of the 
photocurrent is explained by a lower quantum efficiency of the 480nm state. The model is 
shown in Figure ‎3.1B. 
A similar six-state photocycle model was later suggested for Chlamydomonas ChR2 by 
Ritter et al. (191). The ground (470nm) dark state with protonated Schiff base is converted 
(ns) by a light-induced retinal isomerisation into an early intermediate P1 (500nm). This 
intermediate thermally relaxes (s) via transient Schiff base deprotonation to P2 
intermediate (390nm). P2 can convert into an open state P3 (520nm) via pH dependent 
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backbone structural alterations (ms). P3 decays to a closed state P4 (480nm) via changes 
in hydrogen bonding of E90 (ms). P4 decays slowly (=6s) via minor backbone 
rearrangements to a second dark intermediate P5 (480nm) that eventually (=40s) recovers 
back to the ground state via reversal changes in the hydrogen bonding of E90. The authors 
pointed that P4 or P5 must be photoreactive otherwise the photocycle will be completely 
trapped in these states under continuous illumination conditions. Functionally, this model can 
be reduced to a non-circular three-state kinetic model similar to the one proposed by Ernst et 
al. (192) and shown in Figure ‎3.1B. In this case, the two closed states (states G and P6) are 
photo-excited to an open state (P3) that decays to a close state (P6). In contrary to the Ersnt et 
al. model, here the equilibrium between the two dark states is not pH dependent. 
More recently, Radu et al. (190) based on FT-IR and resonance Raman spectroscopy 
suggested a five-state photocycle for Chlamydomonas ChR2. The ground state is photo-excited 
into P1 intermediate via a large conformational change of the apoprotein. The P1 intermediate 
quickly converts into P2 after deprotonation of the retinal Schiff base. Then P2 fast converts 
to an open state P3 via minor conformation changes. P3 relaxes to a closed channel 
intermediate P4. This transition involves reversal of the retinal configuration from cis to trans. 
P4 converts slowly (seconds) back to the ground state by reversing the conformation of the 
apoprotein. In principle, this photocycle can be reduced to a simple three-state kinetic model 
consisting of a ground state, an open state (P3) and a closed-deactivated state, similar to the 
original model shown in Figure ‎3.1A.  
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3.2 Materials and Methods 
Primary dissociated culture of rat hippocampal neurons were used as a cell model. The cells 
were transfected with a fused ChR2-YFP protein. Series of photostimulation experiments were 
designed to explore the properties of the ChR2-evoked currents in those cells. ChR2-evoked 
currents were induced by a blue ~470nm light from a shuttered Xenon lamp or from a fast 
solid-state laser and recorded with a whole-cell voltage clamp (-70mV) technique. The 
photostimulation experiments were carried out by the author in close collaboration with Dr. 
Matt Grubb from Kings College London, who performed the patch clamp recordings. The 
ChR2-evoked currents were analysed using self-written software and the results were used to 
build a functional model that can reproduce the kinetics of the ChR2-evoked currents. The 
model was developed with Dr Konstantin Nikolic, who implemented it in Matlab (MathWorks 
Inc.)  
3.2.1 Plasmid Amplification  
3.2.1.1 Bacterial Transformation  
A ChR2-YFP β-actin plasmid was transformed into NovaBlue bacteria, a K-12 strain of E. coli 
(Novagen). The bacteria were thawed on ice and then 20μl were pippetted into a pre-labelled 
sterile eppendorf tube. To this, 1μl of plasmid DNA was added, and the tube was left on ice 
for five minutes. The tube was then heated for exactly thirty seconds in a 42°C water bath in 
order to heat shock the bacteria. It was then placed back on ice for two minutes. 80μl of SOC 
media (bacterial growth solution) was then added at room temperature, and the mixture was 
shaken at 37°C for thirty minutes. Using a sterile inoculating spreader, the solution was spread 
onto an ampicillin plate and incubated overnight at 37°C. The next morning, a small sample of 
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colonies from this plate were re-streaked onto a fresh ampicillin agar plate using sterile 
inoculating loops and this new plate was then incubated overnight at 37°C.  
3.2.1.2 Bacterial Overnight Solution 
A 10ml of Luria-Bertani, LB broth was added to a falcon tube. To this, a 10μl of ampicillin 
solution of concentration 100mg/ml was added. Using sterile inoculating loop, one colony of 
bacteria was removed from one agar plate (use only one colony from the same plate for 
multiple cultures) and was inculcated in the 10ml of the LB/ ampicillin solution by swirling the 
loop in the broth (for multiple cultures, swirl the same loop into more 10ml LB plus ampicillin 
samples). The solution was incubated for 16 hours in a 37°C shaker to grow the bacterial 
culture.  
3.2.1.3 Bacterial Glycerol Stock Solution 
Typically 10-20% glycerol is sufficient. The optimal concentration of glycerol for long-term 
storage is unknown. The overnight 10ml solution is centrifuged at 13,000 x g for ten minutes 
to pellet the bacteria. The supernatant is decanted and the bacterial pellet is resuspend in 750μl 
of 10-20% glycerol and transferred to a 1ml sterile cryovile (appropriately labelled). The 
glycerol stock is freeze at -80°C. 
3.2.2 Cell Culture and Transfection 
A fusion protein ChR2-YFP (a gift from Karl Deisseroth, Stanford) was subcloned into a 
plasmid containing a chick β-actin promoter. Primary dissociated cultures were obtained from 
rat hippocampal tissue on embryonic day 18.5. Hippocampi were digested in trypsin (1mg/ml 
in HBSS, 15min at 37oC), and dissociated in neurobasal medium with 10% FCS by passing 
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through a series of decreasing diameter Pasteur pipettes. They were then plated at 300 
cells/mm2 on 18mm diameter glass cover-slips coated in PDL (50 μg/ml) and laminin (20 
μg/ml). Cultures were grown in neurobasal medium supplemented with 10% FCS, 0.5% 
penstrep and 1X glutamax for the first 2h in vitro, and thereafter in neurobasal medium with 
B27, 0.5% penstrep and 1X glutamax, at 37oC and 6% CO2. Neurons were then transfected 
with the appropriate ChR2 vector using a lipofectamine procedure at 7 days in vitro (DIV), 
and electrophysiological recordings were performed at ≥ 10 DIV. 
3.2.3 Electrophysiology  
The cells were grown on glass dishes, as described above and the electrophysiological 
responses were obtained using patch clamp method to measure the effect of optical 
stimulation. Individual coverslips were placed in a custom recording chamber and bathed with 
room-temperature HEPES-buffered saline (HBS) containing, in mM: 136 NaCl, 2.5 KCl, 10 
HEPES, 10 D-glucose, 2 CaCl2, 1.3 MgCl2, 0.001 tetrodotoxin, 0.01 gabazine, 0.01 NBQX, 
and 0.025 APV (285mOsm, pH7.4). An Olympus IX71 inverted microscope equipped with a 
40x oil-immersion objective was used. The localisation of the target fluorescent ChR2-
expressing neurons was done with a xenon light source and appropriate filters.  
Patch pipettes, pulled from borosilicate glass (1.5mm OD, 1mm ID, 3-4 M) were filled 
with a solution containing, in mM: 130 K-gluconate or Cs-gluconate, 10 NaCl, 1 EGTA, 0.133 
CaCl2, 2 MgCl2, 10 HEPES, 3.5 Na-ATP, 1 Na-GTP (280mOsm, pH7.4). Conventional whole-
cell patch-clamp recordings were obtained via a Heka EPC10 double patch amplifier coupled 
to Pulse acquisition software. Signals were sampled at intervals of 65-150 μs (6.7-15.4 kHz) 
and were low-pass filtered using a 4-pole Bessel filter at 2.9 kHz (filter 2). The holding 
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potential in voltage-clamp mode was -70mV, uncorrected for any liquid junction potential 
(probably in the range of +10mV) between the internal and external solutions. 
3.2.4 Photostimulation 
A Xenon-arc lamp (Lambda LS; Sutter), or a diode pumped solid state (DPSS) 473nm laser 
(DPBL-9020, Sp3 plus) were used. The Xenon light was regulated by a rapid shutter 
(smartShutter, Sutter) controlled by a Sutter Instruments lambda 10-3 controller. The light was 
fitted with a 470 ± 20 nm bandpass excitation filter (Chroma Tech. Corp.) and suitable neutral 
density filters. The laser was focused to a beam with an observable diameter of 200m (125m 
FWHM) and an irradiance of 40mW/mm2.  
3.2.5 Modelling  
The model is based on a set of rate equations, which were solved numerically using Matlab 7.2 
(MathWorks Inc.) differential equation subroutines (194). In particular the ODE23 solver 
which utilizes the step-size Runge-Kutta-Fehlberg integration method (195) was used. A 




3.3.1 Photocurrents Induced by Continuous Stimulus  
 
Figure ‎3.2 Example of ChR2 Photocurrents. (A) Hippocampal neuron transfected with fused ChR2-
YFP protein. (B) Left: Photocurrents from 500ms pulses of 1, 10, 40, 60, 90 and 110mW/mm2. Inset: A 
magnified view of the peaks region. Experiments were carried out with Dr. Matt Grubb, who 
performed the patch clamp recordings. 
Hippocampal neurons expressing ChR2-YFP (8 cells) or ChR2-mCherry (3 cells) were 
illuminated by 500ms long pulses of blue light. The photocurrents were recorded with a 
standard patch clamp technique in a whole-cell configuration and the potential was held at -
70mV (see Materials and Methods section for more details). All patch clamp recordings 
presented in this chapter were done by Dr Matt Grubb (Kings College London). The design of 
the experiments, the photostimulation control and the analysis of the data were the authentic 
contribution of the author.  Figure ‎3.2 shows an example of hippocampal neuron expressing 
ChR2-YFP and photocurrent responses for different light irradiances. 
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3.3.1.1 Transient and Stationary Phases 
The photocurrent waveforms had transient peaks that decayed to smaller steady state plateaus. 
The magnitude of both the peak and the plateau graded with light irradiance Figure ‎3.3. In 
contrary to the data reported by Bi et al. and Ishizuka et al. (2, 150), the results showed that 
both the magnitudes of the transient (Figure ‎3.3A) and the steady state (Figure ‎3.3B) saturate 
at high irradiances. The saturation irradiance was around 40mW/mm2 (half saturation constant 
of ~10mW/mm2) in all the cells. The magnitude of the photocurrent peaks and plateaus varied 
between 0.4nA and 2.7nA and between 0.2nA to 1.2nA, respectively. The ratio between the 
steady state and the stationary peak currents is shown in Figure ‎3.3C. It reveals that at high 
irradiances (>10mW/mm2) the photocurrent desensitized to on average 40±2% during long 
illumination. Under lower irradiances the desensitization is smaller, for example, the ratio was 
60±8% at 1mW/mm2. The plateau-to-peak ratios shown here are 2-3 fold higher than the ones 
reported by Lin et al. (179). Interestingly, examination of the photocurrents reveals that larger 
peaks decay faster to stationary levels, e.g. Figure ‎3.2B (inset). This feature indicates a light 




Figure ‎3.3 Magnitude of Stationary peak and Steady State plateau Currents. (A) Magnitude of  transient 




Figure ‎3.4 Dark Recovery. (A) Example of photocurrents from two sequential 500ms light pulses. Red 
arrows illustrate the scaling procedure (i.e. peak-plateau) and the red line follows the recovery trace of 
the peak (Experiments were carried out with Dr. Matt Grubb, who performed the patch clamp 
recordings). (B) Ratio between the second peak and the initial peak as a function of inter-pulse delay. 
Results from 3 cells are shown (indicated by different symbols). The experiment was repeated three 
times for each cell. (C) Ratio between the second peak and initial peak as a function of light irradiance. 
Inter-pulse delay was 3s. 
3.3.1.2 Dark Recovery 
The recovery of the photocurrent peak was tested by stimulating the neuron with two 
sequential 500ms light pulses. As expected, ChR2 photocurrents recovered after dark 
adaptation periods as seen in Figure ‎3.4A. The steady magnitude of the state currents was 
subtracted from the peak ones and the recovery was fitted with a single exponential function, 
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Figure ‎3.4B. It was found that the time constant of the recovery process was 2.5s. In order to 
test if the recovery rate is affected by the light irradiance the cells were illuminated with 
different irradiances and constant 3s inter-pulse delay (both pulses had always similar 
irradiance). The results, shown in Figure ‎3.4C, imply that the recovery is independent on the 
light irradiance. 
3.3.1.3 Onset Phase 
The photocurrents reached the highest point a few milliseconds after the stimulation onset, 
Figure ‎3.5A. The time to peak was inversely proportional to the light irradiance and reached an 
asymptotic value at irradiances of ~40mW/mm2, Figure ‎3.5A. The asymptotic peak time was 
4ms which is longer than the values reported by (190-193). The lengthening of the peak timing 
was most likely due to the shuttering mechanism of the light source since the light was 
shuttered using mechanical actuator with 2ms shuttering time (defined as the time from 10%-
to-90% intensity). In order to test this line of reasoning, the experiment was repeated with a 
fast laser source (670s 10%-to-90% opening time). Using 40mW/mm2 irradiance, the 
asymptotic time to peak was reduced to 2ms as was expected.  
During the photocurrent rising phase, there is a stage in which the activation rate, i.e. 
the number of newly opened ChR2s per unit time, is constant.  This is due to the fact that at 
this stage the pool of closed ChR2 molecules is significantly larger than the opened one and 
the desensitization process has not fully started yet. The slope of the photocurrent rise at this 
stage depends on the light irradiance (and on the quantum efficiency of the process which can 
be considered constant). The relation between the activation slope and the light irradiance is 





Figure ‎3.5 Onset Dynamics. (A) time to peak (B) Activation rate with exponential (red) and Hill 
function fittings (blue). 
irradiances and saturated at the same irradiance as the transient and steady state currents. The 
saturation of the activation rate at irradiances >40mW/mm2 implies that there is no practical 
benefit in higher light intensities. Note that although the relation could be fitted using 
exponential function (red) it was better fitted using the Hill equation (blue). 
3.3.1.4 Offset Phase 
When the light is turned off, ChR2 inactivates and the photocurrents decay to zero. The decay 
waveforms were fitted with a mono-exponential function with a time constant of 10ms 




Figure ‎3.6 Offset Dynamics. (A) Semi-log representation reveals two closing processes; Decay 
waveforms were fitted with 2-exponent function. (B) Fitting time constants <1>=6ms, <2>=50ms; 
n=10 (C) Experimental data (dots) and 2-exponent fitting function (full line) (D) Fitting amplitudes of 
1 (upper band) and 2 (lower band); n=10. 
the decay waveforms were better fitted with a bi-exponential function, Figure ‎3.6C. The bi-
exponent nature of the waveform is evident when the currents are plotted in semi-logarithmic 
plot, see Figure ‎3.6A. The mean time constants of the fast and slow closing processes were 
6ms and ~50ms, respectively, as shown in Figure ‎3.6B. Although the time constants are only a 
result of a fitting procedure and do not reflect the physical timing of the protein, they provide 
an important insight on the kinetics of ChR2 photocycle since they indicate two parallel open 
states. Most of the current (~90%) decays with the fast time constant independent on the 
irradiance of the stimuli, as seen in Figure ‎3.6D.  
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3.3.2 Photocurrents Induced by Pulsed Stimulus 
In order to induce high frequency spiking, short light pulses are required. Typically pulse 
widths between 1ms and 10ms are used since longer pulses may limit the pulsing frequency. In 
this section the dynamics of the photocurrents induced by a single short pulse is analyzed. The 
neurons (3 cells) were illuminated with short pulses with 1mW/mm2 irradiance (threshold 
irradiance for spiking). Example of photocurrents is shown in Figure ‎3.7A. The photocurrents 
reached a stationary level after ~12ms.  
 
Figure ‎3.7 Photocurrents Induced by Pulsed Stimuli. (A) Example of photocurrent waveforms for 
various light pulse widths (1mW/mm2 irradiance). Experiments were carried out with Dr. Matt Grubb, 
who performed the patch clamp recordings. (B) Summary of stationary values vs. pulse widths (C) 
Summary of time to peaks vs. pulse widths; Decay waveforms were fitted with 2-exponent function. 
n=3 (D) Fitting time constants <1>=4ms, <2>=33ms;   (E) Relative magnitude of fitting coefficients 
of 1 (upper band) and 2 (lower band). 
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At shorter pulses the magnitude of the photocurrents increased almost linearly with the 
illumination duration, Figure ‎3.7B. At pulse widths between 5ms and 12ms, the currents 
maxima appeared at the end of the light stimuli, Figure ‎3.7C. However, at pulses shorter than 
5ms the currents maxima appeared after the light was turned-off. For example, in the case of a 
1 ms light pulse, the current peak occurred at 2.5ms (approximately 1.5 ms after the end of the 
stimulus). This feature can be attributed to the stochastic characteristic of the channel opening 
(190-193). It has an impact on the spike stimulation strategy since it implies that there is 
inherent ~1ms average delay between the end of the light stimulus and the end of the 
photocurrent build-up. 
The offset (decay) of the photocurrents can be fitted with a bi-exponential function in 
the same way as the offset currents from continuous stimuli. The fast and slow process were 
fitted with time constants of 4ms and 33ms, respectively, Figure ‎3.7D. The relative magnitudes 
of the slow and fast current elements depended on the illumination time, Figure ‎3.7E. At very 
short pulses (<3ms in this case) the contribution of the slow process was very small and in fact 
was not distinguishable (this might be due to the fact that some of the signal was below the 
noise floor). The magnitude of the slow decay element increased at longer illuminations and 
reached a stationary value of 10%-15% (similar to under continuous illumination) after ~20ms. 
The dependency of the slow and fast decaying currents on the illumination time can explain 
the two different time constants that were reported by Ishizuka et al. (150) for 1s and 20ms 
illuminations. 
3.3.3 Effect of Variability in ChR2 Expression  
The number of ChR2 molecules expressed in the cell affects the magnitude of the 
photocurrent response in a very similar way the irradiance does (though the current expression 
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levels are probably still far from saturation). Since each ChR2 was co-expressed with a single 
fluorophore molecule, it was possible to use the fluorescence images to assess the relative 
expression levels of ChR2 in the cells and to compare it with the photocurrent responsiveness 
(it was assumed that the fluorescent molecules were located on the membrane surface). In 
order to avoid inaccuracy due to variability in the shuttering and calibrating of the light source, 
the steady state values (rather than peak) were compared and continuous saturating light 
(40mW/mm2) was used. All images were taken with similar illumination and camera settings. 
The fluorescence of a given cell was calculated by summing the pixels intensities in the 
florescence images. The results, shown in Figure ‎3.8, indicate a linear relation between the 
steady state photocurrent and the fluorescence level. The correlation coefficient was +0.8 
(n=12). A Similar observation was recently reported by Lin et al. (179).  
 
Figure ‎3.8 Effect of Variability in Expression Level. (A) Fluorescent image of pyramidal hippocampal 
neuron expressing ChR2-YFP and a color-map view of the highlighted area (B) Steady state 
photocurrents induced by continuous illumination of whole field blue light of 40mW/mm2 plotted 
against the cells fluorescence. (n=12). 
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The linear relation between the number of ChR2 expressed in the cell and the steady state 
photocurrent makes the latter a useful indication for the former as long as the stimulation and 
recording conditions are consistent. In other words, reporting the magnitude of the steady 
state photocurrent under long, saturating illumination and say -70mV voltage clamp can give a 
rough comparable measure for the number of ChR2 in the cell. 
3.3.4 Examining Contribution from non-ChR2 Factors 
In order to relate the photocurrents characteristics to intrinsic properties of ChR2, it is 
necessary to exclude contribution from external factors. In this study three such factors that 
were thought to have high potential to affect the results were examined. The factors were:  
(1) Cell specific behaviours (i.e. is the dynamics unique to the cell type that was studied?)  
(2) Effects caused by the rise of intracellular Ca2+ concentration and  
(3) Interference from the fluorophore molecule that attached to ChR2.  
First, the experiments were repeated in HEK293 cells instead of hippocampal neurons 
in order to eliminate cell type specific effects. HEK293 cells were plated on 18mm diameter 
glass cover-slips and grown in DMEM supplemented with 100 units/ml penicillin, 100 mg/ml 
streptomycin, 4 mM L-glutamine, and 10% FBS , at 37oC and 6% CO2. The cells were then 
transfected with the appropriate ChR2 vector using a lipofectamine procedure in a similar 
manner described above for hippocampal neurons (see Materials and Methods). The results, 





Figure ‎3.9 Photocurrents Characteristics in HEK Cells. (A) Image of HEK cells transfected with ChR2-
YFP (B) Activation rate, i.e. dI/dt, at the rising phase (C) Transient peak currents (D) Time to 
photocurrent peak (E) Steady-state currents (F) Steady-state current normalized to transient current (G) 
Fitting time constants of closing process (H) Relative magnitude of fitting coefficients of 1 (upper 
band) and 2 (lower band); n=3.   
Next, the experiments were repeated with Ca+ chelator BAPTA (10mM), in order to eliminate 
potential secondary Ca2+ effect. The results, summarized in Figure ‎3.10, show that the 





Figure ‎3.10 Photocurrents with Ca2+ Inhibition. (A) Activation rate, i.e. dI/dt, at the rising phase (B) 
Transient peak currents (C) Time to photocurrent peak (D) Steady-state currents (E) Steady-state 
current normalized to transient current (F) Fitting time constants of closing process (G) Relative 
magnitude of fitting coefficients of 1 (upper band) and 2 (lower band); n=3.   
Finally, the influence of the fused fluorophore was examined. Although YFP has peak 
absorption at 514nm, it has still 24% absorption efficiency at 470nm.  Moreover, once YFP is 
excited, it will emit wavelengths between 510nm and 529nm (Invitrogen SpectraViewer, 
Invitrogen). In this range the action spectrum of ChR2 is still very high (20%-50% of its 
maximum (147)).  Since the spacing between ChR2 and its fused fluorophore is smaller than 
Förster distance (10nm range) (196), ChR2 might experience a non-radiative energy transfer 
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from the fused fluorophore via a Fluorescent Resonance Energy Transfer (FRET) (196). In 
order to exclude the possibility of fluorophore interferences, the experiments were repeated 
with ChR2 in which the fused YFP was replaced by a nonfluorescing myc tag and co-
transfection with EGFP. The results, summarized in Figure ‎3.11, show similar photocurrent 
characteristic as obtained with the fused ChR2-YFP protein. 
 
 
Figure ‎3.11 Photocurrents without Fluorophore. (A) Image of hippocampal neuron trasfected with 
ChR2 (without fluorophore) (B) Activation rate, i.e. dI/dt (C) Transient peak currents (D) Time to 
photocurrent peak (E) Steady-state currents (F) Steady-state current normalized to transient current (G) 
Fitting time constants of closing process (H) Relative magnitude of fitting coefficients of 1 (upper 
band) and 2 (lower band); n=4. 
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3.4 Kinetic Model of ChR2 Photocurrent  
In this section a kinetic model that can reproduce the photocurrents is described. Initially, the 
three-state model originally proposal by Nagel et al. (147) and subsequently tested by Nikolic et 
al. (189) was examined. It was found that although the three-state model can successfully 
reproduce the transient and steady state current amplitudes, it fails to accurately reproduce the 
transitional stages, as shown in figure Figure ‎3.12. Furthermore, the analysis of the 
photocurrent, presented above showed that there are two parallel closing processes. This 
feature can be attributed to two separated open states. In addition, the analysis implied a light 
enhanced desensitization process. This feature can be a result of a light induced transition 
from open state to close state or from one open state to a second less conductive open state. 
Both features cannot be easily implemented in a three-state model.  
 
Figure ‎3.12 Limitations of Three-State Model. Red: photocurrent response induced by 500ms pulse of 
light. Black broken-line: three-state model reproduction of the waveform. The arrows point to locations 
in which the model failed to reproduce the photocurrent. 
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3.4.1 Model Rational  
 
Figure ‎3.13 Branching Four-State Model. ChR2 is photo-excited from its dark adapted close C1 state to 
an open state O1 that can decay back to C1 or convert to a second open state O2. O2 state can convert 
back to O1 or decay to a second close state C2. C2 can be photo-exited back to O2 or thermally 
convert to C1. 
The limitations of the three-state model and the analysis of ChR2 photocurrent described 
above led to the suggestion of a 4-state model that consists of two interconnected branches of 
open and close states, Figure ‎3.13. The model is based on the work of Hegemann et al. with 
ChR1 (197) and on the postulated model of Nagel et al. (147). In the 2-branches model, ChR2 
can be photo-excited from its C1 dark-adapted closed state to an open state O1. From the 
excited state O1, ChR2 either decays back to C1 or converts into a different open state O2. 
The transition from O1 to O2 can be thermal or light induced. The two open states (O1 and 
O2) can differ from each other in their channel conductance and life-times. From open state 
O2, ChR2 either decays to a close state C2 or converts back to O1 (again by thermal or light 
excitation). The model allows different conversion (O1→O2 and O1←O2) and excitation 
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(D1→O1 and D2→O2) efficiencies. From C2 ChR2 can be photo-excited back to O2 or can 
slowly convert (thermally) to C1. 
3.4.2 Governing Equations  
If NO 1, NO 2, NC 1 and NC 2 are the numbers of ChR2 molecules in the open states 1 and 2, and 
the closed states 1 and 2, respectively, and N= NO 1+NO 2+NC 1+NC 2 is the total number of 

























      ‎3.3 
Where 1dK and 2dK are the closing rates O1C1 and O2C2, respectively. rK  is the 
thermal recovery rate C2 C1. 21e  and 12e are the rates of transition between O1 to O2 and 
vice versa and composed of thermal component 
dark
ije and light induced component 
light
ije . 
Ka 1 and Ka 2 are the activation rates C1O1 and C2O2, respectively. If εi is the quantum 
efficiencies of state Ci (where i=1,2) and Φ(t) is the photon flux, then Kai can be approximated 
by  
)(= iai tK         ‎3.4 
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Once No1 and No2 are calculated the photocurrent can be computed using the following 
equation 
)(=)(= 2112211 OOOO NNUgNgNgUI       ‎3.5 
 
Where 
1g  and 2g  are the conductance of a single ChR2 ion channel in the open state O1 and 
O2, respectively. 12/= gg , and U is the holding membrane potential. For convenient, Eq. 3.5 
can be replaced with  
)(= 21max ooII         ‎3.6 
Where Imax is the maximal possible current, i.e. when all ChR2s are in the most conductive O1 
state. o1= NO1/N and o2= NO2/N.  
3.4.3 Testing the Model 
The capacity of the model to reproduce photocurrents was tested. It was found that the model 
can accurately reproduce the photocurrent waveforms (an example is presented in Figure ‎3.14) 
under the following conditions: 
1) O1 conductivity is larger (~x10) than O2 
2) O1 activation is more efficient (~x5) than O2 
3) O1 lifetime is shorter (~x0.2) than O2 





Figure ‎3.14 Comparison of Three-state and Four-state modelling. Red: photocurrent response induced 
by 500ms pulse of light. Black broken-line: three-state model reproducing of the waveform. Blue broken-
line: four-state branching model reproducing of the waveform.
 
These conditions lead to a fast population of O1 which is manifested in a large initial current 
response. The population of O1 reaches a maximum when the deactivation rate of C1← O1 
plus the branching rate of O1→O2 equal the activation rate C1→O1. The O1 maximum is 
manifested in the transient photocurrent peak.  Continued illumination beyond this point 
yields larger depopulation of O1 via O1→O2 and accumulation in the longer-lived O2 state. 
The photocurrent steady state occurs when the two open states reach an equilibrium, i.e. 
e12O1=e21O2. The time to steady state and the equilibrium ratio O2/O1 depends on the light 
irradiance. 
Next, the capacity of the model to simulate the effect of irradiance on the 
photocurrent waveforms was tested. Photocurrent responses from 500ms pulse with 
1mW/mm2 and 10mW/mm2 were recorded and the experimental data were fitted by adjusting 
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the model parameters. The results are shown in Figure ‎3.15A and the fitting parameters are 
summarized below.  
 
Irradiance  ε1 ε2 Kd1 Kd2 e12 e21 Imax 
(mW/mm2)    (ms-1) (ms-1) (ms-1) (ms-1) (nA) 
1 0.05 0.5 0.1 0.13 0.025 0.053 0.023 1.85 
10 0.05 0.5 0.03 0.13 0.025 0.064 0.027 2.05 
Table ‎3.1 Fitting Parameters 
Figure ‎3.15B shows the relative distribution between O1 and O2 during the two stimulations. 
It implies that 
1) Larger activation rates (↑i) 
2) More accumulation at O2 branch   
3) Faster steady-state 
The coupling between the two open states can be in principle spontaneous or via absorption 
of a second photon. It was empirically found to be  
𝑒𝑖𝑗 = 𝑒𝑖𝑗
𝑑𝑎𝑟𝑘 + 𝑐𝑖 ln( 1 +
𝜙
𝜙0




is the spontaneous (thermal) transition rate between Oi and Oj and Ci andare 











Figure ‎3.15 Reproducing Irradiance Effect. (A) Red: photoccurents induced by 500ms pulse of light 
using 1mW/mm2 and 10mW/mm2 irradiances. Black: simulated waveforms. (B) Fractional population 
of the two open states at 1mW/mm2 (182) and 10mW/mm2 (blue) irradiance conditions. 
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 in Figure ‎3.15, the transition rates were e12 =0.053ms
-1 and e21 =0.023ms
-1 and the thermal 
transition rates were e
dark
12




Finally, the capacity of the model to reproduce the effect of pulse width on the 
waveforms was tested.Figure ‎3.16 shows that the model can correctly reproduce the waveform 
of the experimental data presented earlier in Fig 3.7. The fitting parameters in all cases were 





-1), Imax= 0.2(nA).  
 
Figure ‎3.16 Reproducing Pulse Width Effect. Red: photocurrents induced by 1-20ms of 1mW/mm2 
light. Black: waveforms reproduction with four-state branching model. 
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3.5 Summary and Conclusions  
This chapter analyzed the dynamics of ChR2 photocurrents and examined the relation between 
the light stimulus input and photocurrent output. It was found that  
1) The magnitude of the transient and the steady state currents is proportion to the light 
irradiance and has a half saturation constant of 10mW/mm2 
2) Time to current‘s peak is inversely proportional to the light‘s irradiance and has an 
asymptotic value of ~2ms 
3) Large photocurrents decay faster to steady state which indicates a light induced 
desensitization process 
4) When the light is turned off, the current decays in two parallel processes: fast and slow 
indicating two distinguished open states. The fast process dominates the decay current 
~90%  
5) Photocurrents recover in darkness at a rate with 2.5s time constant, independent on 
the light irradiance 
It was shown that similar characteristics are obtained in a different cell type or in cases when 
the intracellular Ca2+ is blocked or the interference from the fussed fluorophore is eliminated. 
Hence, the evoked-current characteristics are very likely to be intrinsic property of ChR2.  
The effect of light irradiance is illustrated in the table below which summarizes the 
photocurrent properties of two extreme inputs 1mW/mm2 (corresponds to threshold 
















1 40 1 40 1 40 1 40 1 40 1 40 
mean 59.4 40 15 4.7 5.9 5.9 54.8 59.5 88.3 84 15.5 11.7 
STD ±7.8 ±2.6 ±2.3 ±0.8 ±1.1 ±1 ±13 ±26.8 ±5 ±7 ±7.3 ±5 
Table ‎3.2 Summary of Photocurrent Characteristics from Spike Threshold and Saturating Irradiances.  
Iss: steady state current, Is: stationary peak current, t-peak: time to peak, t1/2- offset: first/second time 
constant when the light is turned off, A1/2- offset: first/second relative amplitude of corresponding 
time constants. n=10. 
The saturation in the photocurrent can be understood by looking at the process from 
the point of view of a single ChR2 molecule. The absorption area of ChR2 is determined by its 
chromophore, the retinal, which has an effective absorption cross-section of 1.2·10-8m2 (197). 
When a neuron is illuminated with 1mW/mm2 of blue light (photon flux of 2.4·106 
photons/(ms·m2)) each retinal molecule receives on average ~0.025 photons every 
millisecond (which is one photon every 40ms). That means that when the irradiance is 
increased to a value of 40mW/mm2, each retinal molecule will have on average a photon 
passing through its absorption cross-section every millisecond. If we assume that ChR2 has on 
average 1ms opening time and it stays open for about 5 to 10ms (192, 193), illuminations with 
irradiances larger than 40mW/mm2 will result in a large photon redundancy. The actual 
saturation point is clearly affected by the quantum efficiency of the process (~0.5) and losses 
in the system (due to scattering and reflection for example). 
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Based on the experimental observations, a new kinetics model has been proposed for ChR2 
(198). The model is based on two interconnected branches of open and closed states. It was 
shown that the model can reproduce the dynamics of the photocurrents under various 
stimulation conditions. In principle, the model works the best when O1 state has larger 
conductivity, better activation efficiency and shorter lifetime than O2 state. The transition rates 
between the two open states can be thermally and light induced (the dependence of light was 
found to have logarithmic nature). The O1→O2 transition rate is larger than O1←O2.  
The light-input/current-output understanding that was developed in this chapter is 
important for determining the light stimulation shape of the retinal prosthesis. Although the 
chapter examined photocurrent IChR(Φ,t) in a special case in which the membrane potential 
was kept clamped (which is not the case during neuronal spiking) it can be utilized in voltage 
changing conditions by converting IChR to voltage-independent conductivity GChR using GChR= 
IChR/Vclamp (where Vclamp= constant). This feature will be exploited in the next chapter to 




Chapter Four: Dynamics of  ChR2-Evoked Spiking  
4.1 Introduction 
The previous chapter analyzed the dynamics of ChR2 photocurrents. This chapter sets to 
examine how these photocurrents are translated into neuronal action potentials. Despite the 
high impact of ChR2 in neuroscience and the extensive efforts to understand its photocycle 
(190-193, 198), no such study has been published to-date. Since (a) both the conversion of 
light into photocurrents and the conversion of photocurrents into spikes are nonlinear 
processes and (b) the explicit spike output for a given light input is affected by a large number 
of independent factors such as temperature, neuron cell-type, recording solution, this study 
does not try to deduce a specific light-input/spike-output transfer function. Instead, this 
chapter focuses on developing a better understanding on the underling mechanisms that 
govern and perhaps limit the ChR2-mediated light-to-spike process. The following questions 
will be asked: How do ChR2 photocurrents induce action potentials? What role plays ChR2 
photocurrent once the action potential is elicited? What is the temporal resolution of the 
stimulation and what limits it? What illuminations strategy may maximize the stimulation yield?  
Two methodologies were used in this chapter: (1) Experimental investigation in which 
the neurons were systematically illuminated with light patterns and the depolarization 
responses were recorded, analyzed and in some cases compared to responses from equivalent 
current injection stimulations. This was carried out in collaboration with Dr Matt Grubb from 
Kings College. (2) Simulation investigation based on ChR2-neuron model that represents the 
kinetics of ChR2 and the native neuronal ion channels that play a role in the action potential 




Figure ‎4.1 Schematic of ChR2-Neuron Model. Light function is converted via ChR2 to changes in 
membrane conductivity, which modulates the somatic membrane potential and can lead to generation 
of action potential oscillations in the neuronal ion channels. ChR2 is modeled by a four-state system. 
In principle, encoding stimulation amplitude into spiking frequencies can be represented by the 
―Integrate-and-fire‖ model originally proposed by Lapicque (199). However, this basic model 
cannot represent the dynamics of sub-threshold and post-spike depolarizations which directly 
affect the passive (i.e. voltage dependent) ChR2-evoked currents. For that reason a more 
comprehensive Hodgkin-Huxley model (200) which includes a more detailed description of the 
dynamics of the neural ion channels was used. To-date, Hodgkin-Huxley type modelling has 
been successfully done with one or multiple compartments (201). Multiple compartments 
models (202) are useful to study how the spatial structure of a neuron contributes to its 
dynamics and function (203, 204). However they involve high-dimensional systems of 
equations. For example, 1000 compartments were required to simulate spike back-propagation 
in pyramidal neurons (205). Apart from being computationally expensive, the high 
dimensionality and intricate structure can obscure mathematical understanding of the 
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dominant influences (201). Thus, prior work carried out into understanding somatodendritic 
interactions (201), spiking (206) and bursting (207) behaviour have been carried out with a few 
dendritic compartments. For example, a two-compartment model was successfully used to 
show that homeostatic plasticity can follow from cellular ‗‗learning‘‘ rules that recalibrate 
dendritic channel densities (208).  
The appropriate level of description in the model depends on the particular problem it 
addresses. This study aimed to investigate the underlying mechanisms that govern and limit the 
generation of action potentials with ChR2. To this end the illumination was focused largely on 
the soma and hence a dual compartment model is used to maintain a focus on the biophysical 
influence of ChR2 photocurrent. In so doing a fair comparison with the somatic injection 
stimulations can be made. 
4.2 Materials and Methods  
The theoretical investigation shown in this chapter uses a Hodgkin-Huxley type hippocampal 
neuron model suggested by Traub (209) that was modified to include a ChR2 channel 
represented by the model shown in previous chapter. The model was developed with Dr 
Konstantin Nikolic, who implemented it in Matlab (MathWorks Inc.) The experimental 
investigation was done on the same neural model that was used in previous chapter (i.e. 
primary dissociated culture of rat hippocampal neurons). A series of experiments were 
designed to explore the properties of the ChR2-evoked action potentials in those cells. The 
ChR2-evoked spiking was induced by a blue ~470nm light from a fast solid-state laser and 
recorded with a whole-cell current clamp technique. As in previous chapter, the 
photostimulation experiments were carried out by the author in close collaboration with Dr. 
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Matt Grubb from Kings College London, who performed the patch clamp recordings. The 
recordings were analysed using self-written software. 
4.2.1 Cell culture and transfection 
Rat hippocampal neurons transfected with fused ChR2-YFP protein were used. The culture 
and transfection procedures are similar to the ones described in chapter 3.  
4.2.2 Electrophysiology  
The electrophysiological responses were recorded via whole cell patch clamp method, as 
described in chapter 1. Except that the recording solution was room-temperature HEPES-
buffered saline (HBS) containing, in mM: 136 NaCl, 2.5 KCl, 10 HEPES, 10 D-glucose, 2 
CaCl2, 1.3 MgCl2, 0.01 gabazine, 0.01 NBQX, and 0.025 APV (285mOsm, pH 7.4).  
4.2.3 Photostimualation  
The photostimulations of action potentials were done with a fast shuttering (<1ms 10% to 
90%), directly modulated diode pumped solid state (DPSS) 473nm laser (DPBL-9020, Sp3 
plus). The laser was focused using a single lens to a spot with a 125m FWHM and a mean 
irradiance of 40mW/mm2 on the somas. By focusing the light we could make a fair 
comparison with the somatic injection of currents as well as achieving saturating irradiances. 
4.2.4 Analysis of Spike Signals 
All numerical calculations were performed in MATLAB 7.5.0 (The Mathworks Inc.). When 
analysing the action potentials only depolarization spikes that exceeded 0mV were considered 
valid. Once the action potentials were identified, their sizes were computed by subtracting the 
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after (peak) maximal repolarization voltages from the depolarization peak voltages. The widths 
of the action potentials were measured at the half maximal spike amplitude. The rate of change 
in the membrane potential (dVm/dt) was computed as well and the maximum depolarization 
and re-polarization rates were identified. The spiking threshold was defined as the voltage at 
the onset of each spike at which dVm/dt reached approximately 5% of its maximum value. The 
current through ChR2 during the action potential oscillations was computed by first calculating 
the instantaneous conductance of ChR2 from the voltage clamp measurements 
(GChR2(t)=I(t)/Vclamp) and then multiplying it by the instantaneous membrane voltage recorded 
at current clamp mode. 
4.2.5 ChR2-Hippocampal Neuron Model 
Typically pyramidal hippocampal neurons respond to constant depolarising currents with a 
train of action potentials that have frequency adaptation feature. The dynamics of these 
neurons can be represented with the following ion channels: Na+ (transient current), four K+ 
conductance (delayed rectifier (DR), transient (A), slow afterhyperpolarisation (AHP) and rapid 
voltage- and Ca2+– dependent (C)), high-threshold Ca2+, and the leak conductance (209). The 
kinetics of the ion channels and their relative distribution were adopted from Traub‘s model 
(209, 210). Following French et al. (211) suggestion, a persistent sodium current (NaP) was 
added as well.  
In the stimulation protocol only a minor portion (<10%) of the photosensitized 
dendrites were illuminated. The illuminated dendrites were located near the soma (<50m). 
Although, currents induced 50m from the soma can still have a peak latency of 4ms (212), 
the over overall area of the illuminated dendrites, and therefore the magnitude of their 
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photocurrents, was significantly smaller, <15%, than the somatic one. Since ChR2 does not 
affect the electrical properties of the cell membrane in the absence of light (148), the 
photocurrents can be faithfully approximated as originated in the somas.  
This scenario was modeled using a two compartment model in which the effect of the 
dendritic tree is approximated with a current leakage of the form:𝛾 𝑉 − 𝑉  where 𝑉 is the 
membrane potential 𝑉  represents the mean dendritic voltage and 𝛾 is the conductance between 
the compartments (i.e. between the soma and the rest of the neuron). In this case, the kinetics 




 ≈ −𝐼ionic + 𝐼ChR + 𝛾 𝑉 − 𝑉        ‎4.1 
C is the soma capacitance, V is the somatic membrane potential relative to rest (in mV), 𝐼ionic  
is the sum of all the currents through the ion channels, i.e. 𝐼ionic =  ‍k 𝐼k . It does not take into 
account thermal noise in the channels, i.e. a non-stochastic description of the ion channels, Ik 
can be described by Hodgkin-Huxley (200) equation  
 𝐼k =  g k  ξ
𝑝k  𝜂𝑞𝑘  (𝑉 − 𝐸𝑘)                ‎4.2 
where g k  is the maximum conductance of the ion channel k. ξ and η are the ion channel 
activation and inactivation variables, respectively and Ek is the reversal potential of the 
channel. All activation (ξ) and inactivation (η) variables can be described by differential 
equations of the form: 
𝑑𝜉
𝑑𝑡
 =  𝛼𝑘(𝑣)(1 − 𝜉) −  𝛽𝑘(𝑣)𝜉      ‎4.3 
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αk and βk are rate functions according to (209). The values of the parameters from equations 
above that were used in this study are given in Table ‎4.1.  
 
 Na+ K+ Ca2+ leakage 
transient Persistent DR A C AHP   
pk 3 2 2 1 1 1 1 0 
qk 1 0 0 1 0 0 0 0 
𝐠 𝐤 
[nS/m2] 
0.30 0.0017 0.15 0.05 0.1 0.008 0.04 0.001 
Ek [mV] 115 -15 140 ~2 
Table ‎4.1 ChR2-CA3 Hippocampal Neuron model- Fitting Parameters. =0.001 nS/m2 and 𝑉 =  𝑉ini , 
where 𝑉ini  is the initial value for the membrane potential which reduces the sum of all terms  in Eq. 4.1 
to zero at rest. The soma area is 𝐴soma = 1150m2 and soma capacitance is C=0.01 pF/m2. 
𝐼ChR 2 represents the ChR2 stimulating photocurrent. In most generic case, the photocurrent is 
a function of the light irradiance ϕ(t), the ChR2 photocycle and the membrane potential V. 
Assuming that the reversal potential of ChR2 is zero (147), 𝐼ChR 2  can be described by  
𝐼ChR  𝜙, 𝑡, 𝑉 = 𝐺ChR  𝜙, 𝑡, 𝑉 ∙ 𝑈     ‎4.4 
The voltage-dependent ion channels calculation, e.g. Eq. 4.2, uses scaled membrane potential 
(it assumes rest potential is 0mV) it is necessary to convert it back to the real (absolute) rest 
potential (e.g. -65mV) when calculating ChR2 current (otherwise 𝐼ChR 2 = 0 at rest regardless 
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the illumination). Hence, 𝑈 = 𝑉 + 𝑉rest  where V is the voltage used in Eq. 4.2 (i.e. assumes 
𝑉rest =0mV) and 𝑉rest  is the real cell rest potential. 
𝐺ChR  is the ChR2 conductivity function. It is convenient to separate 𝐺ChR  to a voltage 
dependent and a light dependent element. 
𝐺ChR  𝜙, 𝑡, 𝑉 = 𝐺ChR  𝜙, 𝑡 ∙ 𝑔𝐶ℎ𝑅 𝑉       ‎4.5 
The light dependent element 𝐺ChR  is described by the kinetic model presented in previous 
chapter. It conists the two open states  
𝐺ChR  𝜙, 𝑡 = 𝑔O1𝑁O1 𝜙, 𝑡 + 𝑔O2𝑁O2 𝜙, 𝑡      ‎4.6 
𝑔O1 and 𝑔O2 are the relative conductivity of open states O1 and O2, respectively. 𝑁O1 𝜙, 𝑡  
and 𝑁O2 𝜙, 𝑡   are the number of ChR2 at open states O1 and O2 at time t , respectively.  
Bamberg et al. (213) reported recently that ChR2 conductivity depends as well on the 
membrane potential. The voltage dependent element of the conductivity 𝑔𝐶ℎ𝑅 𝑉  can be 
approximated from the the inwardly rectifying current-voltage curve in (213) as a typical diode 
I-V curve 
𝐺 𝑈 = 𝐺0[1 − exp  −
𝑈
𝑈0
 ]       ‎4.7 
where G0 and U0 are fitting constants. Thus, the dynamics of ChR2 photocurrent in a voltage 
changing condition is given by   
𝐼ChR  𝜙, 𝑡, 𝑈 = 𝐺0 (𝑔O1𝑁O1 𝜙, 𝑡 + 𝑔O2𝑁O2 𝜙, 𝑡  ∙  1 − exp  −
𝑈
𝑈0





4.3.1 Single Action Potential 
First, the model was used to examine the dynamics of the photocurrents before, during and 
after the generation of a single action potential. An example of simulated ChR2-evoked action 
potential is shown in Figure ‎4.2. At the initiation phase, the flux of light generates an increase 
in ChR2 conductivity that results in an influx of depolarizing current, the magnitude of which 
is determined by the light, number of ChR2 expressed in the cell and the membrane rest 
potential. The depolarization of the membrane potential reduces the ionic driving force across 
the ChR2 molecules (negative-feedback) and leads, together with the ChR2 intrinsic 
desensitization process (see ‗ChR2 conductivity‘ plot in Figure ‎4.2), to a reduction in the 
photocurrents. As a result, in contrary to a situation where the voltage is clamped, here the 
photocurrents peak (indicated by arrow 1 in Figure ‎4.2) occurs before the ChR2 conductivity 
peak, i.e. the point when activation rate equal desensitization rate (Figure ‎4.2). 
The depolarization currents via ChR2 activate the voltage-gated Na+ channels. The 
action potential is triggered when sufficient Na+ channels are activated to carry the nonlinear 
positive-feedback depolarization burst (indicated by arrow 2 in Figure ‎4.2). The transient 
depolarization via the voltage-gated Na+ channels further reduce the ionic driving force across 
the ChR2s, which eventually, when the membrane potential overshoots the zero value 
(indicated by arrow 3 in Figure ‎4.2), reverse the ChR2-currents direction (i.e. anion dominated 
current). At the spike peak, most of the voltage-gated Na+ channels are inactivated and 
polarizing currents via the voltage-gated K+ channels and the calcium-activated voltage-




Figure ‎4.2 Simulation of ChR2-Evoked Action Potential. Bottom panel: depolarization of the membrane 
potential by a 10ms light pulse of 40mW/mm2. Middle panel: change in ChR2 conductivity. Top panel: 
currents through ChR2 (red); voltage-gated Na+ channel (182); voltage-gated K+ channel (blue). Scale 
bar is 40mV (membrane potential), 40pS (ChR2 conductivity), 100pA (ChR2 current), 1nA (currents 
through voltage-gated Na+ and K+ channels). I initiation phase, II spike upstroke phase, III spike re-
polarization phase. 
The re-polarization of the membrane below zero voltage returns the cation dominated current 
to ChR2s (indicated by arrow 4 in Figure ‎4.2). The depolarization current via ChR2 at this 
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stage works against the natural re-polarization process of the neuron. Once the light is turned 
off, the conductivity of ChR2 drops and the membrane potential is left to re-polarize to its rest 
potential. However, the slow closing of ChR2 (see ‗ChR2 conductivity‘ plot in Figure ‎4.2) leads 
to a large residual post-spike depolarization current via ChR2 (indicated by arrow 5 in Figure 
‎4.2) which prolongs the return to rest potential and potentially the refractory period. 
In the following sections the model is combined with experimental data to examine the 
dynamics of ChR2-induced train of action potentials. In principle, the spiking pattern can be 
modulated by tuning the light irradiance (continuous stimulation) and/or controlling its 
duration (pulsed stimulation); both approaches are tested. 
4.3.2 Spike Train induced by Continuous Stimulation 
Figure ‎4.3A shows representative experimental results of a train of action potentials induced by 
continuous illumination and a similar train reproduced by the model. Under continuous 
stimulation, the frequency of spiking can be adjusted by modulating the ChR2 conductivity via 
the light irradiance. The inter-spike spacing is shorter in the beginning of the spike train during 
the transient phase of ChR2 photocurrent. The inter-spike spacing reaches a steady state when 
the ChR2 conductivity reaches its stationary level.  
Figure ‎4.3B (black curve) presents simulation results of steady state spiking frequency for 
increasing light irradiances. It illustrates that at low irradiance the firing frequency increases 
linearly with increasing irradiance, but then saturates at high irradiances (around 40mW/mm2). 
At steady state, both ChR2 photocurrents Figure ‎4.3B (blue curve) and the spiking frequencies 





Figure ‎4.3 Spike Train Induced by Continuous light stimulation. (A) Experimental and reproduced 
spike trains induced by 500ms of saturating (40mW/mm2) light. Zoomed views of steady state spikes 
(highlighted) are presented above together with their 1st derivative (grey). Experiments were carried out 
with Dr. Matt Grubb, who performed the patch clamp recordings. (B) Mean spiking frequency and 
ChR2 peak conductivity (blue) vs. light irradiance. (C) Comparison with spiking, which had similar 
firing rate, but were induced by the patch clamp apparatus (100pA direct injection of current). Left: 2nd 
(52) and 3rd (bottom) spike. Right: Phase plot diagram of steady-state spikes generated by ChR2 (blue) 
and injection of 100pA (red). 
 Figure ‎4.3C compares between action potential waveforms induced by ChR2 and ones 
induced by direct current injections (using the patch clamp apparatus). In both cases, the spike 
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trains had similar steady state firing rate. It indicates that the efficiency of ChR2 currents to 
depolarize the neuron declines along the pulse train. However, under continuous stimulation, 
spikes induced by ChR2 have stronger after-spike re-polarizations than spikes induced by 
current injection. Since the level of after-spike re-polarization affects the recovery of the high-
voltage N+ channels (that drive the spike upstrokes) it should be an advantage. Indeed, the 
phase-plot diagram, Figure ‎4.3C, shows that although both types of stimulation yielded similar 
firing rate, ChR2-evoked spikes had lower thresholds, stronger depolarization rises and higher 
peaks.  
4.3.3 Spike Train Induced by Pulsed Stimulation 
Continuous stimulation enables control over the mean frequency by tuning the illumination 
intensity. However, the timings of individual spikes in this stimulation approach are practically 
arbitrary. Generation of spike trains, in which each spike is precisely timed, can be achieved by 
pulsed illumination. Figure ‎4.4A shows representative spike trains induced by pulsed 
stimulation. The fidelity of the spiking depends on the stimulation frequency. Using saturating 
irradiance, spike trains with relatively good pulse-spike coupling were successfully generated up 
to a frequency of 40Hz. At frequencies higher than 40Hz, the stimulation failed to induce 
individual spikes. In comparison, using direct current injection, complete spike trains up to a 
frequency of 75Hz were successfully elicited (shown in Figure ‎4.5A). The spike fidelity as a 
function of stimulation frequency is summarized in Figure ‎4.4B. It implies that the stimulation 
failure happened before the natural adaptation process of the neurons. The failure of ChR2 
stimulus to elicit action potentials at high frequency was reported in the literature by others: 
Boyden et al. 30Hz (148), Li et al. 5Hz (149), Ishizuka et al. 20Hz (150), Arenkiel et al. and 
Wang et al. 40Hz (162) and (161) and Zhang et al. 50Hz (218).  
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Figure ‎4.4C shows that the spike loss is associated with a frequency dependent increase 
in the spiking latencies. Figure ‎4.5B,C shows analysis of the spiking parameters during the 
spikes preceding the failure event. It confirms that the increase in the spiking latencies was not 
related to escalation of the spike threshold or significant deterioration in the capacity of the 
neuron to spike. Examination of the spike initiations phase, shown in Figure ‎4.6, reveals that 
the spike loss was a result of a continuous frequency-dependent drop in the capacity of ChR2 
photocurrents to depolarize the membrane. It also implies that the degradation in ChR2 
stimulation capacity happened primarily after the first action potential. 
One reason for the drop in ChR2-depolarization efficiency is the ChR2 desensitization 
process (i.e. light adaptation), which develops along the pulse train till it reaches its stationary 
level. Figure ‎4.7 shows how the photocurrent response decline along the pulse train. It also 
reveals that ChR2 responsiveness declines faster when long light pulses are used. However, in 
these cases, ChR2 reaches steady state level that is closer to the one achieved by continuous 
illumination. This feature is evident in Figure ‎4.8B. The dynamics of ChR2 desensitization 
does not depend on the stimulation frequency, as is demonstrated in Figure ‎4.8A. However, it 




Figure ‎4.4 Spike Train Induced by Pulsed light stimulation. (A) Experimental and reproduced action 
potentials induced by trains of saturating (40mW/mm2) 5ms pulses of light at 10Hz, 40Hz and 50Hz. 
Experiments were carried out with Dr. Matt Grubb, who performed the patch clamp recordings. (B) 
Spiking fidelity vs. stimulation frequency for ● Current injection and ■ ChR2. (C) Spike loss preceded 
by continues increase in spiking latencies. Left: Overlay plot comparing the first (182), second (red) and 
third (blue) action potentials induced by 10Hz and 50Hz light stimuli (40mW/mm2, 5ms pulse 
duration). Right: Summary of spike latency along the spike train for ∆ 10Hz, ● 40Hz, □ 50Hz, ♦ 60Hz 




Figure ‎4.5 Comparison with Current Injection Stimulation. (A) Action potentials generated by train of 
5ms 200pA pulses injected current. Experiments were carried out with Dr. Matt Grubb, who 
performed the patch clamp recordings. (B) Analysis of spike loss scenario. The graphs summarize the 
dynamics of the spiking parameters from the beginning of the stimulus till the first spike failure. ■ 
Spiking induced by 50Hz 5ms light pulses; ● Spiking induced by 90Hz 5ms 200pA pulses of current 
Top-left: Change in (after spike peak) re-polarization rates Top-right: Change in maximum re-polarization 
potentials Bottom-left: Change in action potentials heights Bottom-right: Change in spiking thresholds. (C) 






Figure ‎4.6 Drop in ChR2 Depolarization Efficiency along the Pulse Train. (A) Single action potential 
with the initiation phase highlighted, i.e. the stage in which ChR2 currents need to depolarize the cell 
above threshold, highlighted. (B) Calculated photocurrents at the initiation stage at the 1st (182), 2nd 
(red) and 10th (green) spikes induced by 40Hz train of 10ms 40mW/mm2 pulses. (C) Decline in the 






Figure ‎4.7 Drop in ChR2 Photocurrent along the Pulse Train. Photocurrents induced by 40Hz train of 
40mW/mm2 pulses of light and recorded with voltage-clamp (-60mV). Pulse duration was 1ms (red) or 
10ms (blue). For comparison, photocurrent induced by continues light with similar irradiance is also 
plotted (182).  Experiments were carried out with Dr. Matt Grubb, who performed the patch clamp 
recordings. (B) Zoomed view of first three spikes (highlighted area 1) (C) Zoomed view of steady state 






Figure ‎4.8 Drop in ChR2 Photocurrent along the Pulse Train - Sensitivity to Pulse Width. (A) 
Photocurrent peaks from 60Hz stimuli with 40mW/mm2 irradiance and 1ms (empty symbol) or 10ms (full 
symbols) pulse widths (B) 2nd (circle symbols) and 10th, i.e. steady-state, (triangle symbols) photocurrent peaks 
from 40Hz (full symbol) or 60Hz (empty symbol) stimuli normalized to first peak (C) Minimum inter-pulse 
photocurrents from 40Hz stimuli (full squares) and 60Hz stimuli (empty squares) (irradiance 40mW/mm2, 
pulse width 10ms). (D) Minimum inter-pulse photocurrents after 1st pulse (full symbols) and 10th, i.e. 
steady-state, pulse (empty symbols) induced by 40Hz (circle symbols) and 60Hz (triangle symbols) with different 





Figure ‎4.9 Drop in ChR2 Photocurrent along the Pulse Train - Sensitivity to Irradiance. (A) 
Photocurrent peaks (normalized to 1st peak) induced by ▲1mW/mm2 40Hz, ● 1mW/20Hz, ■ 
1mW/mm2 10Hz, ▲40mW/mm2 40Hz, ♦ 40mW/mm2 60Hz (B) Net photocurrent response from 
1mW/mm2 (182) and 40mW/mm2 (grey) light. Net response was calculated by subtracting the 
preceding inter-pulse current from the pulse peaks. 
The role of the pulse width and the pulse irradiance in determining the kinetics of 
desensitization processes is sourced in the fact that ChR2 desensitization is caused by light 
(‗light adaptation‘), as is discussed in previous chapter, and hence the longer or stronger the 
light stimulus, the faster the desensitization process. 
Figure ‎4.10 shows that the drop in ChR2 depolarization efficiency is affected as well by 
the slow closing of ChR2 that leads to residual post-spike depolarization currents, which 
reduce the ionic driving force during the following light pulse. In other words, since the 
magnitude of ChR2 photocurrents is proportional to the membrane voltage, as was illustrated 
in Figure ‎4.2, the less the membrane re-polarizes after an action potential, the weaker will be 
the ChR2 response to the succeeding light pulse. Furthermore, post spike ChR2-depolarization 
currents can prolong the neuronal refractory period and leads to higher spike thresholds. The 
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magnitude of the inter-spike currents through ChR2 are inversely dependent on the inter-pulse 
period, i.e. larger currents in case of high frequency stimulus, Figure ‎4.10C, and/or longer 
pulse widths Figure ‎4.8C&D. The reason for that is that long pulses and/or high frequencies 
lead to short inter-pulse dark periods. 
 
 
Figure ‎4.10 Post-Spike (Dark) Depolarization via ChR2 Photocurrents. (A) Waveform comparison 
between light (182) and current injection (red) induced by 5ms stimulus. (B) ChR2 photocurrent (182) 
depolarizes the cell membrane (blue) also after light is turned off (red arrow). (C) Maximum inter-spike 




4.3.4 Sensitivity to Irradiance & Pulse Duration 
In the previous sections underlying mechanisms that govern the dynamics of ChR2-evoked 
spiking were analysed and the dependency on light parameters were elucidated. This section 
examines the effect of the light stimulation parameter directly on the spiking yield.  
Figure ‎4.11A simulates how the spiking fidelity is affected by the pulse irradiance. It 
demonstrates that the spiking fidelity increases as the irradiance increases however, it saturates 
at irradiances above 40mW/mm2- when ChR2 response saturates. Figure ‎4.11B simulates how 
the spiking fidelity is affected by the duration of the light pulse. It shows that at high 
irradiances (close to saturation), the duration of the light pulse does not affect the spike 
generation (as long as it is longer than a certain value, in this case 2.5ms). In fact, Figure ‎4.11B 
reveals that long pulses can deteriorate the spike latencies. This feature is related to the 
stronger post-spike ChR2-depolarization process as was discussed above. 
Moreover, experimental results showed that in some cases, e.g. Figure ‎4.11C, long 
pulses can lead to fast spiking break down. The accelerated spike failures were due to the fact 
that the prolong post-spike ChR2-depolarization generated secondary spikes which destroyed 
the fine coupling between the light stimulation and neuronal response, as is seen in Figure 
‎4.11D. In this case, when the pulse duration was increased above 8ms, the ChR2-currents 
induced by the first light pulse, were large enough to trigger double spikes which took the 





Figure ‎4.11 Sensitivity of ChR2-Evoked Spiking to Irradiance and Pulse Width. (A) left: Effect of 
irradiance on spike fidelity. It shows the frequency in which the first spike failure occurs as a function 
of stimulation irradiance. The number of sequential spikes before loss is indicated as well (e.g. at 
20mW/mm2.the first spike that was lost was the 6th during 50Hz train). Pulse widths were 5ms. Right:  
Effect of irradiance on spike latencies. The plot shows spike latencies of 1st (182) and 10th (red) spikes 
during 30Hz spike trains induced by 5ms light pulses. (B) left: Effect of pulse duration on spike fidelity. 
Irradiance was 40mW/mm2 (i.e. saturation), Right: Effect of pulse width on spike latencies. 40Hz spike 
train induced by saturating 40mW/mm2 pulses. (C) Effect of pulse width observed in experiments. The 
plot shows the number of successive spikes till failure as a function of pulse width. The spikes were 
induced by 60Hz trains of saturating (40mW/mm2) light. (D) Left: A single action potential induced by 
1ms (blue), 5ms (green), 8ms (red), 10ms (182) light (40mW/mm2). The red arrow indicates the 
generation of secondary spike when the pulse was sufficiently long. Right: Spike latencies along the 
pulse train till spiking is lost. Spikes were induced by 60Hz pulse train of 40mW/mm2 light. The red 
arrow highlights the leap in 2nd spike latency when the first pulse begins to induce double spikes. 
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4.3.5 Effect of ChR2 Expression Level on Spiking Rate 
The number of ChR2 channels expressed in the cells affects the magnitude of the 
photocurrent response which will modify the spiking pattern for a given light stimulus. The 
effect of the expression level on the spiking response was simulated by changing the 𝐼𝑚𝑎𝑥 (see 
Eq. 3.6 in previous chapter) while keeping the light parameters constant (in this case 500ms, 
40mW/mm2 light stimulus). The results, shown in Figure ‎4.12A, demonstrate that higher level 
of expression leads to large photocurrents which generate spike trains with higher spiking rate. 
However, Figure ‎4.12A also shows that if the photocurrents increased above a certain level it 
can deteriorate the spiking. The reason for that is the fact that on one hand, large 
photocurrents result in strong driving currents at the initiation of the spikes which initially lead 
to short spike latencies and high spiking rates, but on the other hand, larger photocurrents 
generate as well strong post-spike currents that resist the re-polarization of the membrane 
which can temporally widen the spikes and eventually deteriorate and block the neuron 
susceptibility to carry the action potential oscillation. 
4.3.6 Neuronal Accommodation during ChR2-Stimuli 
It is well established that neurons control their excitability by modulating their spiking 
thresholds (217, 219, 220). Neurons use this mechanism to limit the firing frequency in a 
process known as spike frequency adaptation (or accommodation). The threshold of spiking 
can be increased by for example a decrease in the level of after-spike re-polarization (221), 
which reduces the recovery of high-threshold sodium channels and causes accumulation of 
sub-threshold potassium permeability via voltage-insensitive calcium-activated potassium 
channels (216, 222). Or by a decrease in the spikes upstroke rate (221) that can trigger early 
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activation of otherwise high-voltage potassium channels (220). Figure ‎4.12B compares the 
effects of these accommodation related processes between ChR2 and patch-camp stimulations. 
It shows that the thresholds of spikes that were induced by ChR2 were less affected by the 
decrease in the inter-spike re-polarization. 
 
Figure ‎4.12  Effect of ChR2 expression on mean spiking frequency. (A) Simulation of mean spiking 
rate for different level of ChR2 expression, Inset graph: Steady state photocurrent response (at -65mV 
holding potential) induced by 500ms 40mW/mm2 light stimulation vs. level of ChR2 expressed. Main 
graph: Mean spiking rate plotted against steady state photocurrents shown in the inset graph. For 
illustration experimental values are shown (highlighted in red) for the spiking patterns that were shown 
in Fig 4.3A and 4.4A (steady-state photocurrent 330pA and mean spiking rate ~35Hz). (B) Comparison 
of Neuron Adaptations during Electrical and Light Stimulations. Mean spiking threshold vs. inter-spike 





4.4 Summary and Conclusions 
This chapter examined the dynamics of ChR2 mediated light-to-spike process. It used an 
original kinetic model and an experimental investigation to discover the underlying 
mechanisms that govern and limit the process. In continuous stimulation, the steady state 
spiking can be tuned by controlling the light irradiance. In this mode, ChR2 stimulation has an 
advantage over electrical stimulation since it introduces less resistance to the neuron re-
polarization during the inter-spike periods. It was shown that this is manifested in maintenance 
of low threshold and high spike values. In contrast, in pulsed stimulation ChR2 has in principle 
disadvantages over electrical stimulation since it closes slower and hence introduces more 
resistance to the re-polarization during the inter-pulse periods.  
It was shown that in a pulse mode, the fidelity of the stimulation is limited by a 
continuous drop in ChR2 efficiency to depolarize the neuron. This drop is due to (a) light 
adaptation process that degrades the ChR2 conductivity and (b) post-spike ChR2-induced 
membrane depolarization, which reduces the driving force across ChR2 and prolongs the 
neuronal refractory period. The speed in which the desensitization develops along the pulse 
train depends on the duration of the light pulse and on its irradiance and does not depend on 
the stimulation frequency. It develops slower when short pulses are used, however the 
magnitude of the photocurrents in steady state can be smaller in this case. The level of post-
spike depolarization depends on the inter-spike spacing and hence it is more pronounced at 
high frequencies and longer pulses. This may explain the high frequency boundary that has 
been reported by many research groups.  
These findings give a framework for the retinal prosthesis stimulation. In principle, the 
ChR2 expressing retina should be stimulated with high irradiances that will maximize the 
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magnitude of the photocurrent and hence the spiking response. However it was shown that 
there is no benefit of increasing the irradiance above the saturating value (around 
40mW/mm2). In fact, an example was given, in which at high expression level, saturating light 
can have a negative destructive effect. It was also shown that the pulse length should be kept 
as short as possible in order to minimize the post-spike depolarization. An example was given 
in which increasing the pulse length led to a complete demolition of the spiking due to 
generation of double spikes, which broke the coupling between the light input stimulus and 






Chapter Five: Lab Prototype  
5.1 Introduction 
In chapter 1 the need for functional retinal prosthesis was described. In chapter 2 it was 
envisaged that ChR2 can be used as the basis of a new type of retinal prosthesis. Chapter 3 and 
4 revealed the fundamental mechanisms of stimulation neurons with ChR2 in order to enable 
the development of illumination strategies for the prosthesis. This chapter describes the 
development and demonstrates functionality of an optical hardware that is capable of 
generating high-resolution two-dimensional stimulation patterns on the retina. First, the 
requirements from the optical hardware are established. Next, a solution based on a matrix of 
high-power micro-emitters is presented. Then, its performances are characterized and finally 
its functionality is tested in-vitro on ChR2 expressing neurons. 
5.2 Material and Methods 
The prototype developed in this chapter utilizes a micro-emissive matrix that was fabricated by 
Martin Dawson‘s group in the Institute of Photonics at Strathclyde University and a control 
board that was made by Vincent Poher at that time a PhD student in Mark Neil‘s group at the 
Department of Physics. The efficiency of the prototype was tested by Botond Roska‘s 
laboratory (FMI Basel) on retinal slices from blind rd1 mice expressing ChR2 using MEA 
recording and on cultured hippocampal neurons by the author and Dr. Matt Grubb (Kings 
College London) who performed patch clamp recording.  
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5.2.1 Optoelectronic Measurements  
The emission spectrum was measured by placing a spectrometer (Ocean Optics) directly above 
the emitters. The currents through the emitters and the corresponding emission powers were 
measured by placing the chip on an isolated mount and injecting directly currents through 
individual LEDs using a Keithley 2000 multimeter (Keithley Instruments Inc.). The voltages were 
recorded with a Fluke 73111 (Fluke Ltd.) voltmeter and the emitted power with a FieldMaxII-
TO (Coherent) power meter that was placed on chip. In order to test variability in the emission 
power, the micro-LEDs were driven one-by-one using a self written Matlab (Mathworks Inc.) 
code and the corresponding emission powers were recorded with the same power meter that 
was connected to a PC. The shuttering kinetics of the emitter was measured by placing a fast 
silicon biased photo-detector DET 100A/M (Thorlabs) directly on the chip and the signal was 
recorded with Oscilloscope.   
5.2.2 Optics  
An optical setup to image the light source was simulated in Zemax optical design software 
(Zemax development cooperation). The performances of the optics were characterized by measuring 
the spot size and irradiance at the image plain. The spot size was measured from a fluorescent 
image of the matrix on a thin fluorescent sheet. The image was taken with a CCD camera (Orca 
ER) and was analyzed with Origin 8.0 (OriginLabs).  The on-sample power was measured by 




5.2.3 Programming  
Operation software was developed in Matlab 8.1.0 (Mathworks Inc.). The code used the 
frameworks provides in Matlab data acquisition toolbox. In this way, the on-board PIC 
processor was represented as a device object in the PC. The object provides the gateway to set 
and activate the matrix using the conventional Matlab language. The toolbox then translates 
the Matlab comments to the physical device by MEX-file dynamic link library (DLL) file. The 
MEX-DLL also stores associated property values, controls the synchronization of events and 
the storage of acquired or queued data. 
5.2.4 ChR2 Expression in Mice RGCs  
Mice used for these experiments included PV-Cre and C3H/HeNCrl (rd1) mice. In PV-Cre 
mice, kindly provided by Silvia Arber, Cre recombinase is expressed under the control of the 
parvalbumin (PV) locus. At 4-5 weeks after birth, the right eyes of the mice were injected with 
pAAV-double floxed-hChR2(H134R)-mCherry-WPRE-pA, kindly provided by Karl 
Deisseroth.  The rd1 mice were purchased from Charles River Laboratories (L'Arbresle Cedex, 
France). The right eyes of the mice were injected with pAAV-ChR2-mCherry-WPRE-pA. The 
transfection of the rd1 mice was done by Botond Roska‘s lab at FMI, Basel. All animal 
procedures were performed in accordance with the standard ethical guidelines (European 
Communities Guidelines on the Care and Use of Laboratory Animals: 86/609/EEC) and were 
approved by the Veterinary Department of the Canton of Basel-Stadt.  
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5.2.5 ChR2 Expression in Primary Hippocampal Neurons  
Rat hippocampal neurons transfected with fused ChR2-YFP protein were used. The culture 
and transfection procedures are similar to the ones described in chapter 4. 
5.2.6 Electrophysiology  
Patch clamp recording on hippocampal neurons were performed in the same way as was 
described in chapter 4. MEA recording were performed by placing isolated ChR2 tranfected 
retinas on a flat MEA60 200 Pt GND array (Ayanda Biosystems, Lausanne, Switzerland). The 
signals were recorded using MEA1060-2-BC (Multi-Channel Systems, Germany) and filtered 
between 500Hz (low cut-off) and 3500Hz (high cut-off).  
5.3 Requirements for Light Source 
For use in the proposed retinal prosthesis device, the light module‘s emission spectrum must 
match the wavelength sensitivity of ChR2, between 460m and 470nm (147), with enough 
radiance to elicit action potentials. In addition, it must have adequate spatial and temporal 
resolution to generate precisely timed action potentials in large number of individual retinal 
cells. And it has to be small enough to fit in a head-mount device. 
5.3.1 Spatial resolution 
Ideally, the light spot diameter and the inter-spot spacing of the light module will match the 
size of the retinal cells and their density, respectively. According to Rockhill et al. (223), who 
studied the diversity of RGCs in mammalian retinas, the mean density of RGCs is around 
300cells/mm2, i.e. mean inter-soma spacing of 50m. The size of the dendritic tree of the 
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RGCs varies from ~10m inside the fovea (224) to 100m outside the fovea (225, 226) and 
their somatic diameters vary between 10m and 16m (227). Thus, assuming the prosthesis 
will target initially the parafoveal region, the light module should be capable of generating a 
two-dimensional stimulation pattern on the retina, in which a single light spot has a diameter 
of ~15-20m (assuming the light targets the soma) and a minimum inter-spot distance of 
30m. 
5.3.2 Temporal resolution 
Ideally, the temporal resolution of the light module will be sufficient to generate trains of 
action potentials with the maximal possible spiking rate observed in RGCs. In reality, RGCs 
have wide spectrum of spiking characteristics. O‘Brien et al. (228), who studied the intrinsic 
properties of RGCs in cats, reported that alpha type RGCs (3% of total RGCs population 
(229, 230)) have the highest spiking frequency of 262Hz (maximal) and 67Hz (sustained). In 
comparison beta type RGCs (~45% of RGCs population (229, 230)) have 152Hz (maximal) 
and 60Hz (sustained) spiking frequencies (228). Thus, the light module is required to operate 
with a temporal resolution of ~4ms. Nevertheless, it should be remembered that, as was 
discussed in details in chapter 4, the actual temporal resolution of the spiking process can be 
downgraded by the kinetics of ChR2.  
5.3.3 Radiance 
The light module needs to provide sufficient on-sample irradiance to evoke action potentials. 
An irradiance of 0.1mW/mm2 to 1mW/mm2 (106cd/m2 and 107cd/m2) of blue light has been 
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conventionally considered to be the spiking threshold with ChR2 (218). In order to estimate 
the corresponding radiance requirements, the effect of the eye optics has to be considered.  
This situation is illustrated in Figure ‎5.1. In principle, when a light source with a 
radiance L (W·mm-2·sr-1) and a diameter D is imaged by the eye‘s optics on the retina it 
generates an image with a diameter d and radiation power 𝑃𝑟𝑒𝑡𝑖𝑛𝑎  that depends on the pupil 
size and light losses in the ocular media. If all the light source points (X) have approximately 
the same distance r from the pupil and a similar solid angle =𝐴𝑝/r
2 = (p2/4)/r2, the total 
power that falls on the pupil by a light source is 𝑃𝑝𝑢𝑝𝑖𝑙 = L𝐴𝑠 , where 𝐴𝑠=D
2/4 is the area 
of the source. In this case, the irradiation power 𝑃𝑟𝑒𝑡𝑖𝑛𝑎 (W) that falls on the retina is 𝑃𝑟𝑒𝑡𝑖𝑛𝑎  = 
𝑃𝑝𝑢𝑝𝑖𝑙 , where  is the transmittance of the ocular media, which is determined by the scattering 
and absorption at the given wavelength. The irradiance 𝐼𝑟𝑒𝑡𝑖𝑛𝑎 (W·mm
-2) on the retina will 
therefore equal 𝐼𝑟𝑒𝑡𝑖𝑛𝑎 = 𝑃𝑟𝑒𝑡𝑖𝑛𝑎  /𝐴𝑟 , where 𝐴𝑟=d
2/4 is the area of the image of the source  
 
Figure ‎5.1 Principle of Image Formation in the Eye. An Object with diameter D is imaged by the eye‘s 
optics on the retina. 
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on the retina. The diameter of the image d can be approximated by d=(f/r)D, where f is the 
effective focal length of the refracting medium in the eye, consisting of the cornea, aqueous 
humour, lens and vitreous humour. Hence, the irradiance on the retina 𝐼𝑟𝑒𝑡𝑖𝑛𝑎  can be 
expressed solely in terms of the eye optics  
𝐼𝑟𝑒𝑡𝑖𝑛𝑎 =  (Lp
2/f 2 L/F      ‎5.1 
where /4, and F=p/f (the so-called F-number). 
The human eye of an adult has an effective focal length of f=17mm (231) and a pupil 
size (though varies) of approximately 2-3mm (231, 232). Hence, the F-number (F) is in the 
range of 5-8. The transmittance of the human eye for the blue spectrum is below 90% (233) 
and hence conservatively can be considered as =0.5. Using Eq. 5.1 and the parameters 
above, the relation between the on-the-retina irradiance and the source radiance can be 
derived.  
𝐿𝑚𝑖𝑛 = 50· 𝐼𝑟𝑒𝑡𝑖𝑛𝑎       ‎5.2
Where L and I are in the units given above.  
If a minimum of 𝐼𝑟𝑒𝑡𝑖𝑛𝑎 =1mW/mm
2 is requires to generate action potentials in ChR2 
expressing RGCs, a light source with a minimum radiance of 𝐿𝑚𝑖𝑛  = 50 mW·mm
-2 sr-1 is 
needed.  
5.4 Searching for Conventional Solution 
These radiance levels are only achievable today with high power light sources such as arc-
lamps (148, 218), lasers (158, 163, 171, 234, 235) and bulk high power light emitting diodes 
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(LEDs) (160, 236-238). These light sources however, are not applicable for the retina 
prosthesis since they are all limited to a single illumination point and cannot easily realize a 
precise two-dimensional stimulation patterns. On the other hand, the conventional two-
dimensional light sources, such as back-lit Liquid Crystal Displays (LCDs), Plasma screens and 
Organic Light Emitter Diodes (OLED) possess very good spatial resolution, but lack the 
required radiance capacity. Typical displays generate radiance in the range of 0.25·10-4-1·10-
4mW/mm2 (250 and 1000cd/m2. The pulse peak can be higher, but still do not reach the 
required illumination threshold. Hence, currently available light source devices do not meet the 
requirements for ChR2 based retinal prosthesis. 
5.5 Micro Light Emitting Matrix  
5.5.1 Background 
Here, a solution that is based on a custom made matrix of 64x64 micrometer sized Gallium 
Nitride light emitting diodes (LEDs) is proposed. Nitride based LEDs can emit light across the 
entire visible spectrum and into the ultraviolet – wavelengths 0.7-6.2eV, i.e. 1.7m-200nm 
(239, 240). They have high radiation efficiencies of up to 12% (241) due to their direct 
bandgap structure. In addition, Nitride LEDs are very robust and can be driven at very high 
current densities due to high thermal conductivity (typically 1.3 W/cm·°C for GaN), very high 
melting temperatures (typically 500°C to 3000°C), and a high bond strength that make them 
inherently robust compounds (241).  
The micro-LED chip has been developed as part of the UK Research Councils Basic 
Technology Research Program ―A thousand micro-emitters per square millimeter‖, which 




Figure ‎5.2 Micro-LED Matrix. Left: An image of the micro-LED matrix, Right: cross-section of a single 
micro-emitter showing the different micro layers. The matrix was fabricated by Martin Dawson‘s group 
in the Institute of Photonics at Strathclyde University, Scotland (242).  
processing commercial semiconductor wafers into micro-structured arrays of emitters. The 
micro-layers are illustrated in Figure ‎5.2. The wafers consisted of a few micron thick n-doped 
semiconductor that is grown on a sapphire substrate (hundreds of microns) and 0.25 
micrometer thick p-doped semiconductor. The light is produced in the active region (few 
nanometers thick) between the p and n materials. This region typically contains multiple 
quantum wells (MQWs) that effectively ―trap‖ electrons and holes forcing them to recombine 
in the middle of the depletion zone. When a positive potential difference is applied across the 
diode (i.e. the diode is forward biased), carriers are injected in the quantum wells where they 




An image of the matrix chip that was used in this thesis is shown Figure ‎5.2. It was fabricated 
by Martin Dawson‘s group in the Institute of Photonics at Strathclyde University, Scotland. 
Each emitter in the matrix has a 20μm diameter and 50μm pitch length. The fabrication 
process that is required to process a semiconductor wafer into a matrix of micro-LEDs is 
described in detail in (242-244). In brief, in the first stage isolated columns with a common 
cathode are formed using dry etching through the complete LED structure (including the n 
substrate). Then individual LEDs are formed by a second dry etching stage (down to the n 
substrate) to form isolated anodes. The inter LEDs gaps are filled with a non-conductive 
material such as SiO2 in order to electrically isolate the LEDs from each other. The light 
emitted by the micro-LED matrix is extracted either from above, ‗top emission‘ or from the 
bottom, ‗bottom-emission‘. In the top-emission device, all the emitters from a row are 
connected by depositing a semi-transparent metal such as Ni-Au p-electrodes across the mesa 
structure. In this case, the light is extracted through the semitransparent p contacts, which 
results in a trade-off between the transparency and the sheet resistance of the contacts 
(large/thick electrode means low resistance but high light absorption). In the case of the 
bottom-emission device, the light is emitted through the sapphire substrate using reflective p-
contacts made of thick Ni/Au/Ti/Au multilayer. In this section the efficiency of the top-
emission and the bottom-emission configurations will be compared. 
5.5.2 Driving Electronics 
The micro-LEDs used in this thesis were addressed in a matrix fashion. In this case, a metal 
line is deposited along the substrate of each column to form the common cathode contacts 
and a p-metal line anode across the mesa structure to connect all the emitters in a row. A single 




Figure ‎5.3 Driving Electronics. Left: Diagram of the driving circuit Right: Image of a printed-circuit 
board (PCB) with the driving circuit. The circuit was made by Dr. Vincent Poher from Mark Neil‘s 
group (Imperial College London) (245). 
a constant current on the corresponding column. The micro-LED matrix is controlled by an 
electrical driver that enables a display of arbitrary binary images at up to 600 frames per 
second. The circuit was developed during the Basic Technology research program by Dr 
Vincent Poher (245) from Mark Neil‘s group in Imperial College London. A schematic 
description of the driving electronics and an image of the board are shown in Figure ‎5.3. The 
circuit provides a user defined bias voltages and current sinks on the rows and columns, 
respectively. The row voltages are controlled by scanning eight MIC5891 programmable 
voltage sources at a rate from 0 to 38,000 rows per second (~25s per row). Each of the 
latched drivers has eight open emitter outputs able to source up to 500mA and sustaining at 
least 35V in the on-state. The drivers are serially connected together so that the shift registers 
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can be addressed using a single controller pin. The current sinks are controlled via four series-
connected MAX6971 constant current sink drivers. Each driver has 16 constant current 
outputs rated at 36V (able to sink from 3mA to 55mA per output) and adjustable through an 
external quad 256-step digital potentiometer controlled by the board microcontroller. 
The overall control of the driver board is made by a PIC18F4550 microcontroller 
working at 48MHz. The microcontroller handles the communications with the host PC 
through an integrated USB port and stores the transferred binary frames in the internal RAM 
memory. A dedicated pin controls the data sent to the common-line registers thus the raster 
scanning. Data are sent to the current chips using a Serial Port Interface (213) enabling rapid 
modification of the pattern to be displayed at the columns on a microsecond timescale. The 
processor looks after the time dependant processes, such as the 10-bit PWM to control the 
emitter brightness, the raster scanning speed and the total amount of time the array is turned 
on. Apart from a direct modulation of the current sinks, the brightness of the LEDs can be 
also controlled through a pulse width modulation (PWM). In this approach the currents are 
driven periodically and the brightness is tuned by changing the duty cycle (ratio of the on 
period over the flashing period).  
5.5.3 Operation Software  
5.5.3.1 PIC Firmware 
The matrix is controlled by an on-board PIC firmware (245) that receives user inputs in real-
time via a virtual RS-232 serial port that was emulated on top of the USB port. In this way, the 
host computer detects a conventional RS-232 port when the driver board is connected to its 
USB socket while keeping the data transfer speed of USB port, i.e. 12Mbits/s. Once initiated, 
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the PIC continuously polls whether data have been sent from the host computer. Any 
retrieved data are automatically stored into the USB buffer before stored in on-chip RAM 
memory. Strings of up to 64 bytes (or characters) can be transferred at once before emptying 
the buffer.  
Several display and pulsing modes were implemented in the PIC firmware. In principle, 
the array is turned on when the processor receives a 1-byte (‗+‘) software trigger, which 
enables interrupts and starts timer counters. After starting a display, the processor goes back to 
USB polling and branched to the according interrupt routine. 
5.5.3.2 User Interface Software  
A code was written in Matlab (MathWorks) to interface with the on-board PIC controller in 
real-time via a PC. The communication with the PIC uses Matlab‘s data acquisition 8.1 
toolbox, Figure ‎5.4 shows a chart flow of the code. The user defines the required 
 
Figure ‎5.4 Diagram of Operational Software. A complex spatiotemporal illumination pattern is defined 
by combining series of pattern objects: pixel/rectangular. Each pixel/rectangular can have unique 
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temporal and intensity property. The code then integrates the objects into a coherent spatiotemporal 
illumination. 
spatiotemporal pattern via a set of basic illumination objects (also refer to as patterns) that 
comply with the operation of the on-board circuitry and firmware. Each object has a specific 
spatial (pixel, rectangular or full frame), temporal (continuous, pulsed or arbitrary) patterns 
with unique intensity (PWM) value.  Thus, an arbitrary spatiotemporal illumination pattern can 
be generated by combination of multiple objects. Each object is translated into a ‗Display 
Matrix‘, in which the binary status of each pixel is represented by ‗1‘ (On) or ‗0‘ (Off), and a 
timing vector, in which the binary status of the object at each time step is represented by ‗1‘ 
(On) or ‗0‘ (Off) . The ‗Time Matrix‘ that contains all the objects timing vectors is then 
converted to a single ‗Event Vector‘, in which the active objects in each time step are listed. 
The user has the option to run an ‗overlap check‘ routine to avoid cross-talks, in which the 
code check if more than one object is active at each time step. Any detected overlap can be 
then negated by for example cancelling the activation of all but one (typically the first) object 
in that time step. After processing the user input, the code is ready to run the illumination 
pattern. The running routine progresses through the ‗Event Matrix‘ using a global time 
counter, matches the required display and translates it to a set of PIC commands that are sent 




5.6 Characterization  
In this section the functioning of the micro-emitter matrix is characterized and the 
performances of two different fabrication configurations, i.e. top-emission and bottom-
emission, are compared in order to assess their applicability for retinal prosthesis applications.  
5.6.1 Emission spectrum 
 
Figure ‎5.5 Emission Spectrum and I-V curve. TE: top-emission, BE: bottom-emission. 
The emission spectrum of the emitters was characterized in order to check if it matches the 
action spectrum of ChR2. The emitters were driven with 3mA per emitter and their spectra 
were measured using an Ocean Optics spectrometer. The spectrum is presented in Figure 
‎5.5A. It was found that the emission spectrum of the LEDs is centered at 465nm with a 
FWHM of 22nm, overlapping with the peak sensitivity of ChR2 (147). 
5.6.2 IV characteristics 
The output current for a given voltage is characterized in order to find the turn-on voltage and 
to compare the efficiency of the devices. The LED matrices were placed in a chip holder so 
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each emitter could be directly driven. Then the voltage across individual LEDs was set and 
their currents were recorded with a standard ammeter. Figure ‎5.5B shows an example of 
current-voltage (I-V) characteristics of an individual pixel in the bottom-emission and top-
emitting matrices. The graphs indicate that in both cases the turn-on voltage is 2.7V. The IV 
characteristic of bottom-emission device is marginally steeper than the top-emission one, 
which implies that the series resistance of the p-contact in the bottom-emission is slightly 
lower. 
5.6.3  Emission Power 
The output power of a single micro emitter was measured in order check if it can be sufficient 
to match the ChR2-spiking threshold. The optic power was measured with a Newport 1918-C 
power-meter that was placed 1cm above the emitters. Since the diode had 1cm2 active area it 
covered a solid angle of ~1sr. Figure ‎5.6A shows representative Pout vs. Iin curves. The graph 
indicates that for a given input current, the top-emission matrix provides less light that the 
bottom-emission one. At operation current of 5mA, the top-emission device yielded 10W 
light and bottom-emission device yields 70W. Since the micro- emitter has an area of 
~3 ∙ 10−4mm2 and it emits light into a solid angle of 2, the emission radiances is 30mW·mm-
2 sr-1 and 210 mW·mm-2 sr-1 in the case of the top-emission bottom-emission, respectively. This 
implies that the radiance of bottom-emission device is higher than 50mW·mm-2 sr-1 which is 






Figure ‎5.6 Illumination Power and Power Efficiency. TE: top-emission, BE: bottom-emission. 
5.6.4 Emission Efficiency  
The efficiency of the emitter to convert electric power to useful optic power is important since 
it can limit the time the retinal prosthesis can be used with stand-along power supply. Here, the 
emission efficiency of the matrices is analyzed by analysing the electric power to optic-power 
conversion. The electrical power was calculated by multiplying the bias voltages with the 
recorded currents. The results are shown in Figure ‎5.6B. It indicates that both matrices have 
the highest emission efficiency at a bias voltage between 3.5V and 4V. The emission efficiency 
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of bottom-emission is higher than the top-emission one (~order of magnitude higher at typical 
operation voltage of 7V). 
What is the reason for the difference in the light emission efficiency between the two 
devices? In principle the emission efficiency of the LEDs is composed of three elements: (1) 
inj efficiency of injecting current to the junction, (2) rad percentage of radiation type 
recombinant and (3) extract efficiency of extracting the generated light from the diode. The top-
emission and bottom-emission devices have similar chemical composition and hence no 
difference is expected in their inj and rad values. GaNs have typically 12% radiation type 
recombinant ratio (241). However, there is probably a difference in the efficiency the light is 
extracted out in the devices. In the bottom-emission device the light is propagated out via the 
transparent sapphire substrate and hence experience low optical loss. In addition, light emitted 
to the opposite direction is reflected back by the p-contact electrode. On the other hand, in the 
top-emission case, the light needs to propagate out via a semitransparent P electrode, which 
reflects portion of the light back to the chip.  
5.6.5 Emission Homogeneity  
The matrices contain 4096 micro-emitters. There is inherently variation in their emission 
capacity. High degree of variation will introduce uncertainty to the success of the 
photostimulation and might require continuous calibration procedures.  In this section the 
emission histogram is measured. The micro-LEDs were driven one-by-one with a constant 
3mA current and their emission power was recorded with Newport 1918-C power-meter. The 
emission histogram is shown in Figure ‎5.7A. The results indicate that the power emitted by the 
micro-LED pixels has a normal distribution in both matrices. The bottom-emission matrix had 
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second emission peak at higher irradiance. It was found that the second peak, which consists 
of approximately 10% of the micro-LEDs, was caused by on-chip cross-talk, i.e. lighting of 
more than one LED. 
 
 
Figure ‎5.7 Emission Histogram, Emission Stability and Shuttering Speed. (A) Emission Histogram. Top 
panel: top emission matrix, Inset: fitting with a normal distribution. Bottom panel: bottom-emission matrix, 
Inset: fitting first peak (0mW to 1.8mW) with a normal distribution. (B) Stability of Illumination. micro-
LED illumination vs. time in a top-emission (blue) and in a bottom-emission (182) configurations. (C) 




5.6.6 Emission Stability  
The stability of LEDs emission was tested since if its emission degraded with time, the 
photostimulation cannot be reliably applied. The LEDs were illuminated for 50min and their 
output was continuously recorded. A representative result, shown in Figure ‎5.7B, reveals a 
stable emission pattern. The graph indicates that the output emission did not fall below 98% 
and 95% in the case of the top-emission and bottom-emission matrices, respectively.  
5.6.7 Shuttering Speed 
The shuttering speed of the micro-emitters was characterized as well in order to test if it can be 
sufficient to elicit high frequency spiking. The switching on and off times of several randomly 
selected micro-LEDs were measured. A representative waveform is shown in Figure ‎5.7C. The 
micro-LEDs have 10-to-90 (10% to 90%) average rise time of 0.25ms and 90-to-10 fall time of 
2.5ms. The slow offset of the light is abnormal for LED and is probably due to passive 
capacitance of the recording photodiode.  
5.7 Realization of Test Platform 
In the previous section the performances of the micro-emitters matrix was characterized. It 
was found that each micro-LED has the correct emission spectrum, sufficient radiance and 
shuttering kinetics to drive ChR2-spiking. In addition, the emission is stable and has normal 
variability across the matrix. In order to confirm the capacity of the micro-emitters to excite 
ChR2-evoke spiking (first in-vitro) a test platform that images the emitters on the neurons was 
realized. A schematic of the test platform is shown in Figure ‎5.8. In principle, the matrix with 
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the driving board is mounted in a trans-illumination position above a stage of an inverted 
microscope and imaged onto the neuron cells using an appropriate optics.  
5.7.1 Imaging System 
The imaging optics need to provide the required spatial profile and sufficient irradiance for 
photostimulation as well as an appropriate working distance to accommodate for 
electrophysiology recording apparatus such as patch clamp or MEA. The working distance of 
working distance, while the collection efficiency is typically determined by the input NA (large 
NA enables high collection efficiency). The micro LEDs have an approximately Lambertian 
emission profile, i.e. the light is emitted into a solid angle of 2π steradians and the radiant 
intensity is proportional to the cosine of the angle relative to the surface normal. In case of a 
small Lambertian source the collection efficiency η of a lens having a numerical aperture NA is 
given by η ≈ NA2. Thus, in order to collect as much light as possible from the micro-LEDs, 
the imaging system should have large input NA. For example, a lens with a NA of 0.5 will 
collect 25% of the total emission from the LED. However, since the magnification, M, of the 
system is the ratio of the input NA to the output NA, the output NA should be equal or larger 
than the input NA in order to maintain small on-sample spot size. 
Two optical setups that are a trade off between working distance and collection 
efficiency are suggested. In the first setup the emitters are imaged onto the microscope sample 
by a 4f relay configuration comprising two 50mm triplet lenses (Sill Optics GmbH S5LPJ2851) 
to image the matrix with their original size (1:1 imaging) on the neurons. A schematic of the 
lens configuration and representative simulation of the ray path (using Zemax optical system 
design software) is shown in Figure ‎5.9A&C. The optics has input NA of 0.14 which enables a 
large working distance of 40mm allowing good access to recording apparatus. However it 
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requires to compromise in the collection efficiency. The optical configuration is not expected 
to have collection efficiency better than 2%. 
 
 
Figure ‎5.8 Schematic of the in-vitro Test Platform. The micro-LED matrix is imaged onto ChR2-
expressing neurons placed on a microscope stage. The evoked response is recorded via patch clamp or 
microelectrode array (MEA) apparatus. In addition a fluorescent imaging capacity is integrated using 
epi-illumination and camera for identification of successfully trasnfected neurons and for calcium 





Figure ‎5.9 Imaging System. (A) 1:1 imaging configuration consists of two triple lenses. (B) 10:1 de-
magnified configuration consists of a triple lens and a microscope objective. (C) Rays simulation of the 
1:1 configuration (reproduced from Zemax optical system design software). 
The second setup generates 10:1 de-magnified image of the matrix by using one 50mm 
triple lens Sill Optics GmbH S5LPJ2851) and a 40X objective 4.5mm focal length (Olympus 
LUMPlanFI), NA=0.8, Figure ‎5.9B. The de-magnified image improves the on-sample 
irradiance. Progressing through an optical projection system, the Lagrange invariant states that 
the brightness (power per unit area per unit solid angle) can never be increased beyond that of 
the object or rather that collected from the object by the input NA of the system. However, if 
the image is de-magnified then the output NA will be larger than the input NA (the 
magnification, M, is the ratio of the input NA to the output NA) and thus because the solid 




5.7.2 Characterization  
 
Figure ‎5.10 Single Spot (on-sample) Characteristics. (A) On-sample irradiance as a function of bias 
voltage generated by 1:1 imaging. (B) On-sample irradiance by 10:1 imaging. (C) Intensity map of 3x3 
micro-LEDs presented with graphic views of the intensity profile along the white lines. Scale bar is 
25m.  
The properties of the on-sample spots were characterized. The image of the matrix forms a 
stimulation square of 0.3x0.3mm (10:1 imaging) or 3x3mm (1:1 imaging) on the neurons. The 
square is effectively divided to 4096 independent micro stimulation pixels. The spot size and 
peak-to-peak spacing are in the 10:1 imaging case 3m and 5m, respectively, and in the case 
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of 1:1 imaging 30m and 50m, respectively. The on-sample irradiances were measured and 
the results are presented in Figure ‎5.10A&B. It indicates that in both configurations the light 
module can generate light spots with irradiances that are larger than the requirements for 
spiking with ChR2 (1mW/mm2). The on-sample spots power profile is shown in Figure ‎5.10C.  
5.8 Proof-of-Functionality  
In the previous sections, the micro-LED matrix was suggested as a light source for the retinal 
prosthesis. The matrix was characterized and a test platform was realized. In this section the 
functionality of the matrix to generate two-dimensional stimulation patterns and to trigger 
ChR2-evoked spiking in neuronal cells is confirmed. 
5.8.1 Image Transfer  
 




First, the capacity of the matrix to generate two dimensional stimulation images was tested. A 
face image was taken by a standard webcam. Using basic Matlab tools the resolution was 
reduced to 64x64 Figure ‎5.11 (left) and a basic edge detection algorithm was implemented to 
reduce the visual information (in the figure presented here, the edge detection was performed 
by Dr. Patrick Degenaar). The processed image was fed to the driving circuit of the LED 
matrix and the resulting illumination pattern was imaged using Orca ER CCD camera, Figure 
‎5.11 (right). Although few columns and rows did not light up (due to defects in the wire 
bonding of the chip) the details of the face is clearly visible. The image transfer example 
demonstrates the capacity of the module to generate detailed two-dimensional excitation 
images. 
5.8.2 Stimulation of ChR2-evoked Action Potentials  
This section describes the proof-of-concept experiments to trigger ChR2-evoked action 
potentials. The first set of experiments was done by Botond Roska‘s laboratory at Friedrich 
Miescher Institute (FMI) in Basel, Switzerland. Although these experimental results cannot be 
attributed directly to the efforts to the author, they demonstrate the efficiency of the prototype 
developed in this chapter. The experiments tested the capacity to generate action potential in 
blind mice retinas that their RGCs express ChR2. Retinas of rd1 mice, in which most 
photoreceptors are lost by 4 weeks of age (246) were transfected with YFP-ChR2 using in-vivo 
electroporation (247) (see Materials and Methods). Isolated ChR2 tranfected retinas were 
placed on a flat 60 channels multi-electrode array (MEA) and the MEA was placed on the 
stage of a microscope and the micro-LEDs were imaged on the retina. Figure ‎5.12 (top panel) 
shows the micro-LEDs imaged on the rd1 retina in which some of the RGCs express ChR2. 
When a ChR2-expressing RGC was illuminated by a micro-spot it generated a train of action 
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potentials, as seen in Figure ‎5.12 (bottom panel). RGCs that do not express ChR2 did not 
show activity that was time-locked with the light stimulus.  
In the second set of experiments the temporal precision of generating action potential 
was tested. Since at that stage of the project no retinal ganglion cells were available the work 
was done on primary cultured hippocampal neurons. The cell culture, transfection and 
recording procedure are described in detail in Material and Methods in chapter 3 and 4. The 
photonic matrix was imaged using the 1:1 setup on a ChR2 expressing neuron and the image 
was aligned so the soma is covered by a single light spot. First, action potentials were induced 
by continuous illumination and the mean firing rate was tuned by adjusting the output radiance 
of the micro-LEDs. The output power was controlled using a pulse width modulation (PWM) 
technique. Figure ‎5.13 shows an example of spike trains induced by different light irradiances.  
In this approach, spike trains with steady-state frequencies between 0Hz and 15Hz 
were reliably generated. Next, spikes were induced in pulse mode in which a single light pulse 
induces single spike. Here, the spiking frequency was adjusted by tuning the pulsing rate. 
Figure ‎5.14 shows an example of generation of spike trains in pulsed mode. At maximal 
emission power trains of action potentials with frequency up to 20Hz were reliably induced. 
Average first spike latency was 7±1.1ms. The drop in spiking fidelity at high frequencies, in 







Figure ‎5.12 Stimulation of ChR2-expressing rd1 retina. Top: Image of the whole micro-LEDs projected 
1:1 on ChR2 expressing isolated retina of rd1 mouse that was placed on a flat MEA60 (an overlaid 
image of brightfield micro-LEDs illumination and a fluorescence imaging of the mCherry tag). 
Stimulation sites are circled and recorded electrodes are labelled in yellow. Bottom: Example of light 
evoked spike trains induced by spots 1:5. Control-non-transfected RGC; ChR2- transfetcted RGCs; 
spots 1:3 cover ChR2 expressing RGCs; spots 4:5 cover non-transfected RGCs. Spikes (dots) recorded 
from multiple cells are illustrated by raster plots. Measurements were done by Dr. David Balya from 




Figure ‎5.13 Spike Generation in Continuous Mode. (A) Example of spike trains induced by 500ms 
pulse of (from bottom to top) 300W/mm2, 200W/mm2 and 100W/mm2. Experiments were carried 
out with Dr. Matt Grubb, who performed the patch clamp recordings. (B) Mean instantaneous spiking 






Figure ‎5.14 Spike Generation in Pulsed-Mode. (A) Example of generation of individual spikes using 
(from bottom to top) 10Hz, 20Hz and 40Hz trains of 10ms 1mW/mm2 light pulses. Experiments were 
carried out with Dr. Matt Grubb, who performed the patch clamp recordings. (B) Dependence of 
spiking fidelity on stimulation frequency. 
5.9 Summary & Conclusions 
The utility of ChR2 for retina prosthesis application was limited by the lack of a light source 
that can generate two-dimensional stimulation patterns with micrometer (<20m) and 
millisecond (<1ms) resolutions and with sufficient radiance (>50mW·mm-2 sr-1) to induce 
action potentials in neurons. This chapter proposed a solution based on a custom fabricated 
64x64 matrix of GaN micro-LEDs. Two types of such matrices, a top-emission and a bottom-
emission, were characterized and it was shown that bottom-emission device has sufficient 
emission radiance (>200mW·mm-2 sr-1) at wavelength overlapping with the action spectrum of 
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ChR2 (peak emission at 465nm). Its emission is stable (changed by less than 3% i.e. 0.03 
mW/mm
2
 during almost one hour of continuous illumination) and has <20% variability 
across the 4096 emitters. It has a turn-on voltage of 2.7V and emission efficiency, i.e. electric-
to-light power conversion, of ~0.2% at operation voltage of 7V.  
In order to confirm the capacity of the matrix to trigger ChR2-evoked spiking in-vitro, a 
microscope based test platform was made. The test platform included an optics configuration 
which images the micro-emitters on the neurons. It generated on-sample micro-spots with 
diameter of 30m and 3m in case of 1:1 and 10:1 imaging, respectively and maximum 
irradiance of ~2mW/mm2 (1:1 imaging) and ~200mW/mm2 (10:1 imaging). Finally, the 
capacity to photostimulate ChR2-evoked spiking was demonstrated in blind retina in which the 








Chapter Six: Matrix Photostimulation Technique 
6.1 Introduction 
In the previous chapter a light module for the ChR2-based retinal prosthesis was developed. 
The light module was based on a 64x64 matrix of individually addressed micro-emitters. This 
chapter exploits the potential utility of this photonic matrix for dendritic tree and network-
level neuroscience experimentations. First, the scientific need for such an experimentation tool 
is discussed. Then a technique based on the photonic matrix is described. Next, the capacity to 
excite individual neural compartments is demonstrated and an example use of the technique to 
map dendrites conductivity in ChR2 expressing neurons is shown. Finally, future applications 
for un-caging photostimulation using UV emitting micro-array are shown. 
Experiments with precise dendritic excitation, like the one shown in Figure ‎6.1 (right), 
can preserve physiological information flow from synapse to soma to axon and is useful for 
studies of sub-cellular signalling integration rules (248), spike-timing-dependent plasticity (249) 
and back-propagating action potential effects (250). Similarly, coordinating activity in large 
scale neural networks with single neuron resolution, like the one shown in Figure ‎6.1 (left), is 
useful for examining neural dynamics investigations (251) and for studying irregularities in 
coordinated interactions which is associated with number of pathological brain states, such as 
schizophrenia, epilepsy, and other neuronal disorders (252). 
At present, two-dimensional neural stimulation experiments are based on 
microelectrode array (MEA) technology, first suggested by Thomas et al. in  1972 (253). 





Figure ‎6.1 Notion for Network-Level and Sub-Cellular Two-Dimensional Stimulation. Left: Example of 
neural network experiment scenario. Right: Example of sub-cellular experiment scenario. Red arrows 
represent signalling paths 
networks (254), synaptic plasticity (255), visual perception (256) and effects of pharmacological 
compounds and putative therapeutics (257) has been demonstrated, the spatial resolution of 
the MEA is in effect very limited and does not allow to target individual neurons or sub-
cellular compartments. The limitations of the MEA are due to the fundamental nature of its 
operation: (a) non specific stimulus (b) propagation of the electrical pulse through the solution 
and (c) fixed electrodes locations. As a result, each electrode targets all the neurons in its 
vicinity (a diameter of approximately 200m) (258). In addition to its spatial limitations, the 
MEA technique has an inherent short ―dead‖ time between the stimulation pulse and the start 
of the recording and has no practical ability to inhibit action potentials. 
The recent development of photostimulation technology offers new opportunities for 
superior stimulation performances. The light stimuli do not interfere with conventional 
recording techniques (236) and can be focused to sub-micrometer excitation spots (235).  
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Moreover, ChR2 and NpHR provide powerful tool for bidirectional control of neural 
activities. In principle, two-dimensional photostimulation can be achieved by controlling either 
the localization of the protein expression or the pattern of the light stimulus. Under full-field 
illumination, genetic targeting tools have been used to localize membrane potential changes to 
specific cell classes or compartment types. Aravanis et al. (234) used CaMKII promoter to 
stimulate specifically excitatory hippocampal neurons, while Patreanu et al. (151) for example 
used contralateral projections of ChR2 expressing cortical neurons from layer (L) 2/3 of the 
somatosensory cortex to map postsynaptic circuitry in mice. In addition, a specific cell type can 
be targeted as well developmentally. For example, using in-utero electroporation, Patreanu et al. 
(151) succeeded to target specific cortical layers. Genetic techniques have been used as well for 
sub-cellular localization of ChR2 expression. For example, Gradinaru et al. (236) attached a 
motif involved in NMDA receptor clustering at postsynaptic sites, PDZ-domain binding 
sequence ETQV, to concentrate ChR2s in postsynaptic dendrites. Despite the promising 
future of these genetic targeting tools, they are still limited and do not allow the required 
spatial resolution. Moreover, the universal use of these techniques is essentially limited by the 
availability of cell type promoters or sub-cellular specific markers (236).  
Alternatively, neural networks and cellular structures can be universally targeted by 
localizing the light stimulation. However, (as was discussed in details in previous chapter) the 
high irradiance requirements of the optogenetic technique hamper the use of conventional 
light displays. To-date, patterned light excitations has been achieved by scanning a single high 
power light source such as laser, using fast beam modulators such as acousto-optical deflectors 
or galvanometric devices. This principle has been demonstrated on photolysis of caged-
glutamates in two-dimensional (112) and even three-dimensional (259). Yet, although the 
 148 
148 
point-to-point travelling time of the laser beam can be very fast (tens of microseconds), the 
actual time at each stimulation point is lengthened by the time needed to activate the sufficient 
photocurrent effect (260) and hence it becomes impractical in applications where activation of 
large scale neuronal targets is required or when one has to fill a defined contour. 
In this chapter the potential of the photonic matrix to meet the scientific need and the 
technological gap for precise two-dimensional neural stimulation tool is shown. 
6.2 Materials and Methods 
The applicability of the micro-LED array for multi-site stimulations of neurons expressing 
ChR2 was developed and tested on the same neural model used in previous chapters (i.e. 
primary dissociated culture of rat hippocampal neurons). The evoked responses were recorded 
with a whole-cell current clamp technique. As in previous chapters, the photostimulation 
experiments were carried out by the author in close collaboration with Dr. Matt Grubb from 
Kings College London, who performed the patch clamp recordings. Later, the applicability of 
a UV micro-LED array for un-cage stimulation was tested on coverslips coated with caged-
fluorescein. All micro-LED arrays used in this chapter were made by martin Dawson‘s group 
at the Institute of Photonics at Strathclyde University, Scotland (242) and their electric drivers 
were made by mark Neil‘s group as a result of the RCUK (research councils UK) funded Basic 
Technology project (‗1000 microemitters per square millimetre‘). 
6.2.1 Cell culture and transfection 
Rat hippocampal neurons transfected with fused ChR2-YFP protein were used. The culture 
and transfection procedures are similar to the ones described in chapter 3. 
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6.2.2 Electrophysiology  
The electrophysiological responses were recorded via whole cell patch clamp method, as 
described in previous chapters.  
6.2.3 Caged-Fluorescein 
CMNB-caged fluorescein (Molecular Probes) was dissolved in 100% glycerol (100 mM) in order 
to reduce the diffusion of the molecules. The solution was then spin coated onto plasma 
treated microscope cover slips to produce uniform thin films and kept in dark till the 
photostimulation experiments. 
6.2.4 Photostimulation 
The work presented in this chapter used pixels and striped micro emitters devices. The pixels 
matrix and its driving board were described in details in previous chapter. The striped array 
consists of GaN LED stripes in which each stripe is 17μm wide and 3600μm long, and the 
centre-to-centre spacing are 34μm, giving an overall diode structure size of 3.6×4.08mm2. 
Similar to the pixel emitters, each individual micro-stripe had n-electrode rail alongside a light 
emitting mesa running to a common broad area n-electrode contact and each mesa had an 
individual p-electrode running along its length. A particular stripe was addressed by sourcing a 
constant current to its corresponding p-contact with the common cathode held at ground. The 
micro-stripe array was driven by separate electric circuit made by Dr Vincent Poher from Mark 
Neil‘s group (described in (261)) consisted of 15 common cathode TB62710F drivers 
controlled by a PIC18F4550 microcontroller. The constant current value was set using external 
 150 
150 
digital potentiometers on each driver chip, allowing current values from 3 to 90mA, 
reconfigurable in 1.5μs.  
6.3 Results 
6.3.1 Principles of Matrix Photostimulation  
The matrix photostimulation technique is based on imaging the photonic matrix onto 
photosensitized neurons located at the sample plane of a microscope. The matrix can be 
imaged through the microscope epi or side ports or using separate light module like the one 
described in previous chapter. Using the side port (for example via a C-mount adaptor) the 
microscope integrated tube lens can image the micro-emitters onto the sample, in the same 
way it images the sample onto the microscope camera and hence it does not require additional 
optics or complicated alignments. In this case, the matrix is projected into L/M × W/M (mm2) 
image on the sample, where M is the objective magnification and W and L are the width and 
length of the matrix. 
Epi-illumination is typically based on the Kohler principle (262) in which a collector 
lens (usually in the lamphouse) focuses an image of the lamp filament at the front focal plane 
of a condenser lens (also called field lens) where the aperture diaphragm is positioned. Since 
both the field lens and the diaphragm are typically integrated in the microscope, imaging the 
matrix via the epi-port can require adjustments or removal of internal microscope lenses. 
Using separate optical modules, instead of the microscope objectives, has the advantage that 
the size of the stimulation spots is determined independently of the microscope imaging 
optics. Such a module was described in section ‎5.7. In principle it uses a 4f relay configuration 
with two 50mm triplet lenses (Sill Optics GmbH S5LPJ2851) or with one 50mm triplet lens 
 151 
151 
with a 40X objective 4.5mm focal length (Olympus LUMPlanFI) that image the matrix at 1:1 or 
10:1 magnifications, respectively. 
 
 
Figure ‎6.2 Matrix Photostimulation Concept. The experimental area is covered by an image of a 64x64 
matrix of high-intensity micro-light spots. The intensity and temporal pattern of each light spot is 
individually controlled. 
The matrix forms stimulation ―squares‖ of 0.3x0.3mm (10:1 imaging) or 3x3mm (1:1 
imaging) on the neurons. The squares are effectively divided into 4096 micro stimulation 
pixels. Since each pixel acts as an independent stimulation source, the matrix enables to 
simultaneously stimulate arbitrary combination of neuronal locations in a way that each 
location receives unique light irradiance and pulsing pattern. Figure ‎6.2 shows a generation of 




Figure ‎6.3 Cell Coverage. (A) A brightfield image of micro-LEDs projected onto neural sample using 
the 1:1 optic configuration. (B) An overlay image of the micro-LEDs projected using the 10:1 
configuration. Inset: zoomed view. The overlay is a combination of a brightfield micro-LEDs 
illumination and a fluorescence imaging of the YFP tag expressed in the neurons with the ChR2. 
The spatial coverage of the matrix is limited by the inter-spot spacing. An example of cellular 
coverage is shown in Figure ‎6.3. The 1:1 imaging module generates a matrix of spots on the 
cells, in which the spot size and centre-to-centre spacing are 30m and 50m, respectively. 
This coverage can be ideal for large scale dispersed neuron network. On the other hand, the 
10:1 imaging module generates a matrix of spots with a ―dead‖ inter-spot size of only ~2m 
which can be ideal for sub-cellular stimulation. The size of the spot on the sample is 3m and 
the centre-to-centre spacing is 5m. 
6.3.2 Demonstration of Sub-Cellular Stimulations 
In the first proof-of-concept experiments an early version of the micro-emissive device 
consisting of linear stripes instead of pixels LEDs was used. The stripe emitters were 7μm wide 
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and 3600μm long, and had centre-to-centre spacing of 34μm (see Materials and Methods for 
further details). The stripe array was imaged on YFP-ChR2 expressing hippocampal neuron 
using the 1:1 imaging configuration. The stripe LED array was driven using currents between 5 
and 30mA, resulting in on-the-sample irradiances between 50 and 300W/mm2. When the 
stripe was centered on the soma, it was sufficient to generate action potential Figure ‎6.4 (left). 
In contrast, when the stripe illuminating the soma was turned off and the adjacent stripes 
illuminating the axon and dendrites were turned on Figure ‎6.4 (right), no action potentials were 
induced.  
 
Figure ‎6.4 First Sub-Cellular Stimulation Using Striped micro-LEDs. Hippocampal neuron expressing 
ChR2-YFP illuminated by 10Hz train of 10ms light pulses overlaid with the depolarization responses 
(white). Experiments were carried out with Dr. Matt Grubb, who performed the patch clamp 
recordings. 
Later, the pixel matrix device, described in previous chapter, was used. Representative 
results are shown in Figure ‎6.5A&B. Experiments were performed to see if the photonic 
matrix can generate sufficient dendritic currents that can be used in a single neuron 





Figure ‎6.5 Dendritic Excitation Using Matrix micro-LEDs. (A) Illumination (1:1) of three proximal 
dendrites and cell soma of ChR2 expressing hippocampal neuron. (B) Currents evoked by 10ms of 
1mW/mm
2
 illuminations. (C) ChR2 evoked input currents were synchronized to maximize spiking 
output. Scale bar is 30m.  
configuration and its location was adjusted so that a single spot was centred on the soma of a 
ChR2-YFP encoded neuron. Then the central spot and the spots adjacent to the central one, 
see Figure ‎6.5A, were turned on one-by-one for 10ms (1mw/mm2) and their 
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electrophysiological responses were recorded with a whole-cell voltage clamp at -70mV using 
0pA holding currents. The results, shown in Figure ‎6.5B indicated that notable currents of up 
to 60pA were stimulated by illuminating the dendrites 
Next, experiments were performed to determine if the neuron can integrate these 
dendritic inputs with the larger somatic currents. For that reason, the soma and one proximal 
dendrite were illuminated, first separately and then synchronously, with short trains of 10ms 
(1mW/mm2) light pulses repeated at 10Hz and recorded the neuronal depolarization responses 
using a whole cell current clamp (recorded by Dr Matt Grub, Kings College London). The 
results presented in Figure ‎6.5C show that the currents evoked in the soma were sufficient to 
generate only the initial action potential and was not sufficient to sustain further spiking. In 
contrast, when the somatic stimulation was synchronized with the dendritic one it was 
sufficient to sustain a complete spike train. This simple experiment illustrates in fact the 
capacity of the neuron to integrate-and-fire from multiple compartments as was first suggested 
by Lapicque (199). 
6.3.3 Mapping of Dendrites Conductivity  
In the previous section the capacity of the photonic matrix to stimulate a sub-cellular 
compartment was demonstrated. Here, a potential utility of this capacity is shown. Dendrites 
in the central neurons blend together thousands of synaptic inputs to form coherent somatic 
inputs (251, 263, 264). The passive conductivity of the dendrites can determine the efficacy 
with which individual synaptic events influence action potential generation and can affect how 
multiple synaptic events interact spatially and temporally (252). In hippocampal neurons 
dendritic losses could lead to up-to 100 fold attenuation of the initial synaptic response (265). 
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This section demonstrates the use of the photonic matrix to fast probe variation in the 
conductance of proximal dendrites.  
It is based on measuring the relative percentage of dendrite photocurrent which 
reaches the soma. The photonic matrix was used to excite local photocurrents at three 
proximal dendrites of hippocampal neurons expressing ChR2, Figure ‎6.6A. All the stimulation 
points were located 35m ±2m from the soma. The photocurrent responses, shown in 
Figure ‎6.6A (right panel), were recorded with a whole cell patch clamp (at holding potentials of 
-60mV). Illumination of the dendritic locations D1, D2 and D3 resulted in 46±5pA, 62±7pA 
and 15±4pA currents at the soma, respectively (n=3). In comparison, a direct illumination of 
the soma (S) induced 160 ±47pA somatic current (i.e. D1, D2 and D3 yielded 29±3.3%, 
39±4.2% and 9.8±2.6% of S). 
Patch clamp recordings at multiple dendritic sites is a highly complicated task. 
Nevertheless, the relative magnitudes of these photocurrents can be estimated since 
photocurrent response at a dendritic site is a function of the light irradiance, the illuminated 
area and the density of ChR2 at this location. Thus, if the light irradiance and the ChR2 density 
conditions were alike, the magnitudes of the photocurrents are directly proportion to the 
corresponding cellular area that was illuminated. 
The fluorescence intensity from the ChR2-atatched YFP fluorophores was used to 
analyze the local expression level. The results are shown in Figure ‎6.6C (top panel). The linear 
relation between the level of fluorescence and the cell area indicates that ChR2 density was 
similar in those locations. The irradiance of the spots had similar profile (full characterization 
was presented in previous chapter). In order to confirm that the irradiance was not unevenly 




Figure ‎6.6 Mapping Dendrites Conductivity. (A) Left: Illumination of three individual dendrites and the 
soma of a hippocampal neuron expressing ChR2-YFP. Right: Corresponding photocurrents induced by 
10ms 1mW/mm2 stimulation. Patch clamp recordings were done by Dr Matt Grubb (Kings College 
London). (B) Illustration of the neuron (182) with the stimulation locations (red) and the dendrites 
branching (green) highlighted. (C) Top: Local fluorescence from the ChR2-YFP. Bottom: Intensity of the 
Local stimuli. In both cases plotted against the corresponding cellular area of stimulation. (D) Relative 
dendritic conductance, expressed as the percentage of photocurrents that arrived to soma. 
The results are shown in Figure ‎6.6C (lower panel). The linear relation between the total optic 
power and the illuminated area indicates that the cell compartments were excited with similar 
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irradiance. And hence, the magnitudes of the photocurrents at the dendritic sites were 
proportional to the illuminated areas. 
In this case, the ratio between the somatically recorded current and the corresponding 
area of dendrite that was stimulated depends on the relative efficiency by which the dendritic 
segment conducted the signal. Since photocurrents induced in the soma were recorded directly, 
i.e. no loss is expected between stimulated current and recorded one, it is useful to normalize 
the current-to-area values to the somatic one. The normalized values are shown in Figure 
‎6.6D. It implies that only part of the photocurrents that were generated in the proximal 
dendrites actually arrived to the soma and that the level of attenuation varied between the 
dendrites. In this case, 38%, 64% and 28% of the photocurrents that originated in locations 
D1, D2 and D3 were lost before reaching the soma, respectively. 
A study reported by Rinzel and Rall (266) showed that ―injected‖ charges can be largely 
dissipated in dendritic branching since in each branch a portion of the charge is spread into 
other dendritic segments. Hence, it is possible that the difference in conductivity observed in 
this experiment was due to the different level of dendrite branching. The branching locations 
are highlighted in Figure ‎6.6B. It shows that photocurrents that were generated in D2 had to 
propagate through 7 branching points, in comparison to 3 and 2 branching points at dendrite 
D1 and D3, respectively. It should be noted that although the results imply the level of 
attenuation proportional to the number of branches, a large branch point might attenuate 
more than a certain number of small branch points (it all depends on the relative ratios of the 
daughter branch diameters). 
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6.3.4 Potential for Patterned Photolysis Experiments 
The photostimulation technology that was used in this thesis was based on ChR2. 
Nevertheless,  as was stated in chapter 2, photolysis of caged neurotransmitters is another 
widely used technique to trigger changes in the membrane potential of neurons (102). In this 
section the potential use of the micro-emitters to two-dimensional photolysis of caged 
compounds is demonstrated on CMNB-caged fluorescein. Fluorescein is a widely used 
fluorophore due to its large cross-section and strong fluorescent signal. In its caged form, the 
fluorescein is attached to a compound 5-carboxymethoxy-2-nitrobenzyl that hinders its 
fluorescence. Target photolysis of the CMNB-fluorescein has been extensively used in cell 
imaging and microfluidics measurements (267, 268).  
The σ-bond attaching the blocking agent and the neurotransmitter can be cleaved only 
with UV light. Thus an array of micro-LED emitting 370nm light was used. Since no pixel 
version was available at that stage of the project, an early version of stripes array was used. 
Figure ‎6.7 shows an image of a stripe array together with its characteristics such as emission 
profile, emission spectra and emission power.  
First, since the caging ligands have peak sensitivity at 330 nm (3.8 eV) and the micro-
LEDs emit at 370 nm (3.4 eV) the photolysis efficiency at 370nm was initially tested. A caged-
fluorescein solution was placed in a spectrofluorometer (Shimadzu RF-5301PC) and its 
fluorescence signal under 470nm excitation was recorded before and after 370nm illumination. 
The results are shown in Figure ‎6.8. It revealed a 4-fold increase in the fluorescence signal after 





Figure ‎6.7 Characteristics of Striped micro-LEDs array. (A) An image of a 120 micro-stripes array. (B) 
Color-map image of an emission distribution along a single stripe. (C) Output power vs. driving 





Figure ‎6.8 Photolysis of Caged-Fluorescein with 370nm Light.  Fluorescence spectra of fluorescein in 
glycerol under 470nm excitation before (lower trace/black) and after 370nm illumination (upper 
trace/red). 
Next, the capacity of the micro-strip array to generate two-dimensional photolysis pattern was 
tested. The micro-stripe array was placed in a critical illumination in an Olympus BX41 upright 
microscope and the light from the array was collected using a standard Olympus 180mm tube 
lens and a ×20, 0.5 NA UPlanFl Olympus objective. A 470nm Luxeon® V LED was placed in 
Kolher illumination to excite the fluorescence from uncaged molecules and coupled into the 
microscope using a 50/50 beam splitter. Uncaging light was projected onto the sample using a 
UV Olympus dichroic and the fluorescence from the sample was observed using a separate 
standard blue fluorescence filter cube. A schematic of the setup that was used to image the 





Figure ‎6.9 Patterned Photolysis Experimental Setup. 
A random excitation pattern was imaged on a sheet of caged-fluorescein. Then the 
filter cube was switched from UV to blue and the fluorescence light was imaged onto a CCD 
camera (Orca ER). The UV diode elements were driven at 5mA under 10V maximum forward 
voltage, resulting in an average power of 34nW per emitter on the sample. A representative 
result is shown in Figure ‎6.10. It demonstrates that micro-LED array can be used to induce 
two-dimensional un-caging pattern with few micrometer resolution. The light spot stripe had a 
width of 1μm and it induced an uncaged pattern of ∼5μm width. The broadening of the stripe 





Figure ‎6.10 Generation of Two-Dimensional micro Photolysis Pattern.  Left: Image of stimulation 
pattern, i.e. display from the UV micro-LED array. Right: The resulted photolysis pattern on a caged-
fluorescein sheet (100nJ optic power were used in this case, corresponding to 5s of illumination). 
The UV micro-stripe LED array chip used in the experiment was a prototype device 
and therefore still had some non-uniformity in the emission. The stripes appeared brighter 
near their connection end and gradually dimmer away from it, Figure ‎6.7B. This is a result of 
the increasing series resistance along the diode contacts. 
6.4 Summary and Conclusions  
This chapter exploited the micro-LEDs matrix, originally developed for the retinal prosthesis, 
for in-vitro sub-cellular neuroscience experimentations. It was shown that the matrix can be 
coupled to any microscope through the side ports or via independent optics setup. The image 
of the matrix generates two-dimensional pattern of micro light spots. Each acts as independent 
micro-stimulator that has sufficient irradiance to trigger ChR2-evoked depolarization and 
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action potentials in neurons. A sub-cellular stimulation was demonstrated and an example of a 
potential utility to probe variation in dendrite conductance was given.  
Finally, potential application for photolysis of caged-neurotransmitters technology was 
demonstrated by generating micro photolysis of CMNB-caged fluorescein. Since 
photoactivation of caged neurotransmitters such as caged-glutamate requires less optical power 








Chapter Seven: Summary and Future Work 
There is an urgent need for rehabilitation solutions for patients suffering from degenerated 
retina diseases such as retinitis pigmentosa. During the last decades there have been immense 
efforts worldwide to develop retinal prosthesis solution for these patients. A retinal prosthesis 
is a device that images the physical environment, transduces the information into an artificial 
stimulus and delivers the artificial stimulus to evoke a visual perception called phosphenes. 
Prosthetic vision simulations showed that blind patients will be able to regain some basic 
reading and orientation abilities with a minimum of a thousand phosphenes, i.e. independent 
stimulation points (see the discussion in section ‎1.3). 
Thus far efforts were based on implantations of microelectrode arrays primarily in the 
epiretinal or the subretinal domains. However, current retinal implant devices have up-to 60-
electrode resolution and it is becoming apparent that the thousand-electrode target is unlikely 
to be fulfilled in the near future (section ‎1.4.5). Thus the ability of these devices to restore 
sufficient vision that will offer considerable improvement in the quality of life of patients is 
uncertain.  
This thesis examined the possibility for a new type of retinal prosthesis that uses light 
instead of electricity to trigger neuronal signaling. The notion for light based retinal prosthesis 
came from the recent emergence of new technological possibilities that includes Melanopsin 
(Opn4), Channelrhodopsin-2 (ChR2) and light-activated K+ channel (SPARK). The 
applicability of these technologies for retinal prosthesis was analyzed (section ‎2.2.5) and it was 
concluded that at present, the microbial ChR2 has the highest potential to fulfill the 
requirements for prosthetic vision.  
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Chapter 2 (sections ‎2.3‎2.4 and ‎2.4) presented a conceptual design for a retinal prosthesis device 
that is based on an ectopic expression of ChR2. Chapter 3 and chapter 4 analyzed the process 
of stimulating neurons with ChR2 and provided guidelines for illumination strategies. Chapter 
5 described the development of a stimulation prototype and demonstrated its functionality in-
vitro. Chapter 6, showed the potential utility of the stimulation prototype for sub-cellular and 
network-level neuroscience experimentations. The major outcomes of this thesis are discussed 
below. 
Characteristics of ChR2 Stimulation 
In the first part of the analysis of ChR2 stimulation, the conversion of light into photocurrent 
under constant membrane potential conditions was examined. The characteristics of the 
photocurrents and their dependencies on the light parameters were deduced and modeled. It 
was shown that at low irradiances, the photocurrent responses increase linearly with irradiance 
and that the response has a half saturation constant of 10mW/mm2 (Figure ‎3.3). It was argued 
that the saturation occurs at the point in which the photon density is equal to the maximum 
possible density of ChR2 (determined by the molecule dimensions), and that it does not 
depend on the cell type or the actual number of ChR2s expressed. The study showed as well 
that there is an intrinsic ~1ms delay in the photocurrent response (evident in Figure ‎3.7A), 
which is a result of the stochastic nature of ChR2 opening. In addition, the dependency of the 
peak-to-plateau dynamics was analyzed and it was shown that at high irradiances, the 
plateau/peak ratio is smaller (Figure ‎3.3C) and the steady state is reached faster (Figure ‎3.2B). 
Finally, it was shown that when the light is turned off, the photocurrents decay with two 
distinguished time constants which points to the existence of (at list) two separate open states 




Following the detailed characterization of the photocurrents, it was demonstrated that their 
dynamics can be represented by a four-state model consisting of two interconnected braches 
of open and closed states. It was shown, that using this model the stationary and steady state 
stages of the currents as well as the transitional stages can be successfully reproduced. This 
encouraging result does not discourage the merit of previously suggested three-state models 
such as Nagel et al. (147) Bamann et al. (193) Ernst et al. (192) and Ritter et al. (191). On the 
contrary, three-state models have the advantage that they comprised of smaller parameter-
space and hence can be very useful for fast, rough reproduction of the photocurrents. 
In the second part of the study the process in which ChR2 photocurrents induce action 
potentials in neurons was examined. It was demonstrated that using continuous illumination 
approach, the mean spiking rate can be reliably controlled by changing the light irradiances 
(Figure ‎4.3A&B). It was suggested that in this stimulation mode, ChR2 has an advantage since 
it introduces less interference (because it is a passive conductor) to the action potential 
oscillation once it was ignited (Figure ‎4.3C). The disadvantage of using a continuous stimulus 
is that the timing of individual spikes is not accurate. Thus, a pulse stimulation strategy was 
demonstrated in which individual spikes can be precisely timed (Figure ‎4.4A). Nevertheless, it 
appears that the maximum frequency in which pulse stimulation can be reliably applied is 
limited (Figure ‎4.4B). It was found that the high frequency boundary is because of a 
continuous drop in ChR2-depolarization efficiency (Figure ‎4.6) that is due to a frequency-
independent desensitization process of ChR2 (Figure ‎4.7) and due to a slow photocurrent 




Illumination Strategy for Retinal Prosthesis 
The level in which the underlying mechanisms (summarized above) limit the ChR2-spiking 
process depends on the irradiance (Figure ‎4.11A) and duration (Figure ‎4.11B) of the light 
input. In principle, using short pulses with almost saturating irradiances has the highest fidelity. 
However, it was shown that at high expression level condition, high irradiances can lead to 
photocurrents levels that destroy the susceptibility of the cell to maintain the spiking oscillation 
(Figure ‎4.12A).  
Alternatively, illuminating with threshold irradiances has the advantage that it involves 
smaller drop in ChR2-depolarization along the spikes train due to (a) less desensitization 
(plateau/peak ration is almost 20% higher Figure ‎3.3C) and (b) faster closing (smaller 
contribution of the slow decay process Figure ‎3.7E). Nevertheless, threshold irradiances 
require longer pulses (in fact, under 1mW/mm2 the photocurrent peak occurs only after 
~15ms (Figure ‎3.7A), which can limit the temporal resolution of the stimulation, as was shown 
in Figure ‎4.11.  
ChR2-Evoked Depolarization has an Intrinsic Negative Feedback Mechanism 
In analogy to electronics, the ChR2-neuron system is a light-controlled voltage-dependent 
current driver (ChR2) that is coupled to a dynamic-threshold voltage-oscillator (neuron). In 
contrary to the traditional electric stimulation, ChR2 is a passive conductor, which results in an 
integrated negative feedback mechanism. In other words, ChR2 is sensitive to the neural 
system it drives. The negative feedback has disadvantage in the initiation of action potentials 
since it degrades the photocurrents. However, once the action potential is initiated, it enables 
relatively low interference of the stimuli with the native ion channels and thus helps to 
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maintain low spiking thresholds and large spikes (Figure ‎4.3C). In principle, this feature makes 
ChR2 stimulus more natural to the neuronal cell since it resembles the overall depolarization 
pattern that arrives from the synapses. 
Comparison between Somatic and Whole-cell Stimulation  
Although this thesis investigated somatic illumination, the insights on the dynamics of ChR2-
evoke spiking that was presented are generic and apply as well to whole-cell illumination. 
Nevertheless, secondary processes may play a role in whole-cell stimulation. In neurons with 
an extended dendritic tree, a significant portion of the current that is injected to the soma 
flows to the dendrites due to a potential difference between the two cell compartments. The 
soma-to-dendrites currents effectively, lower the input resistance of the soma and thus speed 
the build-up and decay times of the somatic voltages (208). Thus, in whole-cell illumination, 
less current can flow from the soma to the dendrites which can increase the effective input 
resistance and thus will slow the build-up and decay of the somatic voltages. In addition, since 
the dendrites have typically larger time constants than the somas (due to larger capacitance) 
(269), post-spike photocurrents can propagate passively from the dendrites to the soma and 
enhance the after-depolarization. Indeed, the fact that whole-cell illumination can lead to larger 
after depolarization was recently reported by Schoenenberger et al. (235). The large after-
depolarization can reduce the driving force across the somatic ChR2s and even induce 
secondary spikes that destroy the stimulus-response coupling, as was shown in this thesis. 
In addition, dendritic photocurrents can affect the functional state of the dendritic 
voltage-dependent ion channels that play a role in conductance of action potentials that are 
back-propagated from the soma (250) or generated in the dendritic sites (270, 271). 
Furthermore, axonal photocurrents can induce sub-threshold depolarization that can 
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potentially modulate and stimulate neurotransmitter release (272, 273). In recent study, Zhang 
et al. (152) used axonal photocurrents to trigger presynaptic release of neurotransmitters that 
was sufficient to induce postsynaptic plasticity. In addition, post-spike ChR2-depolarization 
might induce short term plasticity by leaving residual Ca2+ (by prolonged activation of the 
voltage-depended Ca2+ channels) at the presynaptic terminal, the so-called residual Ca2+ 
hypothesis (273, 274).  
The level in which ChR2 photocurrents interfere with the dendritic and/or axonal 
functionalities will vary significantly between cells (depending on the actual ion channel 
composition in the dendrites and the axon terminals). Nevertheless, it will be important to 
explore these phenomena experimentally and theoretically. Future theoretical investigations 
will require upgrading of the two-compartment model that was presented in this thesis to a 
more detailed multi-compartment representation of the neurons.  
Development of Optic Hardware for Retinal Prosthesis 
The utility of ChR2 for retina prosthesis application was limited by the lack of an appropriate 
light source that is capable to generate two-dimensional stimulation patterns with micrometer 
and millisecond resolutions and with sufficient intensity to induce ChR2-evoke spiking in 
neurons. In chapter 5 a technological solution that is based on a custom fabricated matrix of 
GaN micro-LEDs was presented. The matrix was characterized and developed for in-vitro 
proof-of-concept experiments. The functionality of the matrix was then proven on retina of 
blind mice with RGCs expressing ChR2. 
The micro-emitters matrix used in this thesis utilized a matrix addressing scheme 
whereby each column of emitters has a common cathode and each row of emitters has a 
common anode. The disadvantage of this driving scheme is that activation of multiple rows 
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can lead to cross-talks (i.e. activation of non desired LEDs). This can be avoided by raster 
scanning between the required lines, but this reduces the output power of each LED by the 
number of activated rows. The solution for that is to use a CMOS driving chip that is flip-chip 
bonded to the emitters matrix, as was recently demonstrated by Rae et al. (275). In this way, 
each micro-emitter has a dedicated driver and hence cross-talks are avoided. Moreover, a 
replacement of the current PCB based driving electronics with a CMOS chip will be useful for 
the realization of a head-mount device.  
In a head-mount device, the amount of micro-LEDs that can be simultaneously lighted 
will probably be limited by the power requirement considerations. The current micro-LEDs 
operate at 4-8V with a single emitter current of 5mA, i.e. 20-40mW per micro emitter. Hence, 
it is expected that the maximal number of micro-LEDs that can be simultaneously opened will 
be around 250 (corresponding to total power consumption of 5W-10W). The current in this 
case will be ~1A, which is feasible with conventional portable batteries such as the Denecke 
Single Channel PS-1A. 
Development of a Tool for Two-Dimensional Photostimulation Experiments 
A precise stimulation of multiple cellular locations or multiple neurons has been a long lasting 
desire of the neuroscience community. Traditional electrical stimulation is limited by the size 
of the conductive electrodes and inability to confine the stimulation field. In chapter 6 the 
potential of the micro-LEDs matrix, originally developed for the retinal prosthesis, to facilitate 
such stimulation experiments was shown. The matrix photostimulation is a simple technique 
that can have immediate high impact applications in modulating the activity of sub-cellular 
compartments, mapping neuronal networks and studying synchrony and plasticity effects. 
Recently, two alternative techniques that are based on Liquid-crystal spatial light modulators 
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(LC-SLM) (260, 276) technology or Digital mirror devices (DMD) (170) were suggested for 
two-dimensional photostimulation. The advantages and disadvantages of each approach are 
discussed below.  
LC-SLMs can modulate the wave front (phase) of a laser beam by displaying a Fourier 
transform of the required illumination pattern. Their use for a single photon (260) and a two-
photon (276) pattern photolysis of caged-glutamate was recently demonstrated. This approach 
has several advantages: it has capacity for spot shaping, two-photon excitation and even limited 
axial control. Nevertheless, its temporal resolution is fundamentally limited by the slow 
(>10ms) reorientation time of the liquid crystals and by the calculation time of the Fourier 
planes (typically requires several iterations). As such, it can be difficult to generate individual 
spike patterns for individual locations. In addition, light features generated by LC-SLM 
technique can have high irradiance heterogeneity (up to 50%). 
DMDs (277) use micromirrors that can be switched at higher frequencies. Its use for 
pattern photostimulation was recently demonstrated on light-activated ionotropic glutamate 
receptors (278) and was suggested for ChR2 (170). Nowadays, research versions of DMD 
which allow for better control than proprietary systems have become available. Nevertheless, a 
key drawback of the DMD devices is that a large fraction of light power is always lost since the 
patterning is created by redirecting unwanted light out of the excitation field. In addition, the 
maximum power which can be transmitted through them may be limited as absorption will 
cause local heating and melting of the mirror. In the longer term, this may be an important 
issue for scalability to in vivo applications since it will require higher power.   
In comparison, the micro-LEDs matrix is a multi-light source device and hence 
fundamentally different from LC-SLM and DMD that modulate the light of a single beam. It 
has the advantage that individual light pixels can operate independently with nanoseconds 
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resolution (279). However, the matrix technique has inherently limiting fill factor. The on-
sample illumination of the 1:1 setup has 20 m dim distance between spots and a low fill 
factor of ~16%. This will limit the choice of neuronal targets which can be critical in some 
neural network experiments such as circuit mapping. In the case of the 10:1 imaging a much 
reduced, 2m dim distance between spots can be used.  However the limiting factor in this 
case is the small field of illumination (0.3x0.3mm2). GaN LEDs can be fabricated down to 10 
μm and less and can be fabricated in hexagonal grid structure to increase the fill factor. 
However, the present technological limiting factor is the bonding process to the chip, which 
limits the interconnections to between 50 and 100 μm pitches. The fill factor of the 
illumination can be improved by integrating array of micro-lenses on top of the micro-LEDs 
that collimate the light (280).  The photonic matrix has a clear advantage in neuroprostheses 
applications since it is practically a single compact chip device.  
Overall this thesis demonstrated the notion of using the photostimulation technology 
for retinal prosthesis application, in which conventional technologies fail to provide tangible 
solution. Although this thesis focused primarily on ChR2, future photogenetic prostheses will 
benefit from the fast growing arsenal of photosensitizers. It is not difficult to foresee the 
appearance of faster melanopsin or better conductive ChR2, perhaps even with a red-shifted 
light sensitivity. In addition this thesis provided the emerging optogenetic technology with a 
detailed analysis of its temporal resolution and a tool to expand its spatial resolution, which can 
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